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Heterogeneity, whether from polydispersity within the polymeric scaffold or due 
to a broad distribution of covalently conjugated products, is a remaining challenge in 
theranostics. Chapter 1 of this thesis presents the challenges conjugate heterogeneity 
introduces to synthesis, characterization, and application of multivalent conjugates. A 
brief review of recent literature approaches to address sample heterogeneity is also 
provided. Chapter 2 highlights the heterogeneity of the scaffold of interest, 
poly(amidoamine) dendrimer. It was found that the mass range of commercial polymer 
was ~1.4-115 kDa, and that skeletal defects in the dendrimer structure occur at a rate of 
8-15%. Methods to isolate dendrimer monomers with decreased polydispersity are 
introduced. Chapter 3 of this thesis presents the first application of these monomers as 
soft superatoms for the assembly of new, precise nanostructures. New chromatography 
strategies to obtain ligand-dendrimer conjugates with precise ratios are introduced, and 
these conjugates are employed as building blocks for novel megamers. In Chapter 4, 
dendrimers with precise numbers of ring-strain promoted click ligands are clicked to folic 
acid-azide derivatives to synthesize dendrimer-folic acid conjugates with narrow ligand-
to-dendrimer ratio distributions. These materials are evaluated for binding to a folate 
binding protein, and the results used to interpret the mechanism of increased binding of 
these conjugates compared to free folic acid. Mathematical models were developed to 
differentiate between three proposed mechanisms, and it was determined that the 
observed increase in avidity is due to nonspecific interactions between the polymer 
scaffold and protein, which are initiated by a specific interaction between folic acid and 
the protein. Chapter 5 examines the impact of scaffold size, ligand-to-scaffold linking 
systems, and conjugate valency on the activity of dendrimer-methotrexate conjugates. 
The larger mass and diameter of dimer impurities contributed significantly to observed 
activity of these and previous conjugates. The weaker methotrexate-folate binding protein 
interaction was not strong enough to key the nonspecific interactions until higher 
valencies in larger conjugates. The final chapter provides conclusions as to how this 
xxii 
 
thesis impacts the current field of multivalent conjugates for targeted drug delivery, and 
gives some insight to where the field must continue to grow. 
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Figure 1.1.  Theranostic consisting of targeting agents, drugs, 
and imaging agents to a polymer scaffold with many 
functional groups, which may be at the terminal ends of the 




Multivalent Polymers for Drug Delivery and Imaging Agents:  
the challenges of conjugation 
This chapter is written as a review article for Biomacromolecules. 
 
The promise of multifunctional polymer scaffolds for therapeutics and diagnostics 
Conjugation of polymer scaffolds with multiple copies of targeting ligands, drugs, and 
dyes has become a popular approach for achieving the aim of “theranostics”; materials 
useful for both diagnosis and 
treatment of disease (Figure 
1.1).[1-3] Such materials may 
include enhanced targeting via 
multivalent binding and optimal 
impact at the target via delivery 
of a multidrug payload.   In this 
manner, researchers hope to 
improve a drug’s therapeutic 
index.[4-7]  This critical review 
examines work to date addressing 
challenges common to all 
multivalent polymer-based 
efforts: heterogeneity introduced 
by conjugation strategies.  First, 
the source of conjugation 
heterogeneity will be examined, 
and some examples will be given of how such heterogeniety is encountered and treated in 
the literature. We will then discuss why heterogeneity is often overlooked and how it can 
impact the behavior of multivalent theranostics. Finally, we will review several 
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interesting approaches from the last ten years to overcome conjugation heterogeneity. 
Scaffold heterogeneity (i.e. polydispersity index of the polymer) is also an important 
consideration for developing well defined, clinically relevant polymer therapeutics. 
Scaffold polydispersity is dependent on both the chemical nature of the polymer 
(common examples being polyamines and polyethylene glycol) and the backbone 
structure (linear, branched, dendritic).  For this review, scaffold heterogeneity will only 
be discussed to the extent it directly impacts conjugation heterogeneity.  
 
Approaches to Forming Conjugates on Multivalent Polymers 
Attachment of multiple copies of targeting ligands enhances binding of the conjugate to 
cells and tissues that overexpress a certain receptor.[8, 9] Active targeting can minimize 
negative side effects in healthy tissues and allow for a higher tolerable dosage of drug. 
High loading of molecular drugs, such as chemotherapeutics like methotrexate[8] or 
antibiotics like vancomycin,[10] onto the polymeric scaffold,[11-13] enables multivalent 
delivery of the drug to the same cell. Commonly, multivalent conjugation of fluorescent 
dyes is performed, either by design or chance, to allow for in vitro and in vivo imaging of 
the polymer conjugate. Two[14-17] or three[18-21] subsequent multivalent modifications 
are performed on the same scaffold to create a multifunctional, targeted, drug delivery 
vehicle that can be tracked by fluorescent microscopy. Coupling reactions are often 
accomplished by one-pot or sequential attachment of the ligands to the scaffold to 
achieve the desired ligand-to-scaffold ratio. The polymer scaffold must have many sites 
available for chemical modification of the desired ligands; for example, 
poly(amidoamine) (PAMAM) dendrimers have (theoretically) 4 to 4000 primary amines 
depending on generation (G1 – G11), available for peptide coupling.[22, 23] For non-
dendritic scaffolds, the number of functionalizable sites varies by formulation, 
architecture (branched, linear), and molecular weight. For example, consider a generic 
case where a multivalent scaffold with a large excess of functional sites conjugated to 4 
targeting ligands, 5 copies of a drug, and an average of 3 molecular dyes as commonly 
represented in the literature by an image such as the conjugate illustrated in Figure 1.1. 
Because each conjugation is a result of a statistical combination between available sites 
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and equivalents of ligand, a Poisson distribution of products is produced (Figure 1.2). In 
the case of attaching 5 targeting agents to the scaffold, approximately 14 unique species 
are produced with targeting ligand-to-scaffold ratios ranging from 0 to 13. Although the 
dendrimer conjugated to 4 targeting agents is the most common species in this theoretical 
conjugation, it only represents approximately one in five (20%) of the sample. To further 
complicate matters, heterogeneity due to stochastic conjugation is cumulative. When the 
targeted vector sample is further reacted with 5 equivalents of a drug, a new distribution 
is created. Again, approximately 15 drug-to-vector ratios are present in this new sample, 
with approximately 9 in 50 (18%) particles having exactly 5 copies of the drug attached. 
However, there are now over 200 unique species present in the sample resulting from the 
product of the first two Poisson distributions. After adding a third entity (3 equivalents of 
dye), there are now approximately 2,500 unique species present in the sample. The single 
entity pictured in Figure 1 illustrates the mean number of each individual distribution (i.e. 
4 targeting agents, 5 drugs, 3 dyes), but it represents just 1 out of every 250 (0.8%) 
particles present.  Although it is the “average” material present, this mean may well not 
be meaningful average in terms of biological behavior for any of the functional 
behaviors; targeting, therapeutic effects, or imaging characteristics.  In addition, for any 
observed function of this material, whether in cell culture or in vivo, a very large 
challenge is presented to understand which fraction(s) of the 2500 species are providing 
the desirable activity.  
Figure 1.2. Distributions resulting from stochastic conjugations with an average of 4, 5, and 3 have a 
cumulative, multiplicative effect on sample heterogeneity.  With each subsequent serial conjugation, 
the resulting set of products is the product of the resulting Poisson distributions. 
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The challenges inherent in these distributions can be further explored by considering 
some of the quantitative aspects. Two percent of the sample contains no targeting entity; 
therefore attached drug will be systemically delivered. One out of every 25 (4%) particles 
has fewer than 2 drugs attached and no longer has the potential for increased activity 
compared to the free drug. One particle in 20 (5%) has no dye on it and is essentially 
“invisible” to further analyses. One particle in 20 also has twice the amount of expected 
dye, and 1 in 100 (1%) particles has three times the average amount of dye, the 
consequences of which will be discussed later. The preceding analysis has not yet 
considered the heterogeneity of the sample resulting from the polymeric scaffold, which 
can vary greatly, or spatial and regioisomers, which can further impact the system.  For 
polymer systems containing substantially restricted motion of the surface groups, spatial 
isomers can rapidly lead to tens of thousands of functionally different isomers from a 
targeting, and possibly therapeutic, standpoint for the simple example illustrated in 
Figure 1.  Size heterogeneity can lead to the presence of the > 2500 species present from 
statistical consideration on materials with remarkably different biodistribution properties.  
For example, although polymers in the 20-30 kDa range are expected to be excreted 
through the kidney, oligomers of 60-100 kDa may instead be trafficked to the liver.  This 
full statistical range of materials for each mass range generates further challenges for 
understanding the origin(s) of both the positive, desired effects as well as origin(s) of the 
negative side-effects.  
 
Analysis of Conjugation Heterogeneity in the Literature 
The above example was a theoretical conjugation; however similar serial conjugations 
are often encountered in the literature. Explicit analysis to determine even averaged 
conjugation numbers are often not reported with product averages assumed from initial 
stoichiometry, further complicating the understanding of the material present. Instead, 
authors give a visual which “represents” the product, or provide a percent loading of 
drugs etc. A theranostic synthesized by Baker et al.[8] of G5 PAMAM covalently 
conjugated to 5 dyes (FITC), 5 targeting ligands (folic acid), and 5 methotrexates showed 
promising in vitro and in vivo activity. Close examination of this conjugate reveals that 
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the three stepwise conjugations result in over 4,000 unique combinations. Only one 
particle in 200 (0.5% of the sample) has 5 copies of each ligand. Additionally, both folic 
acid and methotrexate have two carboxylic acids that can react with the amines of the 
scaffold (one isomer being more active than the other); leading to 14,400 possible 
combinations of generation 5 PAMAM (MN~28 kDa, PDI~1.1, with ~110 functional 
groups) conjugated 5 folic acids and 5 methotrexates. Consequently, less than 1 in 2 
million particles (0.00005%) have the average valency of all three ligands conjugated in 
their most active form. Mullen et al. employed a different approach to generate 
FITC/folic acid conjugated dendrimer system.[24] First, a generation 5 PAMAM was 
conjugated to an average of 1.6 alkyne functionalized click chemistry linkers and 3.5 
folic acids, generating ~117 combinations. A second sample was conjugated to an 
average 2.5 azide click ligands and 3.2 FITC dyes, generating ~140 unique combinations. 
The two samples were then “clicked” together to give a barbell-like dimers with an 
average of 3.5 folic acids and 3.2 dyes. However, around one in five particles of the 
alkyne material, and two particles in 25 (~8%) of the azide material contained zero click 
ligand and was unable to undergo the reaction. Over 80% of both samples contained 
multiple click ligands, allowing for larger-than-dimer structures to form. Of the material 
that does form dimers, ~180 combinations of dyes and targeting agents are still possible, 
of which one in 25 (4%) are still without a dye and 1 in 33 (3%) are untargeted. In 
another example, Minko et al.[20] reported a comparison of three scaffolding systems: a 
bifunctional PEG, a G4 PAMAM (MN~14kDa, PDI~1.1, with ~64 functionalizable 
groups) conjugate, and a liposome. The systems incorporated a luteinizing hormone-
releasing hormone (LHRH) decapeptide as a targeting agent, cyanine Cy5.5 as an 
imaging agent, and paclitaxel, a chemotherapeutic. Equivalents of each molecule added 
or a final average number of conjugates was not reported, however a cartoon of the 
PAMAM conjugate implies that 2 LHRH units, 2 dyes, and 2 drugs were covalently 
attached. However, this single image depicted in the cartoon is just 1 of ~1,500 (0.07%) 
species that would exist in a conjugation with these averages, assuming good mixing 
during the synthetic procedures and a stochastic distribution.  Of these many species, 200 
(13%) would have no dye attached and 200 would not contain a single targeting moiety. 
Consequently, 30 particles (2% of the sample) is both untargeted and “invisible” by 
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fluorescent microscopy, so its in vivo destination remains a mystery. In the bifunctional 
PEG system that was also studied, two modified PEGs were mixed together. In this case, 
only 6 combinations of PEG units are possible (completely unmodified PEG, 3 
monofunctionalized PEGs, and 2 bifunctionalized PEG). However, no single PEG unit 
contains all three entities in this formulation. Holler et al.[25] introduced a particularly 
complex system involving the serial covalent conjugation of a mouse anti-human TfR 
mAB (RVS10) as a targeting moiety, AlexaFluor 680, 2 antisense RNA sequences, and 
PEG to poly(β-L-malic acid) (PLMA) (Mw~50kDa, PDI~1.3, ~435 functionalizable 
carboxylic acids). In this case, the amount of each entity was reported in terms of 
percentage of backbone modified. A brief mathematical analysis reveals that, assuming a 
50 kDa polymer, each polymer unit contains on average only 1 targeting entity, 11 dyes, 
11 copies of each RNA sequence, and around 22 PEGs.  The result is around 20,000 
unique species (without considering another entity incorporated into the backbone at a 
high loading to allow endosomal escape). Seven out of every 20 (35%) of these polymers 
is untargeted. Additionally, there are 600 unique combinations of the two therapeutic 
sequences present. In this discussion of conjugation heterogeneity, spatial isomers 
resulting relative placement of each entity along the polymer background was not 
explicitly considered, and would result in >100,000 species.   
 
Characterizing Sample Heterogeneity 
Heterogeneity in polymer conjugation is often overlooked or underestimated due to the 
difficulty in “seeing” it using traditional characterization tools. Many examples in the 
literature generate an equivalent to the product schematic in Figure 1 via experimental 
values that give an “average” value for the entire sample, such as nuclear magnetic 
resonance or UV/Vis and IR spectroscopies. Although such average values are not 
incorrect, they do not give any information about the distribution of species present. Non-
averaged techniques can also be problematic for characterizing sample distributions due 
to conjugation because of the presence of mass and structural distributions of the 
scaffold.  Dendrimers are often touted as having some of the lowest polydispersity 
indices (PDIs) for a polyvalent scaffold with values reported well less than 1.1. However, 
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G5 PAMAM dendrimers (considered to be highly homogeneous compared to linear or 
branched polymers) have been shown to have branching defects leading to mass ranges 
of ~8,000 Daltons (even after oligomer and trailing defects are removed),[26] compared 
to the molecular weights of the molecular drugs or dyes which are generally under 1000 
Daltons. Therefore, the distribution of molecular weights generated by multivalent 
attachment of such ligands is generally narrower than the mass distribution of the 
polymer scaffold itself (even for a highly monodisperse polymer like a dendrimer). Mass 
spectrometry or size exclusion chromatography are generally incapable of distinguishing 
the unique species.[27, 28] Chromatographic techniques, such as high performance liquid 
chromatography (HPLC), have recently been shown to have the potential to be used to 
visual conjugate distributions of hydrophobic ligands on hydrophilic dendrimers (Figure 
1.3).[27-31] This visualization allows for analyses of the mean and median of 
conjugation, as well as the full distribution of ligands/dendrimer present within a sample. 
In order to enable such an 
analysis, the chromatographic 
methods employed must be 
tailored to resolve the entities (i.e. 
stationary phase selection, mobile 
phase gradient development). 
Such processes can be time 
consuming and are not applicable 
to all scaffold and ligand systems. 
However, at present, these 
approaches offer a powerful 
window into the details of 
conjugate heterogeneity for some 
classes of bioconjugates.  
The previous scenario assumed 
perfectly random statistics, which 
is not necessarily the case for real 
samples where properties such as mass transport, solubility, and cooperativity in binding 
Figure 1.3. HPLC chromatogram of an average conjugate 




may be encountered. Non-ideal conjugations can lead to drastically different samples that 
“appear” the same by various characterization techniques (Figure 1.4). Mullen et al.[28, 
32] examined a scenario where non-optimal reaction conditions created a less reactive 
subpopulation within the parent scaffold.  In the optimized case (Figure 1.4a), a Poisson 
distribution of ligand-to-scaffold ratios is observed, with around 4% of the material 
having no ligands, and around 7% being monofunctional. However, the non-ideal 
distribution generated by the non-ideal conjugation has 4 times as much unfucntionalized 
material, and 10% monofunctionalized material. These two vastly different samples 
would appear the same by NMR spectroscopy, but likely have immensely different 
biological profiles. 
 
Impact of Conjugation Heterogeneity on Multivalent Behavior 
The modes of multivalent binding have been thoroughly reviewed elsewhere.[33, 34] 
Briefly, three mechanisms are generally described to explain the favorable influence of 
multivalency on binding kinetics (Figure 1.5). The first mechanism is effective 
concentration. Attaching multiple copies of a ligand to a single scaffold in essence 
“prepays” the entropic penalty of achieving high local concentrations. This local increase 
Figure 1.4. The distributions of samples  from two actual conjugations with an average of 6.8 ligands-
per-dendrimer scaffold generated by (a) conditions where mass transport was effective and  (b) 
conditions in which ineffective mass transport  hindered the reaction. Adapted from Mullen et al., 
Accounts of Chemical Research, 2012.  
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in concentration is higher than 
the equivalent solution 
concentration containing the 
same amount of free ligand, as 
the scaffold immobilizes the 
ligand in a defined volume 
(Figure 1.5a). Statistical 
rebinding describes the increased 
chance of a reattachment of the 
ligand/target interaction upon 
dissociation of the initial event, 
due to the high local ligand 
concentration (Figure 1.5b). The 
localization of additional ligands 
increases the chances that, upon 
dissociation of the initial 
reaction, the same conjugate will 
rebind to the protein. Both of 
these concentration-dependent 
mechanisms become important when considering sample populations like those in Figure 
1.4. There is a significantly larger population of particles in the non-ideal (Figure 1.4b) 
sample with ligand-to-scaffold ratios over 15 (~20%) as compared to the ideal case 
(Figure 4a, ~7%). This population would have a much greater effective concentration 
than the average sample, which has less than half as many ligands attached. This high 
population will likely decrease the time needed to form a single binding event with a 
target, such as protein on a surface. On the other hand, the non-ideal sample also has 
significantly more unfunctionalized and monofunctional material, which will have 
distinctly different binding behavior as the effective concentration is much lower, and re-
binding events are less favored. The third mechanism, the chelate effect, describes the 
ability of a multivalent conjugate to undergo multiple binding interactions, which can 
increase avidity more than the sum just the sum of the independent interactions. This 
Figure 1.5. Multivalent mechanisms (a) Effective 
concentration increases chances of binding. (b) Statistical 
rebinding is higher for multivalent conjugates if the original 
interaction dissociates. (c) The chelate effect allows for 
multiple interactions through one conjugate 
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mechanism, which is likely the first that comes to mind when discussing multivalency, 
can be achieved by 98% of the blue population in Figure 4, but only 80% of the red 
population. These mechanisms work together, and large differences in behavior as a 
function of sample distributions can be expected. 
Measuring Multivalent Behavior 
Multivalent conjugates are oft touted as having favorable kinetic, thermodynamic, and 
biological activity compared to their monovalent and/or small molecule counterparts. 
This behavior is typically demonstrated by ex vivo and in vitro methodologies that show 
an increase in a desired behavior (i.e. binding, inhibition, toxicity) for the conjugate 
species. Problematically, like many characterization techniques, these methods are often 
“average” techniques that are incapable of measuring separate contributions from 
different species within a sample distribution. Surface plasmon resonance (SPR) 
spectroscopy is employed to measuring the association and dissociation rates of 
multivalent ligand-conjugates being flowed over a surface functionalized with that 
ligand’s receptor.[35, 36] Although each unique binding or dissociation event is 
measured by this sensitive technique, the signal observed is the summation of all 
simultaneous events. Therefore, it is impossible to extract the contribution of each 
individual species to the overall kinetic measurement. A detailed example is provided in 
the next section. Thermodynamic information about multivalent interactions can be 
measured by Isothermal Titration Calorimetry (ITC), which measures the enthalpy and 
stoichiometry of binding in solution.[37] Like in SPR, however, the values obtained are 
averaged across the entire solution. Neither of these techniques can discriminate 
differences in binding affinities, for example, between a bivalent and trivalent interaction 
occurring from separate species within a sample. Instead, the observed measurement is a 
weighted average of all species within the sample. Assays of biological activity, for 
example to measure cellular uptake,[38-40] activity inhibition,[41-44] or cytotoxicity[8] 
of a conjugate are commonly employed to demonstrate clinical advantages of multivalent 
conjugates.  However, such techniques are incapable of identifying the active 
components within a heterogeneous sample.  In addition, for in vivo assays, large 
differences in particle hydrophobicity caused by different total numbers of particles per 
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particle has the potential to substantially change bio-localization properties.  Thus, 
changes in activity can be further complicated by differential localization.  It is not 
unfeasible, for example, to imagine that the high average subpopulation in Figure 1.4 
could be responsible for the majority of cytotoxicity, even though it only composes half 
of the sample. The presence of an inactive population would consequently lead to an 
underestimation of biological activities of active species because of an overestimation of 
concentration. 
 
Challenges in Interpretation of Models 
The presence of a range of ligand-to-scaffold ratios complicates evaluation of physical 
models of multivalent activity. Without a solid understanding of the distribution of 
conjugates present within a sample, it becomes impossible to assign the active 
components in the mixture. What minimum valency is needed to accomplish a 
multivalent interaction on a surface? Is there a kinetic advantage to achieving higher 
valencies? At what valency do thermodynamic effects (i.e. reduced solubility, steric 
crowding) negatively impact binding? How can activity differences be explained for 
samples that appear the same by 
other techniques such as NMR? 
Mechanistic understanding of 
multivalent behavior would 
allow for designing new 
conjugates with optimized 
behavior, but to date has 
remained an elusive challenge. 
Let us consider a specific 
example from the literature. In 
2007, Banaszak Holl et al. 
examined the binding of a series 
of stochastic G5 PAMAM 
conjugates to folic acid via 
Figure 1.6. Three proposed mechanisms proposed to explain 
G5-FA binding behavior. (a) Avidity increases with valency. 
(b) Two populations experience two different binding 
mechanisms. (c) Folic acid keys a stronger, nonspecific 
interaction between the conjugate and protein. 
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SPR.[36] A decrease in dissociation constant was observed as the average valency of the 
conjugate was increased from 2.6 to 13.7. The authors proposed a mechanism to explain 
this trend in which dissociation slows with each additional conjugated folic acid because 
a new ligand-protein interaction is formed (Figure 1.6a). However, upon further 
consideration of the distributions of folic acid-to-dendrimer ratios present in such 
samples, the authors proposed a different mechanism.[45] This model establishes two 
binding populations for each sample; monovalent conjugates that are only capable of 
weak, reversible interactions, and multivalent conjugates with two or more folic acids 
which all experience a strong, irreversible binding (Figure 1.6b). This model attributes 
differences in dissociation between samples not to separate mechanisms, but to the 
decrease in zero and monovalent material as the overall average increases (Figure 1.7). A 
third model was proposed by Licata and Tkachenko in 2008.[46] This model attributes 
the increased interaction of the conjugate to be due to nonspecific interaction between the 
protein and dendritic scaffold. This interaction must initially be keyed by the specific 
interaction of folic acid and folate binding protein (Figure 1.6c). The presence of 8 or 
more species with folic acid valency ranging from 0 to 20 in the original samples make 
distinguishing which mechanism is responsible for the observed behavior impossible. For 
example, imagine the two 
distributions with an average of 6 
were in Figure 4 represent two 
conjugations of G5 PAMAM to 
folic acid that were tested in a 
similar study. The original 
mechanism would likely show an 
overall stronger binding for the 
non-ideal case, because it 
contains significant materials 
with 15 or more folic acids that 
would experience much stronger 
binding than anything in the ideal 
sample. However, the non-ideal Figure 1.7. Ideal distributions for three G5-FA conjugates. 
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conjugation has ~14 in 100 particles (14%) monovalent material compared to just 1 in 
100 (1%) in the ideal conjugation; therefore the second model would predict weaker 
overall binding for the non-ideal case. The third mechanism would likely not distinguish 
between the two samples beyond a ~5% decrease in signal, because binding strength has 
no increase with valency. 
These problems translate to more complicated biological experiments, the effects of 
which are difficult to measure. Earlier, problems due to multiple conjugations were 
introduced, such as the presence of non-targeted particles, “invisible” particles without 
dye, or monovalent drugs without improved activity profiles. The preceding example, 
however, hints that heterogeneity can cause complications due to single distributions, as 
well. The possible effects of ligand-to-scaffold distributions will be closely examined the 
next section. 
 
Impacts of Conjugate Heterogeneity in Biological Applications 
Targeting and Specificity. In 2011, a simulation study by Martinez-Veracoechea and 
Frenkel on targeting specificity determined the relationship of ligand valency and binding 
strength to conjugate specificity to a biological target with high or low expression of a 
receptor.[47] The authors concluded that monovalent conjugates had no specificity 
regardless of receptor density; absorption varies linearly with receptor density. 
Multivalent conjugates, by contrast, exhibit super-selective behavior (i.e. absorption 
increases much faster than linearly with receptor density). Therefore, low concentrations 
of multivalent conjugates can specifically target cell surfaces that are overexpressing a 
receptor protein, without affecting low expressing, healthy cells. However, stochastic 
multivalent conjugates with average ligand-to-scaffold ratios of ~5 or less have 
significant populations of unfucntionalized or monovalent conjugates. The monovalent 
species will bind to healthy or unhealthy cells equally, and may still be up taken via a 
receptor mediated pathway. There is also the possibility that valency may influence the 
localization of a conjugate within a patient’s body, tissue, or cells. Figure 1.8 presents a 
scenario where unfucntionalized materials bind non-selectively to a cell membrane (a 
possible case for positively charged polymer scaffolds), whereas functionalized particles 
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can bind to a surface receptor and be up taken via receptor mediated endocytosis.[48] In 
this hypothetical case, monovalent species cannot cause receptor clustering and 
endocytosis does not occur. By contrast, conjugates with 2 or more ligands are up taken, 
and may escape into the cytosol. However, over functionalized conjugates (with 5 or 
more ligands) are too hydrophobic to escape and are trapped within lysosomes and do not 
deliver their payload. In this case, all therapeutic activity measured would be from the 
subset of particles with 2-4 ligands-per-scaffold, while the remainder of the sample (at 
least 40% of the total) does not reach the intended target. The identification of such 
“active” populations for real samples, however, is impossible with stochastically 
synthesized conjugates.  
Therapeutic Effects. Beyond localization effects, the biological behavior of conjugates 
has been shown to vary as an effect of valency. The simplest mode of therapeutic 
enhancement is the delivery of a higher drug payload to a single cell than the monovalent 
equivalent. The amount of drug delivered, of course, varies directly with conjugate 
valency and therefore a conjugate with a distribution of drug-to-scaffold ratios will 
exhibit a distribution of effective enhancement, with the measured enhancement being the 




average valency. However, a study by DeSimone et al.[49] observed a new behavior at 
high valency that was not observed at all in low valency conjugates or the monovalent 
ligand. The authors demonstrated that non-toxic transferrin and transferrin antibodies, 
which are employed as ligands to target various cancers for drug delivery, when 
multivalently conjugated to a PRINT nanoparticle, exhibit selective toxicity to a Ramos 
lymphoma cell, while remaining non-toxic to solid tumor cells and healthy kidney cells. 
The exhibition of novel behaviors at high valencies can create subpopulations within a 
sample with entirely unique properties. In our non-ideal conjugation in Figure 1.4, for 
example, the high average population may have desired cytotoxicity while the remaining 
50% of the sample would be inactive. 
Imaging Agents. Organic dyes are used as fluorescent probes in order to image biological 
processes, however, organic dyes are prone to photobleaching and self-quenching. The 
effects of the dye can change once conjugated to a polymer which can make polymer-dye 
conjugates useful for biological imaging. Poly(amidoamine) (PAMAM) dendrimers 
conjugates have shown promise as MRI contract agents, since they are large enough to 
prevent extravasation which is necessary for an effective imaging agent in biological 
tissue.[50] In 2013, Schroeder et al. determined the enhancement of organic fluorophore 
optical properties once conjugated to a G5 PAMAM or a G6 PAMAM dendrimer in order 
to create a new set of materials for biological imaging with enhanced stability and 
increased accuracy in single molecule imaging. Cy3 and Cy5 dyes were both used in 
order to determine if their organic properties could be optimized.[51] The fluorescent 
dendrimer nanoprobes (FDN) they synthesized showed that the stochastic materials they 
synthesized with average of 8 and 14 Cy5 dyes
2
. Dendrimers with an average of 8 Cy5 
dyes show slower photobleaching compared to the small molecule dye alone in solution 
with a 6 to 10 times increase in lifetime. The dendrimers with an average of 14 Cy5 dyes 
showed a 17 times increase in lifetime values. Schroeder et al. used these materials in 
single molecule fluorescence microscopy in order to determine localization of these 
materials in a cell. Sets of materials such as these are extremely useful biologically since 
the dendrimer allows for enhanced photostability and increased fluorescence intensity 
(brightness) which allows for more accurate imaging of where materials go in a 
biological environment that contain DNA, RNA, or proteins. Multivalent polymers such 
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as dendrimers are shown that they can be useful imaging agents due to their ability to 
change a small molecule dyes’ photophysical properties to increase stability and also 
their ability to conjugate multiple dyes per polymer. 
 
Synthetic Approaches to Overcoming Heterogeneity Problems in Multivalent 
Conjugates 
As indicated above, heterogeneous product can complicate the synthesis, evaluation, and 
clinical application of these multivalent conjugates. Many synthetic approaches to 
overcome this problem have been employed (Figure 1.9). Methods that have employed 
include using high densities of ligands to avoid under-modified populations with limited 
activity, techniques that create clusters of ligands to optimize local concentration effects, 
and the synthesis of precise conjugates, using biologically inspired scaffolds and both 
bottom up and top down synthetic approaches, in which all species in the sample have the 
same ligand-to-scaffold ratio. In this section, we will provide a brief review of some 
successful applications of 
controlled multivalent conjugates 
over the last 10 years. 
High Density Conjugates. At 
high percentages of modification, 
and assuming ideal or close to 
ideal conjugations (to avoid non-
ideal popluations like the example 
in Figure 1.4), the amount of 
unmodified and low average 
conjugates becomes insignificant, 
allowing for benefits of effective 
concentration based multivalent 
behavior. The average distances 
between conjugated ligands on a 
Figure 1.9. Synthetic approaches to control multivalency 
include (a) ligand density variation, (b) ligand clustering, and 
(c) synthesis of precise ligand-to-scaffold structures. 
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scaffold also decreases, and at some point it can be assumed that the ability to have 
chelate effect type multivalent interaction is limited by the scaffold size and not the 
relative location of the ligands.  
One approach is the complete (100%) modification of a multivalent scaffold, which 
creates a conjugate where the heterogeneity is limited by the scaffold polydispersity. The 
most notable examples of such modification are glycodendrimers.[52-54] This class of 
materials is one of many that exhibit the “cluster glycoside effect”, which is broadly used 
to describe the enhanced binding and activity of multivalent carbohydrates compared to 
the monovalent equivalent to proteins involved in a variety of biological events.[55] The 
surface groups of the dendrimer are modified with a saccharide via coupling or click 
chemistry, using an excess of the saccharide to ensure full conversion. In this way, 
absolute valency can be controlled by generation number, as the number of end groups 
scales with generation.[22] For example, in recent work by Jayarman et al.,[56] 
generation 2, 3, 4, and 5 glycodendrimers were prepared with an expected 4, 8, 16, and 
32 mannos-6-phosphate valency, respectively. These structures were confirmed by NMR 
spectroscopy; however, mass spectrometry and elemental analysis failed due to the nature 
of the structures. The larger dendrimers had less-than-expected valencies (15 and 28, 
respectively). This example demonstrates the limit of such approaches in obtaining 
homogenous structures. Without further structural characterization, it is difficult to 
determine if the coupling reactions failed to go to completion, leaving unreacted 
carboxylic acids on the dendrimer, due to steric crowding. It is more likely, however, that 
this observation is actually a reflection of heterogeneity in the scaffold (PAMAM 
dendrimer), which is known to contain skeletal defects which reduce the average number 
of reactive groups and create a distribution of possible products including variation in 
terminal arm number.[26, 57] Another recent example of glycodendrimers by Riguera et 
al.[42] highlights the inherent coupling of size and valency by this technique. Generation 
1-3 dendrimers with 3, 9, or 27 surface conjugated mannose units were prepared and 
evaluated by SPR for the ability to bind to high and low density Concanavalin A (Con A) 
surfaces. In this work, two separate binding mechanisms were observed: a low affinity 
binding for all generations on the low density protein surface, and a high affinity binding 
for the largest dendrimer on the high density surface. The authors point out that the 
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distance between proteins on the low density surface is greater than the diameter of any 
of the dendrimers, and the only monovalent effects possible are based on effective 
concentration and rebinding. However, the distance between the proteins on the high 
density surface allows for the generation 3 structure to experience the chelate effect. 
However, this work cannot determine what multivalent effects a larger but lower valency 
dendrimer would experience, and whether there is any additional benefit to fully 
functionalizing the dendrimer surface. 
Other scaffolds have been 100% functionalized to achieve the glycoside cluster effect. 
Work by Jimenez Blanco et al.[43] exploited the architecture of β-cyclodextrin (βCD) to 
create multivalent precise, multifunctional mannose and lactose clusters with orientation 
specificity. A convergent synthesis of bifunctional dendrons followed by attachment to 
the βCD scaffold allows for precise control of both ligands and orients all the ligands in 
the same direction to maximize effective concentration effects. The resulting structures 
are monodisperse; however, unlike dendritic approaches this scaffold does not lend itself 
to easily increased valency or extending the reachable surface area of the conjugate. 
Renaudet et al.[44] employed a dendrimer-like multivalent display mannose. Their 
findings confirmed that display of 16 carbohydrates showed more multivalent 
interactions than a corresponding tetravalent unit. However, this work also used two 
linking systems to combine the four tetraclusters, and showed a significant enhancement 
of multivalent interaction with ConA with a more flexible linker. This observation hints 
at the importance of scaffold architecture in multivalent binding, a topic which will not 
be further explored here. 
Other ligands beyond glycosides have been used to 100% functionalize multivalent 
scaffolds. In 2008, Mier et al. showed that a PAMAM dendrimer derivative can be 
functionalized with a variety of different averages of organic dyes in order to show a 
change in fluorescence intensity; they determined a dendrimer 100% functionalized with 
dansyl chlorides showed the highest fluorescence intensity. This conclusion is dye 
dependent as they also show a decrease in fluorescence when stochastically 
functionalizing a dendrimer with multiple coumarins, rhodamines, and fluoresceins.[58] 
Dendrons were also used as scaffolds for multivalent peptides by Welsh and Smith.[59] 
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First and second generation dendrons conjugated to precisely 3 and 9 Arg-Gly-Asp 
peptides were prepared and evaluated for integrin binding affinity as a potential cancer 
targeting agent. Although the trivalent dendron showed enhanced affinity compared to 
the equivalent monovalent peptide, the higher valency generation 2 dendron had lower 
affinity for the integrin. The authors speculate that this trend is due to steric crowding of 
the ligands, interfering with the interaction between the peptide and target. This study 
emphasizes the importance of identifying the ideal valency for complex biological 
systems. 
As indicated by the peptide-dendron example, the higher-valency-is-better approach is 
not always optimal for multivalent activity. Complete modification of the scaffold is not 
always ideal, as well. Not all ligands can be solvated at such high valencies, and non-
toxic ligands may become toxic at high valencies as discussed earlier[49], which may not 
always be a desirable trait. Therefore, the distribution problem has been addressed by 
Choi et al. by systematically increasing the ligand density to reach desired activity levels. 
This approach allows for the comparison of the multivalent behavior at low average and 
high average valencies. In addition to the PAMAM-folic acid sample detailed in an 
earlier section, generation 5 PAMAM conjugates to methotrexate, a chemotherapeutic, 
and vancomycin, an antibiotic, have been studied. In a recent study by Choi et al.[38], 
two conjugates with average methotrexate valencies of 5 and 10 were prepared and 
evaluated by SPR for binding to a folate binding protein, and tested for uptake into FAR+ 
KB cells. The higher averaged conjugate was found to have both stronger binding to 
protein surfaces of various densities, and higher uptake into the FAR+ cells. Interestingly, 
the high (n=10) average sample exhibited multivalent binding on an intermediately dense 
surface, as indicated by incomplete dissociation of the conjugate on the SPR timescale, 
whereas the low (n=5) conjugate did not. This lack of activity cannot be explained simply 
by considering the ~4% of the n = 5 sample that is unfunctionalized or monovalent 
(Figure 1.10a). Therefore, it must be assumed that the portion of the population that is 
active at this protein density is not present at significant concentrations in the n=5 
samples but is in the n = 10, which likely places it somewhere at valency of ~7 or higher. 
Further studies would need to be undertaken to identify the exact ligand-to-scaffold ratio 
of the active entities in the sample. In a vancomycin conjugate SPR study, several ligand-
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to-scaffold ratios ranging from 1.2 
to 8.3 (Figure 1.10b) were tested 
for the ability to bind to two 
surfaces, one which mimicked 
vancomycin susceptible bacteria 
and a second which mimicked 
vancomycin resistant bacteria.[10] 
While free vancomycin did not 
significantly bind to the 
“resistant” surface, all of the 
multivalent conjugates did. 
Interestingly, the strength of 
binding was not influenced by 
valency, even when the average 
valency was increased from 1.2 to 
8.3, a reduction of the monovalent 
population from around 180 
particles of 500 (36%) to less than 
1 in 500 (0.2%). This observation 
suggests that either the 
monovalent species is not 
participating at all in the binding 
and therefore is not observed, or 
that the mechanism of binding 
depends more on the attachment of the ligand to the scaffold than the valency (similar to 
the proposed mechanism for PAMAM-folic acid in Figure 6 c). A purely monovalent 
conjugate without the presence of a distribution of would be necessary to distinguish 
between these mechanisms. As demonstrated by these examples, employing high ligand 
density samples is an approach that can be successful in creating conjugates with desired 
properties, but it does not generally lead to mechanistic insight of the systems being 
studied. 
Figure 1.10. Distributions present in multivalent conjugates of 




Ligand Clustering. High ligand densities are in part successful because they maximize 
local concentration and statistical rebinding mechanisms of multivalency. However, as 
alluded to in the preceding section, 100% modification is not possible for many 
ligand/scaffold systems due to challenges with solubility and steric crowding. However, 
lowering the density increases the separation of ligands on the surface, which reduces the 
effective concentration. This approach can be particularly problematic if the scaffold 
architecture is not flexible enough to allow localization of ligands. An approach to 
increase local ligand concentrations without fully functionalizing a surface is to create 
patches or clusters of the ligand on the scaffold (Figure 1.9b). In a recent study by Gilles 
et al.,[60] polymer vesicles were functionalized with dendritic clusters of ~7 mannose 
units. The surface density of these clusters was also varied by controlling the amount of 
azido-functionalized polymer in the vesicle scaffold to give statistical distributions. As a 
control, the same vesicles were functionalized with a monomeric azido-modified 
mannose to create multivalent mannose structures which did not have the localization 
effects of the clusters. The vesicles were evaluated by a hemagglutination assay, which 
measured the ability of the vesicles to inhibit red blood cell clustering by selectively 
binding the ConA. When compared to free mannose, the multivalent but non-clustered 
vesicle had a proximately 4 times the activity as free mannose relative to the amount of 
mannose present, likely due to a chelate type interaction. However, the activity of the 
equivalent cluster functionalized vesicle was over 40 times that of the monomer on a 
mannose-to-mannose basis. This example highlights the importance of controlling the 
distribution of ligands on a scaffold system for such systems. Pine and coworkers have 
recently published methods to synthesize polymeric scaffolds with localized, directional 
binding patches.[61] In this work, colloidal particles were prepared from nanoclusters 
with 1-7 amidine patches in symmetric orientations. The original work utilized these 
selectively active sites to assemble larger nanostructures; however the translation of these 
sites to directional multivalent binding scaffolds is clear. Complete functionalization of 
these sites with multivalent ligands would create areas of high local concentration, and 
multiple patch sites allow for well-defined, chelate type crosslinking.  Other scaffolds, 
such as PAMAM dendrimers, are more flexible then the cross-linked vesicle, which 
allows the ligands to be localized even if they are bound on different polymer 
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branches.[62] However, creating bifunctional conjugates (e.g. with a drug and a targeting 
ligand) still creates a more heterogeneous population.  In 2012, Baker et al.[63] 
synthesized triazine-based clusters of a single folic acid (targeting ligand) and a single 
methotrexate (drug ligand) with an azide click chemistry group. These clusters were then 
clicked to a previously synthesized, stochastic distribution of dendrimer-alkyne click 
ligand conjugate. In the resulting product, which still contained a distribution of ligand-
to-scaffold ratios, each unique 
species contained exactly the same 
number of drugs and target 
ligands. There is a reduction in 
unique species from ~170 in the 
equivalent, double conjugation 
approach (Figure 1.11a) to ~13 by 
employing only one conjugation 
(Figure 1.11b). Importantly, the 
single distribution conjugate 
exhibited higher growth inhibition 
for KB cells than a double-
conjugation sample that actually 
had a higher methotrexate 
valency. This observation is 
possibly due to the elimination of 
untargeted treatment populations 
and drugless targeted species from 
the sample. In this case, presence 
of a larger distribution of samples 
actually counteracts the benefits of 
multivalency. This example 
emphasizes the importance of 
considering the activity impacts of 
complicated, sequential synthesis 
Figure 1.11. Product species present in (a) a double 
conjugation of methotrexate and folic acid and (b) the single 
conjugation of the bivalent cluster. 
23 
 
of multifunctional systems. 
Precise Ligand/Polymer Ratio Conjugates. Although high density surfaces and ligand 
clustering improve conjugate behavior, mechanistic assignment of activity and 
identification of populations with optimal behavior are best done with homogenous 
samples. The presence of a heterogeneous mixture of products in these approaches 
(except for 100% functionalization approaches) may also present complications in scale-
up, prevent clinical application, or fail to meet FDA requirements for approval. 
Therefore, several strategies have been employed to synthesize precise, multivalent 
conjugates in which all species have the same exact ligand-to-scaffold ratio. These 
approaches can be broadly categorized as biologically inspired approaches, bottom-up 
approaches, and top-down approaches. 
Several groups have taken advantage of the homogeneity of biological nanoparticles as 
precise scaffolds. Proteins are of great interest as multivalent scaffolds because of their 
nanoscale sizes allowing them to span large areas for chelate effect binding, well defined 
structure which allows for precise functionalization, and the possible therapeutic potential 
of the protein itself.  One such application by Zhang and coworkers[64] employed a 
tetrameric far-red fluorescent protein (tfRFP) as both an imaging agent and a scaffold 
conjugated multivalently to cancer targeting peptides. The N and C termini of each unit 
in the tfRFP were conjugated to a copy of the targeting peptide to create conjugates 
consisting of exactly 8 targeting peptides per tfRFP. By comparison, random conjugation 
of an average of one fluorescent probe and 8 peptides to a PAMAM dendrimer would 
result in over 300 unique combinations, of which over 30% would not contain an imaging 
agent. Conjugation of the peptides to the tfRFP significantly increased the uptake of the 
probe, although it was shown to decrease the fluorescent intensity of the tfFRP. The 
location and number of functionalizable sites limits the placement of multivalent ligands 
on proteins, however, which may not allow for optimal effective concentration 
enhancements. Ikkala et al.[65] addressed this challenge by utilizing dendrons of varying 
generations to create DNA binding patches of varying valency on two different protein 
scaffolds, bovine serum albumin (BSA) and a genetically engineered Class II 
hydrophobin (HFBI). This work takes advantage of a single cysteine residue available on 
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each protein for thiol reactions to the dendrons. Employing dendrons with 3 or 9 surface 
primary amines allows for precise valency control of the resulting conjugate. Although 
there was only a 50% yield for the BSA scaffold (due to oxidation of the cysteine), the 
purified products contained a single dendron per protein. The DNA binding of the 
conjugates were then evaluated by an ethidium bromide displacement assay. The 
unmodified proteins did not bind the DNA, whereas the conjugates bound the DNA to 
varying degrees. The smaller HFBI conjugates had relatively higher affinity compared to 
the larger BSA conjugates, which the authors attributed to the differences dendron-to-
protein size (which could translate to a percent functionalization effect). As expected, the 
higher valency of the larger dendron also promoted DNA binding. 
The precise interactions of nucleic and amino acids have also been utilized to craft 
homogenous multivalent structures. Antibodies can be employed to target cancer cells 
presenting tumor-associated antigens. Schultz et al.[66] genetically engineered an anti-
Her2 antibody to site-specifically incorporate two unnatural amino acids, p-
acetylphenylalanine (pAcPhe).  The pAcPhe can be orthogonally modified to form an 
oxime bond with an alkoxy-amine derivatized drug. In their recent work, Schultz and 
coworkers created antibody conjugates containing exactly two copies of a tubulin 
inhibitor, ausirtatin. Comparatively, randomly coupling a drug to natural amino acids can 
lead to up to ~1,000,000 unique species. The precise conjugates showed improved 
selectivity for the drug, due to the targeting ability of the antibody, although there did not 
appear to be a multivalent effect for having multiple drug copies. Importantly, the precise 
conjugate showed favorable pharmacokinetics, selectivity, and stability compared to 
similar work with traditionally (non-site specific) antibody conjugates. Seitz and 
coworkers[67] recently performed a thorough proof of concept study proving the 
usefulness of DNA as a template for creating precise multivalent architectures. In this 
work, base pairing between DNA and synthetic peptide nucleic acids modified with N-
acetyllactosamine (LacNAc) was employed to tailor scaffolds with precisely defined 
valency, precisely defined spacing, and varied flexibility. The binding of LacNAc to 
Ricinus communis agglutinin (RCA120) is known, with two binding sites that are ~130 
angstroms apart across the concave surface of the protein. As such, valency effects were 
studies by synthesizing complexes with 1-4 LacNAc. The strongest absolute binding, as 
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measured by KD, was observed for the tetravalent construct, although this sample did not 
have the highest relative potency per LacNAc, indicating that this enhancement was due 
to increased effective concentration/statistical rebinding. Two different spacers were used 
to vary the length between LacNAc units in divalent complexes. As expected, the spacer 
that more closely matched the separation of the active sites showed approximately twice 
the binding activity as the complex where the distance between the LacNAc units were 
too close. Finally, flexibility was evaluated be synthesizing divalent structures that were 
completely double stranded and partially single stranded between the LacNAc units. The 
less flexible complex had slightly higher binding, which may indicate unfavorable 
thermodynamic penalties to obtain binding conformation in the flexible complex. 
Biologically inspired approaches provide excellent control of scaffold heterogeneity, 
ligand valency and placement.  However, implementation in vivo is often limited by 
immunogenicity. Therefore, non-biological but precise conjugates which may be masked 
from immune systems are still actively pursued.  
Fully synthetic, bottom-up approaches to creating precise multivalent architectures allows 
for molecular control of stoichiometry and geometry optimized for a specific target. One 
such example is the sub-monomer unit assembly of peptoids to form oligomers with 
monomer chemical functionality in the desired positions. Kirshenbaum and 
coworkers[68] demonstrated this technique by synthesizing peptoids with precisely 1-6 
azide entities in the monomer side chains. From these multivalent constructs, multivalent 
displays of estradiol were prepared from alkyne modified steroids. The multivalent 
constructs were evaluated by a radiometric competitive binding assay. The monovalent 
peptoid showed ~6,500 weaker affinity than the free estradiol, perhaps due to entropic 
penalties due to immobilization on the scaffold, however the bivalent conjugate 
recovered to ~100 fold weaker affinity. This observation could possibly be attributed to 
chelate type binding as estrogen receptors can exist as dimers. Minor improvements for 
the tri and hexavalent conjugates can likely be attributed to effective concentration 
effects. The solid phase peptoid synthesis allows for tailoring of space between the active 
monomers, so that the biological structures of interest may be matched. Vidal et al.[69] 
employed peptoid and porphyrins as small scaffolds to match lectin symmetry. Two 
lectins with different symmetries were studied. A flexible, linear tetravalent glycol-
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peptoid conjugates and cyclic peptoids of the same valency were first compared. The 
linear peptoid did not exhibit any inhibition behavior in a hemagglutination inhibition 
assay, while the cyclic cluster selectively inhibited coagulation with one erythrocyte 
(Pseudomonas aeruginosa) but not the other (Erythrina cristagalli) tested. However, 
there was very little measurable effect of multivalency over the monovalent ligand (~4 
times the potency). By way of contrast, a square planar tetravalent porphyrin selectively 
inhibited the Erythrina cristagalli with over 150 times the relative potency of the 
monovalent glycoside. Increasing the valency to 6 had no additional favorable effect, and 
changing the symmetry to orient all 4 glycosides in one direction or placing 2 in an 
opposite direction both negatively impacted the behavior of the conjugate. This study 
demonstrates the importance of precise control of ligand orientation for minimizing 
thermodynamic costs in achieving ligand-target interactions, especially with inflexible 
scaffolds. 
One approach to achieve precise nano-size dendrimer conjugates is to use convergent 
synthesis of dendrons with small molecule precision to form nanoscaled conjugates with 
well-defined functionality. In 2010, Weck et al. developed a method to construct 
generation 2 poly(amide) based dendrons and dendrimer materials using copper catalyzed 
and copper free click chemistry developed by Sharpless and Bertozzi. These materials 
had the multi-functionality of amine, azide, and alkynes.[70] These materials made a 
large step in creating monodisperse polymers since the dendrimers synthesized had 100% 
completion reactions for each generation as determined by various characterization 
techniques which is a major challenge in creating many dendrimer materials, including 
the PAMAM dendrimer.[70] In 2011, Weck et al. used these well-defined dendrimer 
materials to click on near infrared cyanine dyes in order to create monodisperse polymer 
imaging agents that have the ability to be used in biological experiments due to their non-
cytotoxic nature.[71] 
Convergent approaches are difficult to extend to higher generation dendrimers. Recent 
work by Banaszak Holl et al.[27-30] utilized high performance liquid chromatography to 
isolate generation 5 PAMAM dendrimers with precise ligand-to-scaffold ratios. 
Stochastic average mixtures of products are prepared by mixing multiple equivalents of 
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the ligand drop wise into a solution of the dendrimer scaffold. By employing hydrophobic 
ligands, favorable interaction with a reverse phase, hydrophobic stationary phase column 
is exploited so that column retention is determined by the precise ligand-to-dendrimer 
ratio (Figure 1.3). Scaling these methods to the semi-preparative scale allows for 
generation of up to 30 milligrams of product with a single, precise ligand-to-dendrimer 
ratio. Extending this approach from click ligands to biologically interesting molecules 
will provide a route to precise drug/targets/dye-to-dendrimer ratio materials. 
 
Future Directions 
In the pursuit of more active multivalent polymer conjugates, there are many directions 
that must be pursued. First, it is important to acknowledge the heterogeneity present in a 
ligand-scaffold conjugate and the impacts of this heterogeneity on the desired application. 
Then, the best way to minimize or eliminate the impacts of sample heterogeneity can be 
determined. Systematic variation of ligand density has proven to be a facile route to 
improved conjugate activity. Continued studies such as those by Choi et al. lead to 
samples that, while still heterogeneous, limit the population of inactive species. Such 
high average samples, when not plagued with undesired properties such as insolubility or 
nonspecific cytotoxicity, may be the easiest and/or fastest method to bring a conjugate to 
clinical scales. Achieving precise ratio ligand/polymer control of these widely employed 
multivalent conjugates, such as the work by Banaszak Holl et al., must also continue as 
the best way to distinguish mechanisms of activity and identification of active 
components within a sample, although this approach may not be scalable. For other 
applications, a more structured approach to maximize specific multivalent effects is best 
for achieving the desired interaction. If target chelation is not a desired outcome (for 
example, in the PAMAM-folic acid case when even 1 ligand is sufficient to achieve the 
desired behavior), it is best to pursuit conjugate techniques such as ligand clustering to 
maximize local concentration effects.  Employing flexible scaffolds might also minimize 
the need for precise control over ligand spatial distributions. If the exact geometry is 
known, effort might be best spent in optimization of the scaffold choice for precise 
control ligand placement to minimize entropic penalties of bringing multiple ligands into 
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the desired geometry. It is easy to neglect the contribution of effective concentration 
effects in favor of achieving architectures that exhibit chelate binding in such systems; 
however the works highlighted here indicate that that these effects are far from 
negligible. Although much work revolving around clustering has been with glycoclusters, 
it is not unreasonable to believe such effects may translate to other ligands of biological 
interest. An interesting area to pursue would be to combine a precisely tailored geometry, 
such as seen with the square planar complexes of Vidal et al.,[69] with pre-clustered 
ligands on a dendron to high local concentrations and precise localization of cluster 
geometry. Recent work by Baker et al. have shown the promise of heterobifunctional 
ligand clustering on random, flexible architectures.[63] As such, applying ligand 
clustering via click reaction to either distributed or precise conjugates on flexible 
scaffolds like PAMAM may provide new optimization of multivalent behavior. 
In summary, multivalent, multifunctional polymeric conjugates are highly attractive for 
the targeted delivery of drugs and imaging agents. However, common approaches to the 
synthesis of conjugates involve many steps and can lead to complex mixtures of products. 
The presence of these product distributions, while intellectually obvious, is hard to 
visualize by most chemical and biological techniques employed to evaluate the samples. 
As such, progress toward understanding the impact of such heterogeneous distributions 
on the activity of the conjugates is slow. However, recent work in systematically 
modifying the distributions of ligands present and crafting of precise multivalent 
architectures has allowed for better elucidation of multivalent behavior.  
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Chapter 2  
Structural Defects in G5 PAMAM Dendrimer 
This chapter was previously published as “Quantitative analysis of generation and 
branch defects in G5 poly(amidoamine) dendrimer” Polymer (2013), 54, 4126. The 
corresponding supporting information can be found in Appendix A. 
 
Introduction.  
Poly(amidoamine) (PAMAM) dendrimers are a class of polymers characterized by 
dendritic structure and low polydispersity. [1-3] Additionally, water solubility, low 
cytotoxicity when acetyl capped, and readily conjugated surface groups have contributed 
to make PAMAM dendrimers particularly interesting for biological applications.[4] 
Generation 5 (G5) PAMAM dendrimer has been of specific interest because it is able to 
move through biological tissue, due to its 5 nm diameter.  This allows the dendrimer to 
cross cell membranes thereby increasing blood circulation times of conjugated or 
entrapped drugs (for example, from 2 to 6 hours)[5] and avoiding rapid clearance by liver 
and spleen.[6, 7] On the other hand, the G5 material is also large enough to conjugate up 
to at least 14 hydrophobic drugs, targeting molecules, and/or dyes while retaining water 
solubility.[8] Consequently, G5 PAMAM has been extensively studied[8, 9] as a platform 
for multivalent
 
conjugates[10-12] combining specific cell targeting,[13-15] drug 
delivery,[16-19] RNA,[20] and gene delivery,[21-23] and/or imaging agents,[24-29] with 
over 900 publications to date. 
Although PAMAM dendrimers can have polydispersity indices as low as 1.01, they are 
known to have generational defects (trailing generations and oligomers) and branching 
defects (missing arms and intramolecular loops).[30, 31] Generational defects lead to 
substantial portions of the sample population with significantly lower and higher 
molecular weights and diameters.  For example, a G5 sample containing trailing 
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generations and oligomers could in principle contain particles with molecular weights 
ranging from about 1400 Da (G1) to 114,000 Da (G5 tetramer), leading to significantly 
different biodistributions of differently sized materials.[7] Additionally, host-guest 
behavior depends on internal void volume of the dendrimer, which is greatly reduced for 
the lower generations present as trailing defects in a sample.[6]  
The structure of PAMAMs has been explored by a variety of experimental and theoretical 
methods. Theoretical studies using atomistic,[32-37] coarse grain,[34, 38] and explicit 
solvent molecular dynamics,[33, 36] have been carried out to address the size, shape, and 
interior volumes of dendrimers in response to different pH and solvent environments. 
These measurements have been compared to experimental methods such as small angle 
neutron scattering[39-41] and X-ray diffraction[39] with generally good agreement. Mass 
characterization techniques, such as electrospray ionization mass spectrometry (ESI-
MS),[31] matrix assisted laser desorption ionization time-of-flight mass spectrometry 
(MALDI-TOF-MS),[30] centrifugation,[8, 9] and size exclusion chromatography,[8, 
9]  have detected the presence of defects in the dendrimers. Capillary electrophoreses 
exclusion chromatography[42] has been frequently used to explore sample 
uniformity.[43, 44] For example, Lopp et al. employed capillary zone electrophoresis to 
characterize homogeneity for G0 to G4 PAMAM.[45] They observed differences in 
electrophoretic mobilities leading to fast migrating trailing generations, and slowly 
migrating impurities that were attributed to lower charges due to missing or looped arms, 
and high weight oligomers; however, this technique cannot explicitly distinguish between 
these structures, and no further complementary characterization was performed. Lee et al. 
used field flow fractionation to do size dependent separation of G4-G9 at various pH 
conditions.[42] They observed the presence of high (dimers) and low (trailing and 
skeletal defects) molecular weights via changes in sample mobility, in all generations and 
conditions, but did not employ further techniques to study the materials. Baker et al. 
utilized ion-pair reverse phase High Performance Liquid Chromatography (RP-HPLC) to 
analyze G1-G9.[46, 47] This work hypothesized that RP-HPLC can separate dendrimer 
as a function of density of paired primary amine/trifluoroacetate surface groups. Defects 
leading to missing end groups changed retention, readily apparent for lower generations, 
and dimeric species having more surface groups were retained longer. The authors 
35 
 
speculated that this work could be scalable to preparative work for the isolation of large 
amounts of relatively pure materials. 
Recent work has demonstrated the ability to isolate dendrimers with precise numbers of 
click-functional ligands from a stochastically synthesized distribution utilizing RP-
HPLC.[48, 49] Presently, however, the purity of these isolated materials is limited by the 
presence of high weight oligomers that co-elute with the monomer conjugates. These 
materials contain fewer than ideal numbers of ligands but contribute significantly to the 
sample mass due to their high molecular weights. Low weight, trailing impurities are 
often eliminated by size exclusion techniques,[48] but removal of dimer and larger 
structures has to date not been on a preparative scale. Isolation of generationally pure 
dendrimer monomer materials will allow for preparation of conjugates with a narrow size 
distribution and precise numbers of functional ligand with enhanced purity and yield.  
Here we report the isolation and characterization of major generational defects in the 
commercial samples of G5 PAMAM dendrimer typically employed for scientific studies 
and applied uses of these materials. We employed semi-preparative scale RP-HPLC on a 
representative sample of commercial G5 PAMAM to isolate major generational 
components in quantities of hundreds of milligrams. Isolated components were
characterized by mass spectrometry, size exclusion chromatography (SEC), and 
1
H NMR 
spectroscopy. The NMR spectra were found to be highly pH sensitive, so these 
experiments were performed at a series of pH values using a pH 3, 5, 7, and 9 buffers for 
as-received samples, and pH 9 buffer for fractionated samples. The rp-HPLC separation 
procedure described herein has proven robust and been used to obtain gram quantities of 
generationally purified PAMAM dendrimer that is suitable for synthesizing conjugates 
with precisely defined numbers of ligands per polymer particle. 
 
Experimental Section.  
Biomedical grade G5 PAMAM dendrimer was purchased from Dendritech Inc. and used 
as received.  All other chemicals were purchased from Sigma Aldrich, Fisher Scientific, 
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or VWR and used as received.  Size exclusion chromatography and potentiometric 
titration were carried out as previously reported.[48] 
Isolation of Generational Components of G5 PAMAM dendrimer. Isolation of dendrimer 
components was achieved using a Agilent Zorbax 300SB-C18 Prep Column (21.2 x 150 
mm, 5 µm particles) with a Waters 600 Controller, Waters 2707 Autosampler, and 
Waters 2998 Photodiode Array running Empower 2 Software, additionally equipped with 
a Waters Fraction Collector III. The weak solvent (Solvent A) was HPLC Grade Water 
with 0.1% TFA, and the strong solvent (Solvent B) was HPLC Grade Acetonitrile with 
0.1% TFA. The gradient employed was as follows: Flow rate of 12 mL per minute, 2.1 
minute isocratic load step at 95% A and 5% B, 4.9 minute gradient curve 6 to 80% A and 
20% B, 6.5 minute gradient curve 6 to 74% A and 26 % B, followed by a 3.5 minute 
wash of 1% A and 99% B before returning to starting conditions. Eighty, two second 
fractions were collected starting at 9 min into the procedure. Multiple, consecutive, 0.2 
µm syringe filtered, 710 µL injections at a concentration of 18 mg/mL dialyzed G5 
dendrimer dissolved in solvent A were performed with a 5 minute equilibration step in 
between. Chromatograms detected at 210 nm and fractions were then analyzed using 
Origin Pro 8.1 software, which was used to select fractions to combine for each sample. 
A small sample was taken from the combined fractions and analyzed using a Waters 
Acquity Ultra Performance LC with a scaled gradient method calculated using the 
Water’s Analytical to Prep Gradient Calculator on an Agilent 2.1 x 100 mm column with 
all included chromatograms detected at 210 nm. The combined fractions were exposed to 
a nitrogen stream to remove acetonitrile and lyophilized. Dried samples were then re-
dissolved in PBS buffer pH 7.4 and purified using GE Healthcare PD-10 Columns using 
the manufacturer’s gravimetric protocols using DI water as the buffer, and lyophilized 
prior to subsequent analyses. 
Mass Spectrometry. Matrix-assisted Laser-Desorption Time-of-Flight Mass Spectrometry 
(MALDI-TOF-MS) was performed using a Micromass TofSpec-2E running MassLynx 
Version 4.0 software. Dendrimer samples were prepared by dissolving in DI water at 
concentration 10 mg/mL, then serial diluting with methanol 1:1, then 1:4. The samples 
were then mixed 1:1 with the matrix dihydroxybenzoic acid (concentration of 10 mg/mL 
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Figure 2.1. UPLC chromatogram  at 210 nm of as received G5 dendrimer indicates the presence of 
trailing generation impurities as well as oligomerized defects. 
in 1:1 water/acetonitrile) and spotted on to a MALDI plate. Samples were calibrated 
using bovine serum albumin with a matrix of sinapic acid. At least 150 laser shots were 
compiled for each spectrum. The spectra were smoothed using the MassLynx Software 
settings of Smooth window (channels) equals 12, and Number of smooths equals 12. No 
baseline subtraction or peak centering was performed. 
NMR spectroscopy. NMR experiments were performed on Varian VNMRS 500 and 
Varian MR400 instruments. 
1
H-NMR spectra were obtained used 10 second pre-
acquisition delays and a total of 64 scans. All sample solutions were set to a dendrimer 
concentration of 5 mg/mL. Buffered NMR solutions were prepared using deuterium 
oxide, deuterium chloride, sodium deuteroxide, potassium hydrogen phthalate (pH 3 and 
5), potassium dihydrogen phosphate (pH 7), and disodium hydrogen phosphate (pH 9). 
Internal standard NMRs were taken by spiking 1,4-dioxane, chosen for its miscibility 
with water, non-interfering shifts, and pH independence, into deuterium oxide or buffered 





Results and Discussion.  
Biomedical grade G5 PAMAM dendrimer contains substantial amounts of trailing and 
oligomer (dimer, trimer, etc.) type defects as visualized by UPLC in Figure 2.1, the 
relative amounts of which have previously been reported to vary from batch to batch or 
source to source.[48] Previous reports[46, 47] indicate that RP-HPLC of amine-
terminated PAMAM dendrimers operates via ion-pairing of terminal amines with 
trifluoroacetate. By this principle, retention on the column has a positive correlation with 
number of primary amine-terminated arms on the dendrimer species. The largest peak, 
eluting at 8.5 minutes, has been identified as the full molecular weight distribution of G5 
species and contains, even in a sample such as this with a PDI of 1.090, only about 64% 
of the sample, as determined by peak fitting. The smaller peaks eluting prior to the G5 
peak indicate the presence of all possible trailing generations, comprising about 14% of 
the sample by weight  (see supporting information for determination of extinction 
coefficients for all species). Two broad peaks that exhibit higher retention on the reverse-
phase column are identified as the G5 dimer and trimer making up 14% and 8% of the 
sample by weight, respectively, with trace amounts of tetramer also present. Analysis of 
the extinction coefficients in mg/mL of each species at 210 nm (see supporting 
information) indicated a decrease as a function of degree of oligomerization leading to a 
systematic underestimation of the mass fraction of these species if a constant extinction 
coefficient is assumed.  The high percentage of oligomeric defects for G5 leads us to 
conclude that there are likely species such as G4-G4 dimers and G3-G3-G3 trimers 
coeluting with the G5 dendrimers, as these structures would have similar molecular 
weights and primary amine-terminated arms, and cannot be separated by the principles of 
ion-paired RP-HPLC. By these estimates, a commercial sample contains approximately 
30% more particles than calculated using the ideal molecular weight, with only about 
50% of the total number of particles being G5 sized.  
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Semi-preparative HPLC (Figure 2.2) was 
used to collect eluting dendrimer 
components in 3 second fractions 
(vertical white bars). The major species 
were identified and combined (wide 
colored bars T, I-IV). The combined 
fractions represent remaining trailing 
generation (red bar, T), the full range of 
G5 branching defects (green bar, I), G5-
G5 dimer (purple bar, II), trimer (blue 
bar III), and tetramer (orange bar, IV). 
Single, 3 second fractions were also 
collected as indicated by the gray scale 
vertical bars (i-iv). Figure 2.3 a shows subsequent re-injection of the combined fractions, 
T-V, as eluted onto an equivalent UPLC system, while Figure 2.4 a shows re-injection of 
single fractions, i-iv. The single fractions taken from throughout the G5 peak do not re-
center upon injection, indicating that different types and degrees of structural defects 
contribute to the breadth of the G5 peak and that the peak width is primarily controlled by 
polymer defects, as isolation and reinjection of 3 second fractions i-iv result in diffusional 
peak widths of about 75% of the peak-width-at-half-height of the as-received peak, and 
Figure 2.3. Characterization of fractions T,I-IV. (a) UPLC chromatograms at 210 nm of generational 
fractions T,I-IV. (b) Cumulative data plot of contributing molecular weights from GPC analysis of 
fractions T,I-IV. 
Figure 2.2. Fractions (white bars) collected from 
semi-preparative HPLC (210 nm) of dialysis purified 
G5 and combined into generational (colored bars, 
T,I-V) and single fraction (gray scale bars, i-iv) sets.  
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do not re-center. Structures with more 
branch defects, or defects that 
occurred earlier in the synthetic 
process, will contain significantly 
fewer surface amines and have shorter 
retention time. The G5 dimer, trimer, 
and tetramer fractions also do not re-
center to the main peak, indicating a 
significant difference in surface amine 
presence. The isolated trailing 
generation is still contaminated with a 
significant portion of G5, and a small 
amount of G5 peak can be seen in the 
dimer fraction, which was confirmed 
in further experiments. 
After desalting, the trailing generation, 
branch defective G5, dimer, trimer, 
and tetramer fractions obtained by RP-
HPLC were analyzed by size-
exclusion chromatography and 
compared to as-received G5 PAMAM. 
The ideal molecular weight of G5 
PAMAM is 28,826. The as-received 
mixture of material has a Mn very 
similar to this value, but the PDI of 
1.090 is consistent with the 
observation that this Mn is a 
contribution of G5, low weight (trailing), and high weight (oligomer) impurities. 
Fractions T,1-III all showed reduced PDIs (Table A1), indicating improved sample 
homogeneity.  Fraction II (dimer) has a Mn which is slightly less than twice that of an 
ideal G5 dendrimer, and fraction III (trimer) just under three times the Mn of fraction I, in 
Figure 2.4. Characterization of fractions i-iv. (a) 
UPLC chromatograms at 210 nm  of fractions i-iv do 
not re-center about the main G5 peak. (b) Cumulative 
data plot of GPC molar masses for fractions i-iv. (c) 
MALDI-TOF-MS spectra of fractions i-iv. 
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good agreement with the identification of these structures. Fraction IV shows the largest 
weight and PDI, and is most likely comprised of a mixture of trimer, tetramer, and higher 
oligomers. Figure 2.3 b is a cumulative data plot that visualizes the percent contribution 
of Mn to each fraction. The near vertical line in the cumulative molar mass plot for 
fraction I is indicative of very homogeneous material. Fraction II has a very similar 
shape, but is shifted to roughly twice the molecular weight. By fraction III, the average 
Mn has roughly tripled and the cumulative curve is much shallower. This is consistent 
with increased polydispersity due to the formation of trimer from G5 monomers with 
different degrees of branching defects, leading to a larger range of contributing materials. 
About 20% of fraction IV falls into the trimer range, while about 50% falls into a range 
approximately 4 times the mass of a G5 monomer, and species with even higher 
molecular weights are detected. 
Molecular weights were also measured by MALDI-TOF-MS for the five generational 
fraction sets (Table A1) and were in good agreement with GPC data. The higher-than-
ideal weights observed is most likely attributed to presence of various salts, as the peaks 
are all slightly shifted to high weights when compared to the as received material prior to 
trifluoroacetate and phosphate buffer exposure. The presence of phosphate and TFA salts 
can be observed via NMR (Figure A1). Removal of these two salts to less than one 
equivalent per dendrimer can be achieved using less than 20 mg of dendrimer loaded per 
PD-10 column; however they are most likely exchanged for chlorides and other salts that 
cannot be probed by NMR. The commercial material had MALDI peaks at 13kDa, 
26kDa, 52kDa, 79kDa, and 105kDa, corresponding to those observed in each individual 
fraction’s (T, I-IV) spectra. Fraction T has a distinct peak at 7kDa, either a strong [M]
2+
 
signal or G3 sized particles, not seen in the other spectra, which are dominated by matrix 







 peaks (Figure 2.5). Fraction II, dimer, has a peak that could 
correspond to either G5 or a doubly ionized dimer, however fraction III, trimer, has a 
peak at the dimer weight which cannot be explained by ionization alone. Fraction IV, 
tetramer, has a peak at an M/Z ratio around 110,000 which is not present in the dimer or 
monomer samples, although this peak is not the most intense peak in the sample. This 
could be caused by the ionization process favoring much smaller species. Figure 2.4 b-c 
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shows a distinct increase in molecular weight as a function of HPLC retention for the 
fractions i-iv, further confirming that the width of the main G5 peak in the HPLC 
chromatograms is caused by the molecular weight distribution due to branching defects, 
with the least defected material containing the highest number of primary 
amine/trifluoroacetate pairs, and being most retained on the hydrophobic column. The 
presence of a peak in all samples corresponding to the monomer mass arises from 
multiple ionization of single particles (e.g. double charged dimer [M-M]
2+
 has the same 
M/Z as singly charged monomer[M]
+
).  PAMAM dendrimers roughly double in 
molecular weight and number of atoms when they dimerize, making quantitative 
comparisons of the number of hydrogens contributing to each NMR shift challenging. It 
was observed that acidic pH caused by HPLC conditions caused upfield shifts of proton 
peaks, peak broadening, and loss of fine structure in 
1
H-NMR due to swelling and solvent 
penetration when primary amines are protonated (Figure A2). To account for this, 
subsequent spectra were obtained using buffered solvents. To analyze the relative number 
of each type of hydrogen in the purified fractions, an internal standard (1,4-dioxane) was 
used (see supporting Figure A3). Trailing generations (T), G5 monomer (I), dimer (II), 
trimer (III), and tetramer (IV) fractions have similar spectra at the identical mass 
Figure 2.5. MALDI-TOF-MS spectra of fractions T, I-IV. 
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concentration and similar pH. However, the absolute values of all observed peaks 
changed for each fraction. On average, fraction T peaks integrated to 59% of fraction I, 
while II and III integrated to 177% and 215% of the values of fraction I respectively 
(absolute integration values, see Table A2). These substantial changes in integration 
values will impact the calculation of dendrimer-conjugate ratios by NMR if not 
accounted for in the analysis. Solubility of the trimer and tetramer fractions was normal 
for low pH (highly charged), slightly reduced for neutral pH (charged), and significantly 
reduced for more basic conditions (no charge). Broadening seen in the NMR spectra 
could be related to decreased solubility of the samples. All spectra lost some fine 
structure compared to the as received material, which was never exposed to TFA or 
buffer. 
The structural variation of dimer has been further quantified by potentiometric titration. 
A molecularly perfect G5 PAMAM has 128 primary amines, but titration of the as-
received batch used in this paper revealed on average 112 due to a combination of branch 
and generational defects. Fraction I, RP-HPLC-purified monomer, was titrated to have 93 
primary amines per dendrimer (see supporting information).  This indicates the presence 
a substantially larger amount of defects in G5 dendrimer than commonly believed to be 
present based on analyses of mixtures such as that indicated in Figure 2.1 (~110) or as 
compared to the theoretical perfect molecular structure (128).  The number of primary 
amines detected on the RP-HPLC purified material decreases due to the removal of high 
amine-containing dimer, trimer, and tetramer defects, which comprised 22% of the as-
received sample, and is 35 surface groups less than ideal due to branch defects. Likely 
many combinations contribute to the measured average; for example one CAP2 defect 
(vide infra) at G2, or two end caps at G3, or three at G4, would all give an average of 112 
amines per dendrimer. If a new branch defect is formed at every step from G2 to G5, the 
final product would have 98 primary amines. The measured value of 93 amines per 
dendrimer would be obtained if 2.2 capping events occurred during the formation of G2, 
4.4 at the formation of G3, 8.6 at G4, or 17.5 at G5. The purple dimer fraction (II) was 
titrated to have 180 primary amines per dendrimer, about 6 primary amines short of an 
exact dimer of the defected G5; however, this number is in good agreement with the 
scenario of dimerizing two G3 dendrimers with the average of 4.4 cap defects (resulting 
44 
 
in 178 primary amines) or dimerizing the G4 with an average of 8.6 branch defects (182 
amines). This data suggests that dimerization events commonly occur at later synthetic 
steps. 
It has been speculated in the literature that the width of dendrimer peaks from flow-based 
separations is due to molecular weight distributions caused by structural defects,
17, 23
 
however to date no molecular weight measurements have been coupled to these 
techniques. Single, three second fractions were isolated from across the monomer and 
dimer HPLC peaks (Figure 2.4a) and studied by MALDI-TOF-MS (Figure 2.4c). 
MALDI-TOF-MS of these fractions indicate a trend of increasing molecular weight with 
increasing retention time on the hydrophobic C18 column. As all known branching 
defects lead to both decreases in molecular weight and total number of primary amines, it 
can be inferred from this data that dendrimer eluting early in the chromatogram contains 
the most defects, and that a theoretically perfect G5 containing 128 primary amines 
would elute later, on the far right side of the G5 peak.  
Using the GPC and titration data from the G5 monomer sample, we have generated 
simple computational models for two specific defects types that represent limiting cases 
for arm growth defects.[14] The CAP2 model uses an endcapping event that blocks two 
primary amines and does not allow further reaction. To fit the titration data of 93 primary 
amines an error rate of 7.6% was used. This means that at each point of growth in each 
step there is a 7.6% chance of a CAP2 defect. Similarly, a MA2 defect refers to a single 
primary amine not branching to the next full generation.  This leads to an arm that is a 
generation behind the current, but unlike the CAP2 model still able to undergo further 
reaction.  To fit the titration data, an error rate of 15% was used to reproduce the average 
number of primary amines of 93.  Histograms of the simulation results of the primary 
amine number are shown in Figures 2.6 and 2.7, overlaid with the UPLC of fraction I. 
The x-axis of the simulation and RP-HPLC data were aligned by comparing the 
experimental molecular weights obtained from fractions i and iv (the leading and trailing 
edges of fraction I) to the molecular weights predicted by the defect schematics, 
approximate 21kDa and 28kDa.  
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Both types of defect models indicate that perfect G5 with 128 primary amines represents 
less than 0.006% of the total population. The histograms of primary amines of 
dendrimers generated by these models can be overlaid onto the UPLC chromatogram of 
G5 monomer fraction I with relatively good agreement; however when considering the 
predicted masses of the CAP2 and MA2 leading edge and trailing edge structures, the 
MA2 limiting case model compares better to the experimental data.  Despite the apparent 
good agreement of the MA2 model, a mixture of defects, including the CAP2 model that 
has been confirmed experimentally for G1 and G2 material, is expected to be present.
13
   
Schematic CAP2 structures are portrayed in Figure 2.6, which demonstrates the 
fundamental changes in overall shape and internal space in even the most common 
species as compared to the perfect G5. The schematic MA2 type defects, illustrated in 
Figure 2.7, occur almost exclusively on unique branches and not on the same branch 
twice, leading to structures containing both G4 and G5 shells. Some of the more defected 
structures have defects occurring twice on the same arm, leading to the presence of G3 
shells, which are much closer to the dendrimer core. Figure 2.7 indicates that the more 
Figure 2.6. CAP2 model histogram (blue bars) overlayed with fraction I UPLC chromatogram at 210 
nm. Below, from left to right, the most common structures resulting for various numbers of primary 
amines and their corresponding molecular weights. 
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Figure 2.7. MA2 model histogram (blue bars) overlayed with fraction I UPLC chromatogram at 210 nm. 
Below, from left to right, the most common structures for various numbers of primary amines and their 
molecular weights. Core groups are black, shell groups colored. Blue she indicate G5 level amines, red 
have one defect (G4 shell), and purple have 2 defects on the same branch (G3). 
defected structures have roughly equivalent contributions of G4 and G5 like size and 
surface groups if only MA2 defects are considered. By assuming that dendrimer mass 
directly correlates with the number of primary amines present, which is generally 
supported by our UPLC, GPC, and titration data, the PDI of the samples generated by 
both the CAP2 and MA2 models is calculated to be 1.01, which is in good agreement 
with the fraction I value of 1.019. 
This agreement between this model and experimental data concludes that the observed 
polydispersity in generationally pure G5 PAMAM can be explained by experimental 
defect rates of 7-15%. By these estimations, approximately one in four G5 dendrimers 
have less than 85 primary amines, while three in four particles has less than 100. The 
entire molecular weight distribution of commercially available G5 dendrimer consists of 
combinations of these two defect types, as well as defects other known defects such as a 
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Figure 2.8: UPLC at 210 nm.   (a) as-received acetylated G5 PAMAM (G5-Ac, red trace) contains 
high weight impurities with no ligand that co-elute with G5 monomers containing one ligand (G5-
L
1
, green trace) in a conjugated sample (black trace).  (b) Conjugation to an HPLC purified G5 
monomer sample (red trace) has narrowed peak width and improved peak resolution compared to 
the as-received conjugation (black trace). 
half reacted primary amine leading to one missing primary amine as opposed to two, and 
the trailing and oligomer generational defects. HPLC provides a powerful tool to both 
observe and isolate these defect structures to allow for analyses of structure, chemical 
behavior, and eventually biological behavior.  
Previous work from the group[50, 51] has demonstrated the ability to employ rp-HPLC to 
obtain G5 PAMAM samples conjugated to precise numbers of functional ligands from 
stochastic distributions. However, as Figure 2.8a demonstrates, dimeric and trimeric 
contaminants in as-received dendrimer co-elute with the G5 monomer that is bound to 
one ligand. Similarly, G5 dimer with one ligand co-elutes with the monomer conjugated 
to two ligands, etc. The resulting nominally “monomer” products will thus contain 
substantial amount of dimer impurities that also contain n-1 of the desired n number of 
ligands per polymer particle. The work presented here done on a preparative scale can be 
used to obtain gram quantities of generationally pure starting material. This allows for 
synthesis of dimer-free conjugates and subsequently, generationally pure G5 samples 
with precise numbers of functional ligands. Removal of trailing and generational 
impurities from conjugated materials also enhances the effective resolution of the rp-
HPLC separation (Figure 2.8b). This results in samples with improved ligand number 






The narrow size range, aqueous solubility, and functionalizable surface of G5 PAMAM 
dendrimer give it great promise for future biomedical applications. However, structural 
imperfections create sub-populations within the sample that have different chemical and 
biological characteristics. A significant portion of commercial material contains species 
with up to threefold higher molecular weights, reduced solubility, and different chemical 
behavior. This will impact the drug loading capacity, accuracy of loading measurements, 
and likely the biodistribution of dendrimer based drug delivery systems. The G5 sized 
dendrimers present in the as-received material also contained an average of 93 primary 
amines, approximately 23% defected, compared to previous estimates of 110, 14% 
defected, indicating that branching type defects are twice as prevalent as previously 
proposed. We have successfully employed rp-HPLC to not only produce higher purity G5 
dendrimer, but to isolate dimer and trimer samples for study. These samples have been 
thoroughly characterized by molecular weight and NMR techniques.  These new 
purification protocols are of central importance for obtaining materials that can be used to 
generate polymer with precisely defined numbers of ligands. This methodology can be 
used to isolate gram-scale quantities of generationally purified, well characterized G5 
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PAMAM Dendrimers for Quantized Megamers 
This chapter was previously published as “PAMAM dendrimers as quantized building 
blocks for novel nanostructures” Soft Matter (2013), 9, 11188. The corresponding 
supporting information can be found in Appendix B. 
Introduction.  
The need to address biological challenges across multiple hierarchical levels ranging 
from molecules to cells to tissue has increased the demand for synthetic strategies 
leading to well-defined structures on a nanometer to micron scale. Achieving such 
size ranges with classic synthetic strategies remains challenging. Tomalia proposed 
the utilization of dendrimers as quantized building blocks, termed “soft super atoms”, 
combined with controlled assembly to substantially expand the range of size scales 
available for soft synthetic materials with controlled morphology and other physical 
properties.[1-4] Glotzer and Solomon have discussed an analogous proposal for the 
use of  nanocrystals and colloidal particles as “hard super atoms”.[5]  To function as 
super atoms, it is necessary to have control over size, shape, and surface chemistry 
(i.e. reactivity) to create materials with nano-periodic trends independent of variations 
in the monomeric material. The assembly of synthetic nanomaterials or super atoms 
generates larger nano to microscale structures that fall into the following classes:  I) 
Extended Nanostructures, which extend infinitely in one, two or three dimensions, a 
class that includes fibers, sheets, and lattices  II) Stochastic Nanoclusters and III) 
Precise Nanoclusters (Figure 3.1).  Extended Nanostructures have precise control of 
local architecture in one, two, or three dimensions and stochastic sizes. Stochastic 
Nanoclusters have control of particle size with heterogeneity in terms of numbers of 
super atoms per particle. Precise Nanoclusters have monodisperse assemblies of super 
atoms, allowing for a digital control of nanocluster size and properties.  Substantial 
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progress has been made in the assembly of hard super atoms for all three classes 
employing  rigid polymers,[6, 7] gold,[8-13] and other particles.[14]  Substantial 
efforts have also been made in the area of soft super atoms, despite the challenges 
associated with polydispersity of polymeric building blocks.  It is the use of polymers 
as soft super atoms, which offer tunable surface qualities such as charge and 
conjugation chemistry that can enhance solubility, biological compatibility, and allow 
for modification with drugs, dyes, and targeting agents of interest,[15] that are the 
focus of this report. 
The dendritic polymer architecture has the potential to provide a well-defined and 
highly functionalizable structure for utilization as a soft super atom, building block.  
Assemblies utilizing dendrimers as the monomer units result in larger polymer-like 
structures or megamers.[16, 17]  Work in this field has been pioneered by 
Tomalia[18-21] with the “tecto-dendrimer” strategy of self-assembling shell 
dendrimers around a core dendrimer followed by covalent cross-linking. This class of 
nanostructures utilizes steric hindrance to saturate the core dendrimer with various 
sized (i.e. generation) shell dendrimers to create megamers resulting in precise 
Figure 3.1. Controlled super atom-based nanostructures can be classified as:  I) Extended 
Nanostructures including in one to three dimensions (for example: fibers, sheets, and lattices)  II) 
Stochastic Nanoclusters and III) Precise Nanoclusters. 
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nanostructures. Surface modification, with reactions such as acetylation, allows for 
fewer shell dendrimers to saturate the surface to give modular control of the resulting 
structures, but relying on stochastic reactions leads to a loss of precisely controlled 
structures.[22] Tecto-dendrimer assembly allows for building large megamers without 
encountering limiting generation effects[23] such as loss of flexibility, low solubility, 
and increased polydispersity of monomeric dendrimers of similar size ranges.[18]  
The self-assembly approach has been shown to yield structures of Class II with a 
fairly narrow mass and size range but does not allow systematic, modular variation of 
the number of components. 
An alternative approach has been to use cross-linkers to assemble groups of small 
dendrimers or dendrons into hierarchical structures. Such techniques have been 
successfully employed to synthesize extended supramolecular structures such as Class 
I porous networks[17, 24, 25], one dimensional structures[26], and two and three 
dimension structures (exemplified by Percec et al.).[27, 28]  There are also examples 
of the assembly of dendrimers into  Class II supramolecular nanoparticles with 
modular size control via crosslinking with linear polymers.[29]   
Class III precise, three-dimensional architectures have been synthesized using 
chemistries to specifically link controlled numbers of dendrons together through the 
focal point[30] or through single ligands on two dendrimers.[31, 32] The former 
approach, while resulting in precise nanoclusters, is limited by control over 
functionality of both the linking system and the dendron. To date, only small (4,000 to 
30,000 Da) precise dendron-based dumbbell nanostructures have been assembled.[30, 
33] A particularly interesting example by Liu et al. assembled dendrons around a 
streptavidin to form tetramer-like clusters, an approach limited by the number of 
binding sites on the protein linker system.[34] Table 3.1 gives a summary of the 
synthesis strategy and characterization of previous soft super atom Class II and III 
materials. 
Table 3.1. Summary of soft superatom synthetic approaches and characterization. 
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Poly(amidoamine) (PAMAM) dendrimers are of particular interest for 
implementation as soft super atoms due to their advantageous properties such as 
aqueous solubility, biocompatibility, and functionalizable surface groups. The 
dendrimers implemented in this work are fifth generation synthesized divergently 
from an ethylenediamine core.[35] In this work, the positively charged primary amine 
surface has been neutralized via acetylation, which decreases the cytotoxicity of the 
material and increases resolution of the species in the reverse-phase high performance 
liquid chromatography (rp-
HPLC) methods employed. 
Although previous studies 
indicated the potential of 
dendrimers to serve as soft 
super atoms, synthetic by-
products in PAMAM 
dendrimer lead to trailing 
generation and oligomeric 
impurities ranging from 1.4 to 
115 kDa (Figure 3.2).  The 
presence of these impurity 
species represent an important 
Figure 3.2. The monomer G5 PAMAM material used for this 
study is indicated by the 26 – 30 kDa fraction within the 
dashed red lines.  Isolation of monomer G5 reduces size range 
of PAMAM building blocks by over an order of magnitude. 
Table 3.1. Summary of soft superatom synthetic approaches and characterization. 
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limitation on the degree of homogeneity one can hope to achieve for the self-
assembled or linked megamer products and represent an important difference between 
this class of super atoms and the actual atoms they are meant to mimic. 
 Recent work by van Dongen, Banaszak Holl et. al has enabled the isolation of 
monomeric PAMAM dendrimer for use as a soft super atom.[36] Here, we implement 
a method to synthesize assemblies of monomeric dendrimers via click chemistry.  Our 
approach differs from previous strategies in the following ways:  1) our soft super 
atom, G5 PAMAM, does not contain the trailing generations, dimer, and trimer that 
typically remain in G5 and higher generation PAMAM preparations[36, 37]  2) we 
assemble dendrimers containing defined numbers of ligands per dendrimer particle, 3) 
a digital set of precise, flexible structures has been generated ranging from 30 to 150 
kDa using ~30 kDa units.  This strategy differs from previous approaches that relied 
on self-assembly determined by dendrimer size or employed dendrimers containing a 
stochastic distribution of ligands per dendrimer or polymer particle. 
 
Materials. All chemicals and materials were purchased from Sigma Aldrich or 
Fischer Scientific and used as received unless otherwise specified. Monomer G5 
PAMAM dendrimer was purchased from Dendritech and purified as previously 
reported to remove trailing and oligomer impurities.[36] Click-Easy™ MFCO-N-
hydroxysuccinimide was purchased from Berry & Associates Synthetic Medicinal 
Chemistry. 3-(4-(2-azidoethoxy)phenyl)propanoic acid (azide ligand) was prepared as 
described previously.[38] 
Preparation of G5-Ac-MFCO4.0(avg) and G5-Ac-Azide4.0(avg) conjugates.  Conjugates 
were prepared using monomer G5, and azide ligand or Click-Easy™ MFCO-N-
hydroxysuccinimide. Amine-terminated G5 (319.6 mg for azide conjugate, 299.5 mg 
for MFCO conjugate) was dissolved to give a 0.16 uM solution in deionized water 
(DI). The azide ligand (10 mg) was pre-activated in a solution at 22 mM in 
acetonitrile (2.5 mL) with 58 mM 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
(24.1 mg) and 60 mM N-hydroxysuccinimide (14.4 mg). Click-Easy™ MFCO-N-
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hydroxysuccinimide (9.3 mg) was not pre-activated and was prepared by dissolving to 
10.5 uM in acetonitrile (2.3 mL). Four molar equivalents of the ligand solution was 
added dropwise via syringe pump to the dendrimer solutions. The solutions were 
stirred overnight. The products were purified using Amicon Ultra Centrifugal units, 
10kDa cutoff membranes, 2 PBS washes and 4 DI washes. A white solid was isolated 
via lyophillization for each conjugate (204.7 mg for azide conjugate, 231.1 mg for 
MFCO conjugate). The materials were then fully acetylated by re-dissolving in 
anhydrous methanol (0.19 uM, 30 mL) and adding 450 equiv of triethylamine and 360 
equiv of acetic anhydride, stirring for 4 hours, the methanol was then removed and the 
sample redissolved in water, purified by the same centrifugation protocols previously 
described, and isolated by lyophillization. G5-Ac-MFCO4.0(avg) and G5-Ac-
Azide4.0(avg) were characterized by rp-UPLC and 
1
H-NMR (see supporting 
information). 
Isolation of conjugates containing precisely defined ratios of G5-Ac-MFCOn (n = 1 – 
4) and G5-Ac-Aziden (n = 1 – 4).  Dendrimers containing precise ratios of MFCO or 
azide ligands per particle were isolated via rp-HPLC. Multiple injections of G5-Ac-
MFCO4.0(avg)  or G5-Ac-Azide4.0(avg) were performed on a C18 column using a 
water/acetonitrile gradient with 0.1% TFA. Fractions were collected as the material 
eluted and combined to obtain samples with ratios of n = 0, 1, 2, 3, and 4 MFCO or 
azide ligands, and a final sample that contained dendrimer with 4 or more click 
ligands. Products were purified using PD-10 desalting protocols as specified in the 
instruction manual, with DI used as the equilibration buffer and samples initially 
dissolved in 10xPBS, then lyophilized to dry. Samples were characterized by rp-
UPLC and 
1
H-NMR. Curve fitting of UPLCs using Igor Pro was performed to provide 
yield, purity, and rp-HPLC number of MFCO averages (see supporting information). 
Synthesis of megamer samples. n (n = 1 - 4) equivalents of G5-Ac-Azide1was 
dissolved to give a 300 µM solution in dimethylsulfoxide. To this, 1 equivalent of G5-
Ac-MFCOn (n = 1 - 4) was added. For example, to prepare the tetramer sample (n = 
3), 2.7 mg of G5-Ac-Azide1 was dissolved in 273 µL of DMSO, then 0.9 mg of G5-
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Ac-MFCO3 was added. Solutions were protected from light and agitated for 48 hours.  
The samples were lyophilized to give white solids. 
 
Methods.  
High Performance Liquid Chromatography. Isolation of G5-Ac-MFCOn (n = 1 – 4) 
and G5-Ac-Aziden  (n = 1 – 4) fractions was achieved using a Phenomenex Jupiter 
300Ȧ C18 Prep Column (21.2 x 150 mm, 5 µm particles) equipped with a Waters 600 
Controller, Waters 2707 Autosampler, and Waters 2998 Photodiode Array running 
Empower 2 Software, additionally equipped with a Waters Fraction Collector III. The 
weak solvent (Solvent A) was HPLC Grade Water with 0.1% TFA, and the strong 
solvent (Solvent B) was HPLC Grade Acetonitrile with 0.1% TFA. The gradient 
employed was as follows: 2.1 min load step at 95%A/5%B, 3.9 min gradient to 
80%A/20%B, 15 min gradient to 65%A/35%B, 5 min gradient to 55%A/45%B, 
followed by 3 min was at 20%A/80%B, then equilibrating at starting conditions for 5 
min before next injection. G5-Ac-MFCO4.0(avg) or G5-Ac-Azide4.0(avg) was dissolved to 
20 mg/mL concentration and 910 uL injections were used. Five second fractions were 
collected starting at 9 min 30 sec into each run for a total of 120 fractions. rp-UPLCs 
were performed with a scaled method using an Agilent 2.1 x 100 mm column. 
LC Peak Fitting. rp-UPLC chromatograms were fit with Gaussian peaks using Igor 
Pro Version 6.0.3.1 software. Peak widths within a chromatogram were kept constant.  
Nuclear Magnetic Resonance Spectroscopy. NMR experiments were performed on 
Varian VNMRS 500. 
1
H-NMR spectra were obtained used 10 second pre-acquisition 
delays and a total of 64 scans. All sample solutions were set to an approximate 
dendrimer concentration of 5 mg/mL in deuterium oxide.  
Gel Permeation Chromatography. Gel permeation chromatography experiments were 
performed on an Alliance Waters 2695 separation module equipped with a 2487 dual 
wavelength UV absorbance detector (Waters Corporation), a Wyatt HELEOS Multi 
Angle Laser Light Scattering (MALLS) detector, and an Optilab rEX differential 
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refractometer. Columns employed were TosoHaas TSK-Gel Guard PHW 06762 (75 
mm × 7.5 mm, 12 mm), G 2000 PW 05761 (300 mm × 7.5 mm, 10 mm), G 3000 PW 
05762 (300 mm × 7.5 mm, 10 mm), and G 4000 PW (300 mm × 7.5 mm, 1 mm). 
Column temperature was maintained at 25 ± 0.1 °C with a Waters temperature control 
module. The isocratic mobile phase was 0.1 M citric acid and 0.025 wt % sodium 
azide, pH 2.74, at a flow rate of 1 mL/min. The sample concentration was 10 mg/5 
mL with an injection volume of 100 μL. This was used to calculate the weight 
average molecular weight, Mw, and the number average molecular weight, Mn, with 
Astra 5.3.2 software. Values for dn/dc were kept at a constant of 0.215. 
 
Mass Spectrometry. Matrix-assisted Laser-Desorption Time-of-Flight Mass 
Spectrometry (MALDI-TOF-MS) was performed using a MALDI Micro MX running 
MassLynx Version 4.0 software. Dendrimer samples were prepared by dissolving in 
DI water at concentration 10 mg/mL, then serial diluting with methanol 1:1, then 1:4. 
The samples were then mixed 1:1 with the matrix dihydroxybenzoic acid 
(concentration of 10 mg/mL in 1:1 water/acetonitrile) and spotted on to a MALDI 
plate. Samples were calibrated using bovine serum albumin with a matrix of sinapic 
acid. At least 150 laser shots were compiled for each spectrum. The spectra were 
smoothed using the MassLynx Software settings of Smooth window (channels) equals 
12, and Number of smooths equals 12. No baseline subtraction or peak centering was 
performed. 
 
Results and Discussion.  
PAMAM dendrimers have been extensively studied as nanoscale biomedical devices 
due to their low polydispersity, multiple sites for chemical modification, flexibility, 
water solubility at high generations, and biocompatibility.[15, 39, 40] Recent work 
has employed rp-HPLC to remove both generational and oligomer (primarily dimer 
and trimer) impurities from generation 5 (G5) PAMAM to obtain samples of G5 
monomer with a PDI under 1.02 (Figure 2).[36] The mass dispersity of the building 
block materials has been reduced from greater than 100 kDa to less than 3 kDa.  In 
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order to assemble these 
monomeric units into controlled 
megamer units, we have 
employed our methods for 
attaching precise numbers of 
click conjugation functional 
groups per dendrimer 
particle.[38, 41, 42] This synthetic strategy generates materials with precise 
ligand/particle ratios in a manner that is independent of the mass dispersity of the soft 
super atom scaffold, thus decoupling mass dispersity and particle assembly. Although 
work in the tecto-dendrimer field has been successful in generating highly 
homogenous assemblies of dendrimers, the size of these clusters is pre-determined by 
the size of the core and shell dendrimers and cannot be modularly controlled.   For 
example, assembly of G5 PAMAM around a core G7 PAMAM yielded primarily 
G7(G5)12, with incompletely packed shells containing 9 to 11 G5 per G7 also 
observed.[20] The self-assembly process does not allow for the generation of a 
controlled set of samples to stoichiometry G7(G5)n were n is digitally varied.  In 
addition, dispersity in numbers of G5 packing around G7 may arise from the 
molecular weight distribution present in both the G5 and G7 samples including 
trailing generations and oligomers. 
 The synthetic strategy for the click conjugates and megamers is outlined in Scheme 
3.1. First, a stochastic conjugation via a peptide bond to an azide or ring-strained 
cyclooctyne click ligand is followed by acetylation of all remaining primary amine 
groups (Scheme 3.1).  These materials are designated G5-Ac-MFCOn(avg) and G5-Ac-
Aziden(avg).   In order to optimize the amount of material for isolation of dendrimer 
containing 1-4 click linkers, an initial stochastic average of 3-4 ligands/particle was 
typically employed.  Isolation of dendrimer samples containing precise click-
ligand/dendrimer ratios, as opposed to an average ratio made of up a Poisson 
distribution, was achieved using semi-preparative scale rp-HPLC (Figure 3.3 a) 
following previously published protocols.[38, 41] The dendrimers are retained on the 





column as a function 
of the number (n) of 
hydrophobic ligands 
conjugated to the 
dendrimer surface. 
This model is 
supported by the 
increased resolution of 
the MFCO conjugate, 
which contains the 
hydrophobic cyclooctyne entity and a 5 carbon linker, as compared to the azide 
conjugate.  The successful application of this isolation process to the commercially 
available MFCO ligand demonstrates a broader versatility for this separation process. 
rp-UPLC was employed to confirm that successful separation was achieved (Figures 
3.3 b, B1). The initial stochastic distribution of click ligand on the dendrimer can be 
visualized[43] and subsequently separated via rp-HPLC due to increased retention 
time with the increasing numbers of hydrophobic ligands available for interaction 
with the hydrophobic C18 stationary phase.[38, 41, 42] These materials are 
designated G5-Ac-MFCOn (n = 1 – 4) and G5-Ac-Aziden (n = 1 – 4).  
1
H NMR also 
confirmed that the desired click-ligand/dendrimer ratios had been achieved (Figures 
B2, B3; Tables B1, B2).  In assessing the purity of each isolated fraction containing 
the precisely defined ligand/particle ratio (n ligands per dendrimer), rp-UPLC 
provides the most direct measure.  The separation is based on the number of 
hydrophobic ligands per particle and excellent separation is achieved.  The G5 
PAMAM dendrimers are flexible enough to effectively display the ligands to the 
hydrophobic C18 support regardless of their relative conjugation point on the 
PAMAM scaffold.  The assessment of the ligand/particle ratio by 
1
H NMR requires a 
number of key assumptions and relies on average polymer properties at key points of 
the analysis.  The NMR-based ratio is determined by comparing the integration of the 
ligand protons to the integration of the terminal –NHC(O)CH3 groups on the 
Figure 3.3. (a) Semi-prep rp-HPLC isolation of precisely defined G5-
MFCOn species, colored bars represent combined fractions. (b) UPLC 
of combined fractions demonstrates that each sample now contains a 
single particular ligand/dendrimer ratio.  
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dendrimer. This analysis suffers 
from comparing a small value 
(the ligand) to a large value 
(acetamide group) and from 
having to employ an average 
number of these groups for G5 
PAMAM of 93, although this 
number varies from ~70 to 116 for each particle.  For these reasons, we believe the rp-
UPLC measurement provides the better quantitative analysis of ligand/particle ratio.   
Peak fitting of rp-UPLC also allows for an estimation of the relative amount of each 
ligand/particle ratio in the initial averaged sample and in turn for an estimation of 
percent recovery of the precise product from the stochastic mixture (supporting 
information). The recovery of the components utilized in this work (G5-Ac-MFCOn n 
=1 – 4 and G5-Ac-Azide1) range from 43% to 77%. These represent the yield of the 
final clicked megamer products as well since complete recovery of samples is 
possible without further purification. 
Through combination of precise ratio ligand-to-dendrimer G5 monomers containing n 
= 1 azide ligand and n = 1 - 4 cyclooctyne ligands, we have synthesized a digital set 
of modular and precise megamer nanostructures (Scheme 3.2, Figures 3.4 and 3.5).  
Figure 3.4.  (a-d) UPLC chromatograms at 210 nm of dimer (a, orange), trimer (b, green), tetramer (c, 
blue), and pentamer (d, purple) products with the starting materials, G5-Ac-Azide1 (cyan) and 
corresponding G5-Ac-MFCOn ( n= 1 - 4) (pink). The symbol “#” indicates peaks that have been assigned 
as incompletely clicked products and “*” indicates unreacted G5-Ac-Azide1 in the product. 
Scheme 3.2. Click reaction for synthesis of megamers from 
precisely defined dendrimer conjugates. 
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G5 dimers, trimers, tetramers (one core with three shell dendrimers), and pentamers 
(one core with four shell dendrimers)  have been synthesized from a click reaction 
between G5 with 1 azide ligand to G5 conjugated to 1, 2, 3, and 4 monofluorinated 
cyclooctyne (MFCO) ligands, respectively. Briefly, G5-Ac-Azide1 was added in 
equimolar, two-fold, three-fold, or four-fold equivalents to 1-2 mg G5-Ac-MFCOn (n 
= 1 - 4), respectively and mixed for 48 hours.  The product peaks illustrated in Figure 
3.4 (orange for dimer, green for trimer, blue for tetramer, purple for pentamer, color 
designations that will be kept for the remainder of this article) are shifted to the left 
with respect to the G5-Ac-Azide1 starting material (yellow) and G5-Ac-MFCOn (n = 1 
- 4) starting material (pink), indicating less interaction with the hydrophobic column 
after formation of the click linkage.  Solid samples were isolated for G5-(G5)n (n = 1 - 
4) megamers by lyophillization. For n = 1 and 2, each reactant peak was entirely 
consumed.  For n = 3 and 4, smaller peaks (*) are present in addition to the desired 
product peak that are most likely unreacted G5-Azide1 although partially reacted G5-
Ac-MFCO4-n-(G5-Ac-Aziden) cannot be ruled out.  Small peaks for partially reacted 
G5-G5m-MFCOn-m species also appear for the trimer, tetramer, and pentamer samples 
(#), which may result from cyclooctyne ligands becoming sterically blocked by 
previously clicked dendrimers on the particle or by small errors in the stoichiometry 
Figure 3.5. Scale cartoons of monomer and megamer structures generated using the COMPASS 
force-field in Materials Studio.  The top row illustrates megamers separated by the largest distance 
allowed by the linker system (~4 nm). The bottom row depicts structures in which the dendrimers 
units are at a van der Waals separation distance. 
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of addition.  Other possible assignments for the * and # peaks include regioisomers of 
the location of the clicked dendrimers on the central dendrimer surface as well as 
structural isomers resulting from the two possible click isomers.  We do not favor 
these last two hypotheses since we do not anticipate this large of a shift (click 
regioisomers) and believe a broad distribution of products (resulting from surface 
regioisomers) is unlikely to result in the discrete peaks observed.  Possible side 
products resulting from incomplete reaction and the regiochemistry of the click 
reaction are schematically depicted in Figure B4.  The purity of the isolated materials 
as illustrated in Figure 3.4 can be compared to anticipated distribution of products if 
stochastic averages of G5-Ac-Azide1 and G5-Ac-MFCOn (n = 1 - 4) had been 
employed.  Combining the stochastically prepared materials for cycloalkyne navg 1 – 4 
and azide navg = 1 would yield mixtures containing roughly 16, 24, 28, and 36 primary 
products.[41, 42]  
In order to help visualize the structures, scale models are illustrated in Figure 3.5.  
The top row, with dendrimer units spaced apart, emphasizes the connectivity, 
although it is important to note that for all megamer samples the dendrimers on the 
periphery are bound to a distribution of the flexible surface arm locations.  The 
bottom row, with dendrimer units in van der Waals contact, is likely the more realistic 
view of megamer structure in aqueous solvent based on previous computational 
work.[44]  
MALDI-TOF-MS (Figure 3.6) was consistent with the rp-UPLC structure 
assignments. A mass increase of approximately 30 kDa, corresponding to expected 
molecular weight change from the monomer (red), to the dimer (orange), trimer 
(green), tetramer (blue), and pentamer (purple) is observed. In the pentamer, the [M5]
+
 
peak can be readily seen at approximately 150 kDa, which is not present in the 





 peak is present for the trimer at 90 kDa with a [M3]
2+
 peak 
evident at 45 kDa.  A peak for the parent ion of [M4]
+ 
appears at 120 kDa along with a 
peak at the expected mass of 60 kDa for [M4]
2+
; however, in this case an interfering 
peak precludes an unambiguous assignment for the doubly ionized species.  Similarly, 
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a peak is apparent at 60 kDa 
for dimer [M2]
+
 although the 
monomer also gives some 
signal at this position, albeit at 
a substantially reduced 
intensity.  These data are 
consistent with the formation 
of the controlled ratio 
materials; however, similar to 
the NMR analysis it is 
complicated by the dispersity 
of the monomer G5 scaffold, 
which has mass distribution 
ranging from roughly 22,000 to 
27,000 kDa.[36]  
The samples were further 
Figure 3.7. (a) Cumulative data function of Mn from GPC results. (b) Cumulative data function of each n-
mer divided by n. 
Figure 3.6. Normalized MALDI-TOF-MS spectra of commercial 
G5 PAMAM (black), G5 monomer (red), dimer (orange), trimer 
(green), tetramer (blue), and pentamer (purple). The [M5]
+
 peak 
has been magnified by 10 for ease of visualization. 
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characterized by gel permeation chromatography (GPC). The cumulative data 
function shows steps of approximately 30 kDa, corresponding molecular weight of the 
acetylated G5 monomer (Figure 3.7a). Increased heterogeneity, as demonstrated by 
deviation of the megamer slopes from vertical, arising from additive branching-type 
structural defects that are still present in the G5 monomer starting material, is both 
expected and observed as number of monomer units increases from 1 (red, monomer) 
to 5 (purple, pentamer).  
This can be further demonstrated by dividing each megamer structure by the number 
of monomer units it contains (e.g. dimer by 2, trimer by 3, see Figure 7b) where the 
resulting plots have similar slopes.  In this instance, the presence of the mass 
dispersity actually provides additional support for the assigned structures.  Steps in 
the larger megamers are also seen, corresponding to small amounts of incompletely 
reacted materials still present in the sample. Table 3.2 summarizes the GPC molecular 
weight results. The average molecular weight changes in multiples of the monomer 
mass. The less-than-ideal ratio for the pentamer is consistent the presence of 
unreacted partial click reaction as observed by UPLC. 
The removal of oligomeric defects that constituted over 20% by mass of commercial 
PAMAM material has enabled the synthesis of these megamer structures with low 
polydispersity. As demonstrated in previous work from this group[36], the rp-HPLC 
methods employed here to isolate dendrimers as a function of number of hydrophobic 
ligands also separate oligomer defects within the G5 PAMAM. As a result, oligomers 
conjugated to n-1 ligands co-elute with monomers conjugated to n ligands (for 
example, Dimeric G5-MFCO1 co-elutes with Monomeric-MFCO2). Such impurities in 
Species Mn Mw PDI Mn (megamer)/Mn (monomer) 
Monomer 29,790 31,333 1.052 1.0 
Dimer 57,340 59,340 1.017 1.9 
Trimer 79,230 81,560 1.029 2.7 
Tetramer 116,700 120,700 1.035 3.9 
Pentamer 131,500 139,800 1.063 4.4 
Table 3.2. Quantitative summary of GPC results. 
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the starting material would create side products in megamer assembly with molecular 
weights double the theoretical value and greatly increase the polydispersity.  The 
successful removal of the oligomeric side products reduces the high molecular weight 
impurities as measured by GPC in Figure 3.7 a. 
 
Conclusions.  
This work, demonstrating the use of PAMAM dendrimers containing precisely 
defined ligand/particle ratios as building blocks for generating controlled 
nanostructures in the 30 to 150 kDa size range, advances the use of dendrimers as 
quantized building blocks for homogenous megamers the size of large proteins and 
multi protein constructs. The HPLC isolation platform has proven to be efficient and 
versatile,[38, 41] with similar preparation and isolation procedures for at least 4 
complimentary click ligands to date allowing for diverse chemistries to be utilized 
with high (30%-80%) recovery of precise ligand/particle materials from the stochastic 
mixture. The one-pot self-assembly creates stable, covalently bound megamers that 
are soluble in water and organic solvents methanol and dimethylsulfoxide, making 
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Avidity of Dendrimer-Folic Acid Conjugates with Controlled Valency 
 
Introduction.  
Folic acid (FA) targeting has been extensively studied for improving the therapeutic 
index of drugs.[1-5] Although the structure of this interaction has only recently been fully 
elucidated,[6] substantial progress has still been made over the last 20 years in FA 
targeting with four drug conjugates advancing to clinical trials. Targeting of a drug or 
drug conjugate exploits the interaction of this vitamin with a high affinity (Kd ~ 0.1 
nM)[2] folate receptor, which is overexpressed in many cancer cells. This receptor is also 
found in healthy epithelial cells; however, these are generally inaccessible to FA bearing 
conjugates in the blood,[2] making it an ideal target to exploit cytotoxic effects of drugs 
while minimizing the concern of collateral damage in healthy tissues. In addition to cell 
surface targeting, FA conjugation provides a selective uptake pathway for the conjugated 
drug via folate receptor mediated endocytosis and release of the FA/conjugate from the 
receptor and endosome.[7, 8] Many drug delivery designs have been employed to take 
advantage of this highly specific interaction to target small molecule chemotherapeutics 
such as doxorubicin,[9] methotrexate,[10] protein toxins,[11] imaging agents,[12, 13] and 
immunotherapeutics[14] both in vitro and in vivo by exploiting carrier mechanisms 
including liposomes,[15] inorganic nanoparticles,[12] and organic polymers.[16-18] 
Multivalent conjugates of ligands to nanomaterials are often employed, purposefully to 
increase the avidity and/or specificity of an interaction, or accidently as a result of 
stochastic synthetic approaches. The enthalpic and entropic mechanisms through which 
multivalency increases the interaction of a ligand and its target have been extensively 
studied from a theoretical viewpoint.[19-23] Briefly, there are two main multivalent 
effects that may contribute to the system studied here; those dependent on the increased 
effective or local concentration, and those due to multiple binding events occurring for a 
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single conjugate.[24] The term effective concentration describes the localization of many 
ligands in a nanoscale volume by a carrier (scaffold or vector), resulting in a local 
concentration of ligands much higher than a solution containing an equivalent amount of 
free ligands. Higher local concentrations can result in higher affinities, and an increased 
chance of re-binding upon dissociation of the initial interaction (“statistical re-binding”). 
The binding of one ligand to a 
target brings the other ligands on 
that vector into closer proximity to 
the target (and the surface if the 
target is immobilized), increasing 
the chances of additional binding 
events.[25, 26] These binding 
events can be of three types; (1) 
Interaction with a nonequivalent 
site on the same receptor, (2) 
Interaction with an equivalent site 
on a oligomeric receptor , or (3) 
Interaction with a site on a second 
receptor (also known as receptor 
clustering). These multivalent 
classifications have been discussed and reviewed elsewhere by Kiessling, [27, 28] 
Whitesides,[24] and Cloninger.[25]  
Although multivalent conjugates of many dyes, drugs, and targeting ligands (including 
FA) have been developed, the actual impact of the specific number of ligands on 
improvements in avidity and/or biological activity has been difficult to analyze due to the 
heterogeneous mixtures generated by statistically random conjugation chemistries 
employed in their synthesis.[29] For example, a stochastic conjugation of 3 equivalents of 
FA to a scaffold with multiple functionalizable sites (≥30) results in a sample with a 
mean of ~3 FA per scaffold, but also a distribution of unique conjugates with FA-to-
scaffold ratios ranging from 0 to ~11 FA molecules per scaffold (Figure 4.1). Previous 
efforts to quantify multivalent binding constants have employed surface plasmon 
Figure 4.1. Distribution of conjugates resulting from a 




resonance (SPR) to measure increases in binding between materials containing different 
average numbers of ligands (folic acid[30] and methotrexate[31-33]) and folate binding 
protein (FBP) modified surfaces.  Although these studies have reported a general trend of 
greater avidity with increased valency, the utilization of averaged materials did not allow 
for precise understanding of the mechanisms involved in multivalent binding, or 
elucidation of the relative activity of the various components in the sample. For example, 
does the entire population illustrated in Figure 4.1 with 2 or more conjugated FA (80% of 
the population) enable equivalent receptor clustering in a cell? Or does a higher valency, 
and consequently higher effective concentration, such as 5-11 FA-per-scaffold (18% of 
the population) contribute all of the observed activity? 
Poly(amidoamine) (PAMAM) dendrimer is an extensively studied vector for the 
multivalent, targeted delivery of drugs, genes, and imaging agents.[34, 35] The dendritic 
architecture has many advantages for biomedical applications, including very low 
polydispersity, internal core space available for the entrapment of drugs, and multiple 
branches providing terminal groups for functionalization.[36] PAMAM dendrimer is 
particularly suited for such applications due to its protein-like architecture, low 
immunogenicity, ability to solubilize hydrophobic small molecules, and easily 
functionalized primary amine terminal surface groups.[37-39] The size of generation 5 
(G5) PAMAM (5 nm) is also ideal for vascular delivery and excretion due to kidney 
filtration.[40] Recent advancements[41] have enabled the isolation of monomeric G5 
PAMAM dendrimers from oligomeric (dimer, trimer, etc.) and trailing generation defects 
(G1 – G4), narrowing the experimentally realized size distribution of this vector from 1 
kDa-115 kDa to 25 kDa to 29 kDa. Possible convolution of results by large mass 
differences and vector-accessible surface area is eliminated by removing both trailing 
generations and oligomers from the G5 PAMAM monomer material.  
In 2007, Banaszak Holl et. al. employed SPR to examine the increased avidity to FBP 
and cellular uptake of G5 PAMAM-FA conjugates as a function of average number of 
attached FAs (Figure 4.2).[30] The dissociation constant (kd) was observed to 
exponentially decrease as the average valency of FA increased; however, this calculation 
assumed that given a long enough experiment all bound materials would dissociate from 
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the surface and that the experimental sensogram would return to the level of signal 
present prior to G5-FAn(avg) exposure. The nonlinear behavior in kd was attributed to a 
saturation of FA-FBP binding events limited by the immobilized protein density on the 
SPR flow cell surface and not to the valency of FA (Figure 4.2a). Interestingly, the same 
trend in signal saturation as a function of FA valency was observed for mean 
fluorescence as measured by flow cytometry when equivalent conjugates labeled with a 
dye were evaluated for binding to folic acid receptor upregulated KB cells. This 
observation was interpreted as an indication that the dendrimer conjugates do not trigger 
receptor clustering on the cell surface, which would allow for higher affinities as more 
proteins became available.  
Subsequent analyses of this data set have employed different assumptions in the analysis 
of the data. These interpretations have resulted in two alternate mechanisms for 
explaining the changes in binding as a function of average valency.  In 2010, Sander et al. 
proposed that the binding of the conjugates occurs via two distinct interactions.[42] This 
Figure 4.2. Proposed models for enhanced G5-FA binding to FBP. (a) Multivalent binding increases 
avidity with increasing valency. (b) Any multivalent binding (2 or more interactions) is irreversible and 
monovalent binding is reversible. (c) FA "keys" the initial interaction between conjugate and FBP, which 
is followed by strong nonspecific interaction between the dendrimer and protein. 
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mechanism acknowledges the broad distribution of ligand-to-dendrimer ratios present in 
stochastically synthesized materials, including dendrimers that have zero FA, one FA, or 
two or more FA.  It was proposed that (1) monovalent interaction between G5-FA1 and 
on FBP attributes to the binding that is reversible on the time scale of the experiment and 
(2) multivalent binding between G5-FA≥2 to two or more FBPs is permanent on the SPR 
experimental timescale (Figure 4.2 b). The authors argue that the increased avidity 
attributed to valency increase by Banaszak Holl et al.[30] is actually a result of decreased 
amounts of zero-functional and mono-functional conjugates in the stochastic average 
material.  This mechanism still proposes that FA-based multivalent binding is important.  
Indeed, it ascribes the binding constant for G5-FA≥2 as large enough to prevent any 
measurable dissociation over the timescale of the experiment.  The original flow 
cytometry data can be similarly interpreted; receptor clustering is achieved by bivalent 
conjugates and further increasing of valency has no measureable effect on the cell. A 
very different mechanism based on kinetic limitations of cooperativity to explain the 
plateau of high avidity of the conjugate species was proposed by Licata and Tkachenko in 
2008.[43] This study concludes that the increased avidity proposed for the G5-FAn(avg) 
conjugates[30] is higher than can be attributed to cumulative effects of multivalent 
binding and that kinetic limitations actually prevent the type of multivalent interactions 
proposed in Figures 2a and 2b. They propose that the enhanced interaction observed by 
SPR is a result of non-specific surface (van der Waals) interactions between the polymer 
vector and protein/surface that are enabled by the initial key-lock binding between FA 
and FBP (Figure 4.2c).  
The broad distribution of folic acid-to-dendrimer ratios present in each sample, including 
both monovalent and multivalent conjugates in the low averaged materials, prevented a 
clear experimental elucidation between the three mechanisms. In particular, a conjugate 
with precise ratio of 1 FA-per-dendrimer (G5-FA1) was lacking to determine if the 
observed increase in avidity was a product of multivalent binding between the conjugate 
and SPR surface (Banaszak Holl and Sander mechanisms)[30, 42] or a single FA-FBP 




In order to address these materials-based challenges to understanding multivalency, we 
have developed click chemistry and reverse-phase High Performance Liquid 
Chromatography (rp-HPLC) methods to isolate dendrimers conjugated to precise 
numbers of ligands (ie G5-Ln n = 1-5 where n is not a mean value).[29, 44, 45]  These 
methodologies, which have been previously demonstrated to be successful for azide[29, 
44, 46] and fluorinated, ring-strain-promoted click ligands,[46] are now extended to a 
second ring strain promoted ligand (cyclooct-1-yn-3-glycolic acid (COG)), which has 
been used in previous G5-FAn(avg) SPR studies.[32] In principle, isolating the precise ratio 
samples G5-FAn, n = 1, 2, 3, etc., would allow SPR experiments where the multivalent 
binding effect are decoupled from the heterogeneity of stochastic samples (G5-FAn(avg)). 
In order to generate non-stochastic FA-dendrimer ratios, dendrimer samples conjugated 
to 1, 2, 3, or 4 ring-strain promoted click ligands were isolated by semi-preparative scale 
rp-HPLC. This isolation was followed by a click reaction with a -azide-Lys-Asp-FA 
derivative (-azide-FA). The resulting samples include a G5-PAMAM dendrimer with a 
FA-to-dendrimer ratio of 0.96 that contains no multivalent G5-FA≥2 species.  This 
conjugation provides the key G5-FA1 sample needed to differentiate the three 
mechanistic hypotheses proposed to date.  The remainder of the click reactions did not 
proceed with 100% efficiency, but still yielded samples that contained a well defined 
high-n cutoff and had a narrower-than-stochastic distribution of FA-to-dendrimer ratios. 
The binding kinetics of these conjugates were analyzed by SPR on both high and low 
protein density surfaces. The results indicate that at either surface FBP density, the total 
folic acid concentration present is the dominant factor leading to increased amount of 
bound material with increased valency. A small deviation from the overall binding trend 
was observed for the monovalent G5-FA1 sample.  In this case, the lower amount of 
binding as compared to the G5-FA≥2 species was attributed the difference in local 
effective concentration.  In other words, a small multivalent effect is observed for G5-
FA≥2 material because of increased statistical rebinding as compared to G5-FA1. Most 
importantly, the G5-FA1 sample exhibited the same irreversible binding to the FBP 
surface, on the SPR timescale, as the G5-FA≥2 samples.  This observation conclusively 
rules out the earlier mechanistic hypotheses by Banaszak Holl et al.[30] and by Sander et 
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al.[42] and provides strong experimental support for the key-lock/non-specific binding 
mechanism proposed by Licata and Tkachenko.[43] 
 
Experimental Section 
Materials. All chemicals and materials were purchased from Sigma Aldrich or Fischer 
Scientific and used as received unless otherwise specified. G5 PAMAM dendrimer was 
purchased from Dendritech and purified as previously reported to remove trailing 
generation and G5 oligomer impurities.[41] Cyclooct-1-yn-3-glycolic acid (COG) was 
synthesized from a modified literature preparation (see Supporting Information).[47]  
Preparation of G5-Ac-COG4.0(avg) conjugates. Conjugates were prepared from G5 
dendrimer and COG via amide coupling. In brief, amine-terminated G5 was dissolved to 
0.16 uM in DI. COG was activated by dissolving to 10.5 uM in acetonitrile with 2.65 
equiv of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) (EDC) and 2.78 equiv of N-
hydroxysuccinimide (NHS) and stirring for 2 hours. The activated COG was added drop-
wise via syringe pump to the dendrimer solution and allowed to stir overnight. The 
product was purified using Amicon Ultra Centrifugal units, 10kDa cutoff membranes, 
with 2 phosphate buffered saline (PBS) washes and 4 deionized water (DI) washes. 
Product was isolated via lyophillization. The material was then fully acetylated 
(converting 100% of the remaining primary amines to acetyl groups, henceforth 
designated “Ac”) by re-dissolving in anhydrous methanol (0.19 µM) and adding 450 
equiv of triethylamine and 360 equiv of acetic anhydride, stirring for 4 hours, purified by 
centrifugation and isolated by lyophillization. G5-Ac-COG4.0(avg) was characterized by rp-
UPLC. 
Isolation of precisely defined G5-Ac-COGx conjugates. Dendrimers with precise ratios of 
COG ligands per dendrimer were isolated via rp-HPLC according to literature 
procedures.[46] Briefly, multiple injections of the averaged material were performed with 
a C18 column on a water/acetonitrile gradient with 0.1% TFA. Fractions were collected 
as the material eluted and combined to obtain samples with precisely x = 0 - 4 COG 
ligands per dendrimer. Products were purified using PD-10 desalting protocols, with DI 
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as the equilibration buffer and samples dissolved in 10xPBS, then lyophilized to dry. 
Samples were characterized by rp-UPLC and 
1
H-NMR spectroscopy. Curve fitting of 
chromatograms by Igor Pro was performed to assess purity of precise ratio materials and 
to determine the average number of COG ligands of stochastic materials (Table S1). 
Synthesis of -azide-Lys-Asp-Folic Acid (-azide-FA). FA-Azide derivative was obtained 
from collaborators at Purdue University. 
Synthesis of G5-Ac-FAn conjugates. Dendrimers with well-characterized numbers of 
covalently bound folic acids were synthesized via click reaction of G5-Ac-COGx 
conjugates and -azide-FA. Briefly, dendrimer conjugates were dissolved in methanol to 
40 mM with respect to COG, and a 10 fold excess of -azide-FA (40 mM in DMSO) was 
added. Solutions were agitated for 24 hours, then an additional 5 volume equivalents of 
DMSO was added to fully dissolve the dendrimer. Solutions were agitated for an 
additional 24 hours, then diluted to 2.5 mL with DI and purified using PD-10 desalting 
columns, gravity protocols, followed by 16 rounds of dialysis against DI. The samples 
were then further purified by repeating the PD-10 desalting column using 10X PBS to 
dilute the sample, followed by 2 rounds of dialysis against 1X PBS and 4 rounds against 
DI. Recovered samples were characterized by 
1
H-NMR spectroscopy and rp-UPLC. 
Curve fitting of chromatograms provided yield, purity, and FA average and distribution 
species for G5-FAn materials. 
 
Methods. 
High Performance Liquid Chromatography. Isolation of G5-Ac-COGx was achieved 
using a Waters 600 Controller, Waters 2707 Autosampler, and Waters 2998 Photodiode 
Array running Empower 2 Software, additionally equipped with a Waters Fraction 
Collector III on a Phenomenex Jupiter 300Ȧ C18 Prep Column (21.2 x 150 mm, 5 µm 
particles). The weak solvent (Solvent A) was HPLC Grade Water with 0.1% TFA, and 
the strong solvent (Solvent B) was HPLC Grade Acetonitrile with 0.1% TFA. The 
gradient employed at 16 mL/min was as follows: 2.1 min load step at 95%A/5%B, 3.9 
min gradient to 80%A/20%B, 15 min gradient to 65%A/35%B, 5 min gradient to 
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55%A/45%B, followed by 3 min was at 20%A/80%B, then equilibrating at starting 
conditions for 5 min before next injection. Averaged conjugate was dissolved to 20 
mg/mL concentration and 910uL injections were used. Five second fractions were 
collected starting at 9 min 30 sec into each run for a total of 120 fractions. Analytical 
chromatograms were collected on a Waters Acquity UPLC equipped with a scaled 
method using an Phenomenex Jupiter 4.6 x 100 mm column. 
LC Peak Fitting. Chromatograms were fit with Gaussian peaks using Igor Pro Version 
6.0.3.1 software. Peak widths from chromatogram to chromatogram were kept constant. 
Nuclear Magnetic Resonance Spectroscopy. NMR spectroscopy experiments were 
performed on a Varian MR400 instrument. 
1
H NMR spectra were obtained used 10 
second pre-acquisition delays and a total of 64 scans. All sample solutions were set to a 
dendrimer concentration of 1-5 mg/mL in deuterium oxide. 
Surface Plasmon Resonance Spectroscopy. SPR experiments were conducted in a 
Biacore® X instrument (Pharmacia Biosensor AB). Two immobilized folate binding 
protein (FBP) chips were prepared following the instrument prompted protocols, using a 
solution of 0.2 M EDC and 0.05 M NHS as an activating solution, an immobilization 
solution of FBP at 1mg/mL for the “low density” chip and 1.5 mg/mL for the “high 
density” chip, with ethanolamine as the deactivation solution. Flow cell two was 
employed as a control cell by activating and deactivating the surface without the addition 
of protein. The chips were characterized using free FA solutions and checked for non-
specific binding with a control of G5-Ac containing no COG or FA. Immobilization and 
free FA chromatograms can be found in the Supporting Information. The “high density” 
chip contains roughly double the amount of immobilized FBP according to total change 
in response units. Conjugate samples were dissolved in fresh HBS-EP buffer at 100 µM 
and serially diluted to 20, 10, 5, 2.5, and 1.25 µM in HBS-EP buffer from Fischer 
Scientific. Runs were multichannel, FC1-FC2, at 10 µL/min. The system was allowed to 
equilibrate at the beginning of each run for no less than 300 seconds, followed by a 2 
minute, 30 µL (50-5-5-5 bubble method) injection. The system was monitored for no less 
than 500 seconds post-injection. Between each run, the chip was washed with a 5 µL 
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Preparation of G5-Ac-COG4.0(avg) 
conjugates (Figure 4.3a). 41.2 
mg of G5-Ac-COG conjugate 
was prepared with an average of 
4.0 COGs per dendrimer as 
calculated by rp-UPLC peak 
fitting (overall yield 39%). All 
samples were characterized by 
1
H-NMR spectroscopy and rp-
UPLC. 
Isolation of G5-Ac-COGx 
conjugates with precise COG-to-
dendrimer ratios (Figure 4.3b-c). 
Dendrimer samples with x = 0-4 
were isolated in quantities 
ranging from 1 to 8 mg. All samples were characterized by 
1
H-NMR spectroscopy 
(Figure C1) and rp-UPLC (Table C1). 
Synthesis of G5-Ac-FAn conjugates (Figure 4.3d). One equivalent of G5-Ac-COGx  and 
10*x (x = 1 - 4) equivalents of -azide-FA were dissolved to give a dendrimer 
concentration of 10 mg/mL in DMSO. Reactions were shaken for 48 hours with 
occasional vortexing. Samples were then desalted according to the manufacturer’s gravity 
protocol with PD-10 desalting columns (equilibration buffer as DI, sample dissolved in 
10xPBS), and then dialyzed against DI using 10,000 Da cutoff membranes (16 media 
changes). Large amounts of unreacted -azide-FA remained after initial purification as 
detected by rp-UPLC. Two additional rounds of dialysis against 1xPBS buffer followed 
Figure 4.3. (a) Synthesis of PAMAM-COG conjugate. (b) 
Semi-prep rp-HPLC isolation of PAMAM with 1, 2, 3, 4, or 5 
COGs. (c) Isolated samples elute from rp-UPLC as a function 
of ligand-to-dendrimer ratio. (d) Scheme of G5-COG click 
reaction of -azide-FA. 
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by 4 rounds against DI removed all visible traces of unreacted -azide-FA as assessed by 
rp-UPLC. Samples were characterized by rp-UPLC (Figure C2) and 
1
H-NMR 
spectroscopy (Figure C3). The n=1 click reaction had an efficiency of 96%, while all 
other efficiencies ranged from 54-64% with mass recoveries over 95%. A detailed 
analysis of each sample’s fractional composition is summarized in Table 4.1. 
Surface Plasmon Resonance Spectroscopy. Sensograms for G5-Ac-FAn (n = 0, 1.0, 1.2, 
1.0, 2.7) were collected for both 
the low (Figure 4.4) and high 
(Figure 4.5) density chips. The 
unfunctionalized, neutral 
conjugate (n = 0) showed no 
specific binding at either chip 
density across all concentrations 
tested. All G5-FA conjugates 
showed specific binding to the 
FBP immobilized flow cell 1, 
which increased in an FA 
concentration dependent manner. 
After injection completion, all FA 
conjugated samples had a release 
profile. The association and 
Figure 4.4. SPR sensograms of conjugates a) (n=1.0, red; 
n=1.2, orange; n=1.9, green; n=2.7, blue) and controls (n=0, 
grey; free FA, purple) on lower density chip. The color 
gradient represents concentration from low (light) to high 
(dark). Free FA samples were run at milimolar as opposed to 
micromolar concentrations to obtain adequate signal. 
Table 4.1. Quantitative analysis of click products. 
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dissociation phases were fit with various models for evaluation of ka, kd, and Kd. 
 
Discussion. 
rp-HPLC has shown to be an 
effective tool for isolating 
dendrimers with precise 
numbers of clickable 
ligands.[44, 45] To date, four 
unique click ligands have been 
employed using the same 
gradient, with functional groups 
of azide,[46] alkyne, a 
fluorinated ring strain promoted 
ligand,[46] and the cyclooctyne 
ligand presented here for the 
first time. The robust 
methodology developed has proven effective for isolating various species containing 
single ligand/dendrimer ratios from heterogeneous, averaged samples containing 10 or 
more species. Due to the flexible nature of the PAMAM dendrimer and transient 
interaction of the ligand with the hydrophobic column, this technique has proven to be 
non-specific to the relative location of the multiple ligands conjugated to the same 
sample, i.e. all dendrimer conjugated to three ligands co-elutes, simplifying the 
separation process. Isolation of the G5-Ac-COGx conjugates utilized in this paper reflect 
the success of prior studies with other click ligands. All isolated samples of G5-Ac-COGx 
had single species purities over 95%. In the averaged sample, the most common species 
was dendrimer conjugated to 2 COG ligands, and this precise ratio comprised only 16% 
of the sample. However, the isolated sample labeled G5-Ac-COG2 contained only G5 
conjugated to 2 ligands as measured by rp-UPLC, with no detectable presence of 
dendrimer conjugated to 0, 1, 3, or other numbers of ligands. 
Figure 4.5. SPR sensograms of conjugates (n=1.0, red; n=1.2, 
orange; n=1.9, green; n=2.7, blue) and controls (n=0, grey; 
free FA, purple) on higher density chip. The color gradient 
represents concentration from low (light) to high (dark). 
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Here, we present the first application of the G5 PAMAM precise ligand-to-dendrimer 
ratio materials to a multivalent targeting system. Folate binding protein, employed as a 
model for the folic acid receptor overexpressed in various cancer cell lines, and the 
interaction of this target with folic acid has been a highly studied system for both cancer 
cell targeting of chemotherapeutics and for the more basic understanding of multivalent 
nanoparticle interactions. To understand how multivalency affects nanoparticle-ligand 
conjugates behavior in biological systems, it is vital to compare monovalent particles to 
those with 2 or more targeting ligands. However, stochastically synthesized conjugates 
contain a distribution of ligands per particle, making it difficult to distinguish the 
behaviors of the individual populations. The controlled ligand/dendrimer ratio conjugates 
allowed for the synthesis of functional G5-FAn materials with well-defined sub-
populations, including a conjugate with a FA-to-dendrimer ratio of 1, with no higher 
valencies present. These materials, when studied by SPR, allowed comparison of the 
binding strength and potential for multivalent interaction of conjugates containing no 
more than 1, 2, 3, or 4 FA ligands (Table 4.1).  
Reaction of the conjugates with precise ligand-to-dendrimer ratios with complimentary 
click functionalized FA allows for the generation of dendrimers with well-defined 
numbers of covalently conjugated FAs via orthogonal click chemistry between the ring-
strained cyclooctyne on the dendrimer and an azido group on the modified FA. The 
reaction between G5-Ac-COG1 and -azide-FA yielded a product that has 96% conjugate 
with a FA-to-dendrimer ratio of precisely 1 and 4% of a conjugate with no FA. Because 
the original sample had no dendrimer conjugated to 2 or more COG ligands, the resulting 
product has no material with the ability to undergo multivalent binding. The lack of 
multivalent products allows us to test both the Licata and Tkachenko key-lock/non-
specific binding interaction mechanism (Figure 4.2c),[43] which attributes the 
irreversible binding to dendrimer-protein van der Waals interactions and not multivalent 
FA binding, and the Sander mechanism[42] that assumes monovalent behavior will 
significantly differ from bivalent and higher behavior. This critical piece of data would 
also have prevented the (incorrect) assessment by Banaszak Holl et al. that avidity 
increase is an exclusive function of conjugate valency.[30] 
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The remaining click reactions with the higher COG valent material went to about 60% 
completion despite a ten-fold excess of the -azide-FA. This result has been duplicated 
for G5-COGx conjugates with this -azide-FA and other small molecules (unpublished 
data) within the lab, where reaction times greater than 48 hours were tested. Similar 
reaction conditions employed in the literature between a G5-Ac-COG~20(avg) conjugate 
and a -azide-modified methotrexate yielded 100% reaction efficiency, however in this 
case the limiting reagent was the small molecule.[47] This observation suggests that 
limiting the number of COG ligands on the dendrimer may limit accessibility for click 
reaction,   perhaps via folding of hydrophobic ligands into the dendrimer core. The 
interior cavity of G5 PAMAM is limited, therefore with a high number (i.e. 20) of 
conjugated COG ligands, the dendrimer cannot internalize all the ligands at once, so at 
any given time COG ligands are available conjugation. However, at lower numbers of 
COG ligands (i.e. 1 – 4 as described here) there is likely enough void volume in the 
dendrimer to hold all COG ligands at once, therefore preventing click reaction with 
solution species. Additionally, utilization of click chemistry with -azide-FA eliminates 
the less active -FA that is bound through the -carboxylic acid.  Both structural isomers 
of the click reaction are likely present, although this fact would not be expected to have 
great effect on binding to the FBP. The presence of both isomers may contribute to peak 
broadening of the products in rp-UPLC (See Figure C2). rp-UPLC also provides a useful 
tool for monitoring the click reaction, as the reaction of the hydrophobic ligand leads to a 
decrease in retention of the dendrimer conjugate on the C18 column. This technique 
provides a more accurate measurement of FA-to-dendrimer ratio of the product than 
techniques such as NMR, which only provides an average number and provides no detail 
about the individual ligand-to-dendrimer ratios that are present within a sample. For this 
measurement the NMR spectroscopy based averages suffer from low signal for the 
conjugated species as compared to the polymer scaffold, and from the polydispersity of 
the scaffold employed (see Supporting Information).  
Figure 4.6a compares the monovalent sample, G5-Ac-FA1.0, to the Poisson distribution 
expected for a stochastically synthesized G5-FA conjugate with an average ratio of 1. By 
way of comparison, G5-Ac-FA1.0 has only 4% unfunctionalized material compared to 
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37% in the stochastic material. More importantly, 26% of the stochastic material has two 
or more FA covalently attached, meaning this material is not truly representative of 
monovalent behavior. The G5-Ac-FA1.0 material may only undergo a single, monovalent 
specific interaction with a single FBP.  Although the higher FA conjugates are not 
monodisperse, their heterogeneity has been significantly reduced as compared to an 
equivalent average stochastic conjugation. rp-UPLC has also revealed the relative amount 
of each ratio present in the samples (Figure 4.6 b–d), allowing for a much better 
Figure 4.6. Comparison of distributions in click reaction products vs. theoretical stochastically 
conjugated products (purple bars) of the same average for ratios of (a) 1.0 (red bars) (b) 1.2 (orange 
bars) (c) 1.9 (green bars) and (d) 2.7 (blue bars). 
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understanding of the contribution of each “n” valency species in the sample to the 
binding as a whole. For example, the product of the G5-Ac-COG3 click reaction (G5-Ac-
FA1.9) has an average of ~2 FAs per dendrimer, but UPLC reveals that 23% of the 
material has three FAs attached, while 49% has two FAs, 24% is monovalent, and only 
4% of the material has zero FA. The presence of dendrimer conjugated to more than 3 FA 
is not possible as the starting material contained no dendrimer conjugated to 4 or more 
COG. The equivalent stochastic average of n = 1.9 has significant concentrations of 10 
unique FA-to-dendrimer ratios (ranging from 0 to ~9), and ~15% of the sample has zero 
FA. The decreased sample 
complexity and improved 
characterization for the samples 
summarized in Table 4.1 allow 
for more accurate interpretation 
of subsequent SPR results.  
As illustrated in Figures 4.4 and 
4.5, G5-Ac-FA0 shows no 
binding to either of the FBP 
immobilized chips at the 
concentrations tested. However, 
G5-FAn=1.0-2.7 have a binding 
curve that saturates at higher 
concentration. The total signal during binding phase (0 – 200 sec) (Figure 4.7) increases 
as a function of polymer concentration, FA valency (n), and density of protein 
immobilization.  
At 200 sec, injection is complete and the dissociation phase begins (Figures 4.4 and 4.5). 
Several noteworthy observations can be made. First, at free FA concentrations ~100 fold 
higher than the equivalent conjugated FA conditions, free FA returns to baseline in the 
low density chip and nearly to baseline in the high density chip. This observation is 
consistent with the expected, reversible binding of FA to FBP. G5-Ac-FA0 also returns to 
baseline, indicating no permanent interaction with the surface on the timescale of the 
Figure 4.7. Definition of fitting parameters. 
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experiment. Most significantly, monovalent G5-Ac-FA1.0 has a significantly reduced 
dissociation rate as compared to FA (Figures 4.4 c and 4.5 c). In addition, G5-Ac-FA1.0 
does not return to baseline during the time scale of the experiment (500 sec) at any 
concentration for either FBP surface density. The dissociation level off substantially 
above the initial baseline, indicating a portion of the material remains bound to the 
surface. This observation is true even though the highest relative FA concentration tested 
for G5-Ac-FA1.0 (10 µM) is 25 times lower than the lowest FA concentration (0.25 mM).  
The permanent binding on the time scale of the SPR experiment has previously been 
attributed to multivalent binding between the conjugate and receptor,[30, 42] however 
that cannot be the case for this purely monovalent conjugate. This data strongly supports 
the key-lock/non-specific binding mechanism proposed by Licata and Tkachenko[43] in 
which only one FA to FBP interaction is necessary to initiate the stronger interaction 
between the dendrimer and FBP, which itself is a result of the summation of many weak 
van der Waals interactions. This result contradicts the mechanism proposed by Sander et 
al.[42] that attributed all observed reversible binding to the G5-Ac-FA1 species. 
More generalized observations can be made for the higher average conjugates. All G5Ac-
FAn=1.0-2.7 have dissociation 
sensorgrams similar to those 
previously reported results on 
both the high and low density 
chips.[30] All samples appear to 
have a portion of material that is 
permanently bound to the FBP 
surface on the timescale of this 
experiment (Figures 4.4 and 4.5). 
The saturation value (y
o
 in Figure 
4.7) changes as function of FBP 
surface density (Figure 4.8). On 
the low-density chip, the 
maximum signal from Figure 4.8. Saturation of permanent bound material (y
o
) as a 
function of FA concentration. 
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permanently bound material is 14 ± 2 response units, which is achieved at a total FA 
solution concentration of ~10 µM. On the high-density surface, the response unit values 
saturate at 46 ± 4 at ~10 µM.  The only exception is G5-Ac-FA1.0 for which 10 µM is the 
highest concentration tested.  For both low and high FBP density, this conjugate did not 
reach the saturation value by 10 µM. 
 This surface density-dependent saturation of signal is indicative of a limiting number of 
FBP binding sites available for binding to the conjugates. Figure 8 also suggests that the 
total amount of permanently bound material is determined primarily by (i) total FA 
concentration in solution and (ii) surface FBP density. All differences in the permanently 
bound fraction for the multivalent (n = 1.2 – 2.7; orange, green, and blue) samples can be 
attributed to the difference in FA concentration of these samples, which completely 
saturates when total FA concentration is ~10 µM. The monovalent material (G5-Ac-
FA1.0, red) appears to have slightly lower binding compared to the multivalent samples 
based on total FA concentration. This occurrence may result from the enhanced effective 
concentration in the multivalent samples due to dendritic architecture forcing the multiple 
FAs into a ~5 diameter spherical area. This effect is small, and there appears to be no 
additional effect when valency is increased above n = 2.  
Qualitative observations (i.e. permanent binding fraction in the G5-Ac-FA1.0 sample and 
nonzero y
o
) indicate that this data will not adhere to the simple single phase Langmuir 
isotherm. To demonstrate this observation quantitatively, the data was fit with several 
models. In a single event binding between conjugate species A (here, G5-FAn=1.0-2.7) and 
species B (here, FBP immobilized on the SPR chip): 
               Equation 1 
The response difference (R) from SPR in the association phase at a given time (t) can be 
written as: 
 ( )  
       
      
(   ) (      )   Equation 2 
where ka is the association rate constant, kd the dissociation rate constant, and C is the 
conjugate concentration (in µM).[48] Assuming a single association event leads to a 
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single dissociation event, and acknowledging that the monovalent interaction between FA 
and FBP is reversible, the dissociation can be modeled by an exponential decay: 
 ( )                   Equation 3 
where A relates to the initial condition and y
’
 is equal to zero, because the species is 
expected to completely dissociate. Initially the dissociation phase was fit with equation 3 
to obtain kd.  This value for kd  is then employed when fitting the association phase with 
equation 2 to obtain ka.  
Alternatively, two event association models allow for both permanently bound and 
transiently bound fractions. A two phase association in SPR can be modeled as: 
 ( )  
        
        
(   ) (        )  
        
        
(   ) (        )  Equation 4 
Equation 4 can be simplified according to several models. If the assumption is made that 
there are two binding events; a “permanent” binding (the fraction of response is equal y
o
 
and kd1 = 0) and a transient binding (the fraction responsible for the remainder of R(t)); 
and all observed dissociation is from transient bound material, then the dissociation phase 
can be fit with: 
 ( )                    Equation 5 
and Equation 4 becomes: 
 ( )    (   ) (    )  
    (      
 )
        
(   ) (        )   Equation 6 
If one assumes that all transient binding is attributed to nonspecific interactions between 
remaining unfunctionalized (n = 0) dendrimer and the protein, the binding phase can be 
modeled with: 
 ( )    (   ) (   (     )  
      (      
 )
        
(   ) (          )  Equation 7 
where n0 is the percentage of the sample that corresponds to G5-Ac-FA0. Conversely, if 
one assumes that both unfunctionalized and monovalent interactions are transient, than n0 
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is the equal to the sum of the percentages of G5-Ac-FA0 and G5-Ac-FA1.0. Binding 
phases were fit with Equation 7 with both assumptions. The fit for the G5-Ac-FA1.0 
samples was poor with the second assumption, as expected, since this model would 
assume no permanent bound material, even though these samples clearly do not 
completely dissociate. A quantitative summary of the four fitting models is found in 
Tables 4.2 and 4.3, where Kd is defined as: 
   
  
  
    
   
       












































Avg 60 5.2 0.31 
St Dev   3.0 0.20 
High 
Density 
Avg 20 6.0 0.12 
St Dev   3.2 0.53 
Low density 
Avg 100 4.6 0.47 
St Dev   2.7 0.12 





    
  observed K
d 



































)      Combined 
Avg 480 5.4 14 9.1 
St Dev   3.7 17 6.5 
High Density 
Avg 570 5.9 17 1.3 
St Dev   3.4 17 8.1 
Low 
Density 
Avg 380 5.0 11 6.1 
























)  Combined 
Avg 190 6.8 42 9.1 
St Dev   3.4 50 6.5 
High Density 
Avg 210 6.5 2.2 6.1 
St Dev   3.2 3.0 0.9 
Low 
Density 
Avg 180 7.1 66 13.0 


























)  Combined 
Avg 300 7.5 23 9.1 
St Dev   6.4 36 6.5 
High Density 
Avg 570 5.9 17 13.0 
St Dev   3.4 17 8.1 
Low 
Density 
Avg 230 6.4 20 6.1 
St Dev   5.2 45 0.9 
Table 4.3. Quantitative summary of two phase assoc. fits. 
As indicated in Tables 4.2 and 4.3, the measured ka and kd values vary from sample to 
sample, but values are on the same order of magnitude for each run and fit value. 
Although the absolute values vary from injection to injection, the individual fits of the 
data are much more consistent. Figure 4.9 gives some exemplar data (solid lines) and 
corresponding fits (dotted lines). The full set of data can be found in the supporting 
information (Figures C6 and C7). 
Several qualitative observations can be made. Firstly, as expected, a single phase model 
that assumes complete dissociation of the complex is a poor fit for the dissociation phase 
of all samples (dotted green lines). The single phase association appears to have a good 
fit with the experimental data, however as this equation is dependent on the single phase 
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dissociation constant, the overall mechanism is still invalid. Secondly, because the two 
event model where no = 0, 1 (dotted orange lines) is equivalent to a single event model 
for the monovalent case, this model results in a poor fit for all the G5-Ac-FA1.0 data. For 
some data (Figure 4.9d,e) all models fit the data approximately the same, while in other 
cases particular models clearly fit the data better (Figure 4.9c, purple dotted line) or 
worse (Figure 9f, orange dotted line) than others.  To assess which mathematical model 
provide the best global fit to the data, the average residual (difference between calculated 
and actual data) was taken for both the association phase and dissociation phase for each 
model at each valency and concentration tested (Table C2). The two phase dissociation 
model (Equation 5) had a ten-fold better fit for all samples when compared to the single 
(total) dissociation model (Equation 2). For the low density chip, the basic two phase 
association model (Equation 6) had the lowest average residual for all valencies tested 
with an average residual across all valencies of 0.44 response units. By comparison, the 
next best model (single phase, equation 3) had an average residual across all valencies of 
0.95 units. However, the poor fit of the corresponding dissociation phase data for 
Equation 3 renders this model invalid. The high density chip had slightly higher residuals 
Figure 4.9. Examples of modeled data (dotted lines) compared to experimental data (solid lines). 
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for the association phase, with the lowest average across all valencies being the single 
phase (Equation 3) at 1.84 response units. As this mechanism is still ruled out due to poor 
agreement with the dissociation phase, it is important to note that the simple two phase 
model (Equation 6) had the next best fit with an average residual of 2.39 response units. 
The alternative two phase model (Equation 7) had the poorest agreement with 
experimental data for n0 = 0 for both chip densities, and the second poorest agreement 
when n0 = 0, 1. From this analysis, two main conclusions can be drawn: (1) There are at 
least two types (or steps) of association for G5-FAn to the immobilized FBP, which leads 
to (2) the presence of both a transiently and permanently bound material for all G5-FAn, 
including monovalent material. 
The initial model proposed by Banaszak Holl et al.[30] (Figure 4.2a) is mathematically 
equivalent to Equations 2 and 3, where Kd is expected to change with average number of 
FAs per conjugate sample. Clearly, in the original analysis of SPR data by Banaszak Holl 
et al., (Figure 2a) the assumption that all bound material would eventually dissociate (i.e. 
y’ = 0) from the surface was erroneous.  The model proposed by Sander et al.[42] (Figure 
4.2b) correctly noted that a fraction of the material remained bound to the surface for the 
length of the experiment (essentially permanently); however, the additional assumption 
that G5-FA1 was entirely responsible for the observed dissociation in stochastic mixtures 
of G5-FAn was incorrect. This model is clearly contradicted by the G5-Ac-FA1.0 results, 
which are poorly fit by Equation 2, and which clearly show enhanced binding to the FBP 
over free FA. When the other samples were fit with Equations 7, allowing for n = 0 or n = 
0 and 1 to reversibly bind and n ≥ 3 to irreversibly bind, poor association phase fits were 
observed (especially at lower FBP densities). The third theory, put forth by Licata and 
Tkachenko,[43] proposed that an initial binding event between conjugate and FBP is 
keyed by FA, then the binding strength becomes dominated by van der Waals forces 
between the ~30 kDa polymer and ~40 kDa protein (Figure 4.2c). These summed weak 
interactions are responsible for the increased avidity for the conjugates, which the authors 
hypothesized are too great to be attributed to the comparatively weak (Kd ~ 0.1 nM)  
FA/FBP interaction. Mathematically, this model would not show a dependence of Kd on 
degree of FA valency and is best represented by Equation 6, which allows all conjugates 
to undergo both transient and permanent binding events. The increased avidity for the 
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G5-Ac-FA1.0 conjugate as compared to free FA on both the low and high surface density 
chips, which is not further improved even with the G5-Ac-FA2.7 conjugate, best agrees 
with this model qualitatively and quantitatively. 
Therefore, we propose that the binding between G5-Ac-FAn conjugates and immobilized 
FBP can be explained by a two-fold mechanism. First, G5-Ac-FAn binds to a FBP 





. Because the initial binding is dependent on the concentration of FA, there is an 
apparent enhancement of avidity due to an increased total concentration of FA when 
multiple copies of the ligand are attached to the same dendrimer. This effective 
concentration may also lead to an increased chance of rebinding, as the FA/FBP 
dissociation constant (kd2) of ~9 s
-1
 allows for dissociation of the conjugate from the 
surface on the SPR experimental timescale. Therefore, although strong binding is 
observed for all samples, the G5-Ac-FA1.0 binds slightly less total material at the same 
relative FA concentration as compared to higher valency samples. In the second step, the 
acetylated dendrimer arms, which are brought close to the protein surface by the initial 
FA-FBP key-lock interaction, interact via van der Waals forces with the protein and/or 
dextran surface of the SPR chip.  The interaction may be further energetically driven by 
desolvation of both the protein and dendrimer surfaces.  Because these interactions are 
short ranged, it is only observed when are there are both conjugated FA and immobilized 
FBP available (i.e. it is not observed for G5-Ac-FA0 control or on the unfunctionalized 
Flow Cell 2.  Although van der Waals interactions are weak, the sum of many 
interactions available between the two ~5 nm entities, and the associated desolvation, 
creates a force that is irreversible over timescale of these SPR experiments. 
 
Conclusions 
In summary, we have synthesized a monovalent G5-Ac-FA1.0 conjugate that allows for 
the distinction between three previously proposed mechanisms for the high avidity 
interaction with FBP. We have also synthesized multivalent G5-FA conjugates with 
narrow FA-to-dendrimer ratio distributions to examine the kinetics of interaction between 
dendrimer-conjugated FA and FBP. The removal of trailing generation and oligomers in 
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the PAMAM dendrimer starting material enabled the decoupling of mass and polymer 
surface area effects from FA valency. rp-HPLC enabled the isolation of dendrimers 
containing precise ratios (1, 2, 3, and 4) of a copper-free, ring strain promoted click 
ligands to a dendrimer scaffold. A -azide-FA was clicked to these precise ratio 
conjugates to synthesize FA functionalized dendrimers with narrow, well defined 
distributions of FA with average ratios of up to 2.7 FAs-per-dendrimer. Importantly, the 
monovalent conjugate G5-Ac-FA1.0 was synthesized with no portion of the sample having 
more than 1 conjugated FA, allowing for the distinction of polymer contributions (i.e. 
solubility and van der Waals interactions with the surface) from multivalent contributions 
(i.e. effective concentration and chelate binding) to the increased binding of dendrimer 
conjugates to FBP surfaces.. SPR studies revealed that G5-Ac-FA1 experiences the 
enhanced avidity over free FA that has previously been attributed to multivalent FA 
binding. Through examination of four quantitative models, it was concluded that the 
mechanism of interaction between G5-Ac-FAn and surface immobilized FBP is two-fold: 
an initial, reversible, FA concentration dependent key-lock interaction between the 
conjugate and protein, followed by irreversible interaction between the dendrimer and 
protein surfaces.  The confirmation that these samples exhibit permanent binding on the 
time scale of the FA experiment disproves, even for a monovalent sample, the original 
Banaszak Holl et al.[30]  These findings also provide evidence against the model 
proposed by Sander et al.,[42] which attributed the increase in avidity to dendrimer 
species with 2 or more conjugated FA and assigned all dissociated material as G5-Ac-
FA1. However, the model proposed by Licata et al.[43] explains the original data[30] and 
agrees well with these new findings.  
The interaction of G5-Ac-FITC-FAn with folic acid receptor upregulated KB cells, 
reported along with the original SPR experiments,[30] exhibited the same saturation 
behavior. Based on the data and mechanistic interpretation presented here and in the work 
of Licata and Tkachenko,[43] the observed enhancement of residence on the KB cell 
surface as a function of n could result from a combination of overall increase FA 
concentration and increased rebinding with increasing n.  Alternatively, it is possible that 
conjugate-initiated receptor clustering occurs on the cell membrane.  An event that is 
impossible for the FBP immobilized to a dextran model system.  Experiments to 
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synthesize fluorescent materials containing precise ratios of FA targeting ligand for cell 
culture and in vivo experiments are in progress. 
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Methotrexate/PAMAM Conjugates: A Comparison of Key, Scaffold, and Linkers 
 
Introduction  
Multivalent drug-polymer conjugates, in which multiple copies of a drug are covalently 
attached to a polymeric scaffold either directly or through linker chemistry, are a highly 
studied pathway to improve therapeutic index. Particularly, conjugation of the 
chemotherapeutic methotrexate (MTX) to a poly(amidoamine) (PAMAM) dendrimer has 
been extensively studied, with over 100 related publications since their first introduction 
in 2002.[1] The clinical potential of dendrimer conjugated MTX has been shown in many 
biological studies, which indicate favorable activity compared to free MTX.[2-4] 
However, to date, the ability to produce large-scale quantities of such materials while 
retaining desirable activities has been elusive.[5] Several variations to the system have 
been attempted to examine the impact on activity, including conjugation of targeting 
agents,[6] employment of various linker systems,[6, 7] and perturbation of valency.[8] In 
a recent study by Silpe, Choi et al., dendrimers conjugated to an average of 10 MTX 
exhibited stronger binding to surface immobilized folate binding protein (FBP) and more 
cytotoxicity to folic acid receptors (FAR) on KB cells than those with an average of 5  
MTX.[8] However, there are often disadvantages to employing high valent systems, such 
as loss of solubility of the conjugate or loss of targeting specificity.[9] Systems 
containing an average number of ligands also contain a wide range of ligand-to-vector 
ratios present within a sample,[10-12] complicating identification or in-depth mechanistic 
study of the active components. Although work to date has made progress in improving 
sample reproducibility and activity, full mechanistic understanding is not yet achieved. 
 
MTX is a structural derivative and competitive inhibitor of folic acid (FA), therefore 
multivalent MTX conjugates may have a similar mechanism of increased binding and 




et al.[13] reported increasing avidity for stochastic average conjugates of FA to PAMAM 
dendrimer as a function of increasing valency. The authors attributed this effect to the 
multivalent effect of increasing clusters of folic acid-folate binding interactions (for 
example, 3 interactions having a stronger affinity than 2 interactions, which is stronger 
than a single interaction).  For thorough descriptions of this type of  ligand-based 
multivalent binding mechanism see reviews by Whitesides[14], Cloninger,[15] and 
Kiessling[16]).  Since the original report of the FA-PAMAM conjugate multivalency in 
2007, two alternate mechanisms to explain the data have been proposed. Waddell, Sander 
et al.[12] proposed that two types of interactions dominate the system: weak monovalent 
interactions and strong bivalent interactions. The apparent difference in observed avidity 
was attributed to different amounts of unfunctionalized and monovalent material in the 
stochastic distributions. Licata and Tkachenko,[17] proposed that the increased avidity 
reported was too large to be the sum of the relatively low affinity folic acid-protein 
interactions, and instead was due to van der Waals type interactions between the polymer 
vector and protein surface. In this mechanism, folic acid keys the initial binding between 
the conjugate and protein, bringing the polymer close enough to the protein surface for 
the van der Waals interactions to occur.  
The original data, obtained using material containing consisting stochastic averages of 
FA per dendrimer, cannot distinguish between these three mechanisms. However, recent 
work by van Dongen, Banaszak Holl et al.[18] has enabled a closer examination of the 
PAMAM-FA multivalent system. In this work, a conjugate with exactly one FA per 
generation 5 (G5) PAMAM dendrimer was prepared. This sample was unique in that it 
provided a means to distinguish between avidity increases due to the polymer itself 
interacting with the protein (possible in a monovalent conjugate) and avidity increases 
due to multivalent FA binding (not possible in a monovalent system).   The monovalent 
folic acid-dendrimer conjugate had similar avidity increases as the multivalent 
conjugates, strongly supporting the “lock and key” theory by Licata and Tkachenko, 
wherein FA serves is a strong key to unlock the nonspecific (van der Waals) 
polymer/protein interactions.[17] However, there are still many aspects of this system 
that should be more thoroughly studied. For example, MTX is a “weak key” as compared 




vector size influence binding avidity in this lock-and-key system?  And finally, as 
proposed by Licata and Tkachenko, what is the impact of tuning key strength by varying 
the linker used in conjugating the key to the polymer? 
 
PAMAM dendrimers are often employed as multivalent vectors due to their low 
immunogenicity, ability to solubilize hydrophobic molecules, and the presence of 
multiple primary amines available for multivalent modifications.[19-21] They are also 
highly flexible vectors,[22] which allow them to deform and possibly reach multiple 
surface-immobilized receptors at time.[23] The size and number of functional groups of 
dendrimers increases with increasing generation, and consequently the amount of surface 
area that they can reach goes up as well.[24] Therefore, generation number gives a 
mechanism to control vector size. Unlike many polymer architectures, dendrimers have a 
narrow mass range which also makes them more ideal as vectors. However, recent work 
by van Dongen, Banaszak Holl et al. indicates that the presence of oligomers in G5 
PAMAM dendrimer creates subpopulations within a sample that are two, three, or four 
times larger than the expected weight of the monomer.[25] These larger vectors may 
impact the chemical and biological behavior of resulting conjugates as they can 
potentially cover twice as much surface area. Recent results quantifying the amount of 
dimer (D), trimers and even tetramer present in G5 PAMAM dendrimer are particularly 
interesting in light of the Licata and Tkachenko models as the presence of the oligomers 
substantially changes the total magnitude of non-specific van der Waals interactions that 
are possible per particle.  In the process of developing the rp-HPLC-based 
characterization of oligomers, the methods to separate and isolate the monomer G5 from 
the other oligomers were also elucidated.  This accomplishment allowed a direct test of 
the role that varying the ratio of non-specific interactions to key-locks would play in 
surface adsorption.   
  
In this work, we examine the individual and combined impacts of vector size variation, 
linker chemistry, and dendrimer valency by synthesizing monomeric (~30,000 MW) and 
dimeric (~60,000 MW) G5 conjugates with well-defined numbers of MTX attached to 




ratio ligand-to-dendrimer conjugates from stochastic distributions[26, 27] were employed 
to create conjugates with narrow, well-defined populations. We employ both chemical 
and biological assays to measure the impact of these parameters on sample activity. 
Several new conclusions can thus be drawn. (1) We have found that dimeric material 
present in commercial PAMAM dendrimer, and consequently conjugates synthesized 
from this material, contributes significantly to observed chemical and biological 
activities. Conjugates to MTX of dimer isolated from commercial PAMAM exhibit 
binding via surface plasmon resonance, in particular binding that is irreversible on the 
timescale of the experiment, similar to that observed in previous studies[8] employing 
commercial PAMAM. Additionally, multivalent conjugates of monomeric dendrimer to 
methotrexate did not exhibit a change avidity derived from multiple MTX binding events, 
presumably because the MTX is a “weak key” and cannot initiate the polymer/protein 
interactions at the same valencies as the “strong key”, folic acid. (2) A longer and more 
flexible linker system is also shown to negatively impact the conjugate’s ability to bind to 
FBP when compared to a shorter, less hydrophobic linker. This observation is attributed 
to increased hydrophobicity which could have several effects including reducing the 
overall enthalpy of the interaction and increasing the time that the linker, and 
consequently the attached MTX, spends in the interior regions of dendrimer. (3) We 
observe increased avidity over free MTX only at minimum valencies of n = 3 in dimer 
systems. This sample has an average composition, so it may still require more than three 
MTX-per-conjugate to trigger this behavior. Monomer systems were only tested to a 
valency of 3, which was not able to trigger higher avidity. 
 
Experimental Section 
Materials. All chemicals and materials were purchased from Sigma Aldrich or Fischer 
Scientific and used as received unless otherwise specified. G5 PAMAM dendrimer was 
purchased from Dendritech and purified into monomer (G5) and dimer (D) samples as 
previously described.[25] Click-Easy™ MFCO-N-hydroxysuccinimide was purchased 
from Berry & Associates Synthetic Medicinal Chemistry. -azido-MTX was synthesized 
as described previously.[7] Cyclooct-1-yn-3-glycolic acid (COG) was synthesized as 





Preparation of G5-Ac-COG4.7(avg) conjugate.  Conjugates were prepared using G5 via 
EDC-NHS coupling. In brief, 240.4 mg of amine-terminated monomer G5 was dissolved 
to 0.16 µM in DI. 12.0 mg of COG ligand was activated by dissolving to 10.5 µM in 
acetonitrile with 2.65 equiv of EDC and 2.78 equiv of N-hydroxysuccinimide and stirring 
for 2 hours. The activated COG solution was added dropwise via syringe pump to the 
dendrimer solution and allowed to stir overnight. The product was purified using Amicon 
Ultra Centrifugal units, 10kDa cutoff membranes, 2 PBS washes and 4 DI washes. 170.6 
mg of white solid was isolated via lyophillization. The material was then fully acetylated 
(100% of remaining primary amines converted to acetyl groups, henceforth termed “Ac”) 
by re-dissolving in anhydrous methanol (0.19 µM) and adding 450 equiv of triethylamine 
and 360 equiv of acetic anhydride, stirring for 4 hours, purified by centrifugation and 
isolated by lyophillization. G5-Ac-COG4.7(avg) was characterized by rp-UPLC. 
Preparation of G5-Ac-MFCO2.0(avg) conjugate. Conjugates were prepared using G5 and 
Click-Easy™ MFCO-N-hydroxysuccinimide. In brief, amine-terminated G5 was 
dissolved to 0.16 µM in DI. Click-Easy™ MFCO-N-hydroxysuccinimide was activated 
by dissolving to 10.5 µM in acetonitrile and added dropwise via syringe pump to the 
dendrimer solution. The solution was stirred overnight. The product was purified using 
Amicon Ultra Centrifugal units, 10kDa cutoff membranes, 2 PBS washes and 4 DI 
washes. Product was isolated via lyophillization. The material was then fully acetylated 
by re-dissolving in anhydrous methanol (0.19 µM) and adding 450 equiv of triethylamine 
and 360 equiv of acetic anhydride, stirring for 4 hours, purified by centrifugation and 
isolated by lyophillization. G5-Ac-MFCO2.0(avg) was characterized by rp-UPLC. 
Preparation of D-Ac-COG4.8(avg) conjugate. Conjugates were prepared using EDC/NHS 
coupling to isolated G5 dimer according to the same procedures outlined for the 
monomer utilizing 100.8 mg of dimer and 5 equiv of CO ligand. D-Ac-COG4.8(avg) was 
characterized by rp-UPLC. 
Preparation of D-Ac-MFCO6.2(avg) conjugate. Conjugates were prepared using Click-
Easy™ MFCO-N-hydroxysuccinimide to isolated G5 dimer according to the same 
procedures outlined for the monomer utilizing 115.5 mg of dimer and 6.4 equiv of MFCO 




Isolation of precisely defined G5-Ac-COGx, G5-Ac-MFCOx , D-Ac-COGx and  D-Ac-
MFCOx conjugates (x = 0-3, 3+, or 4+) (Figure 1). Dendrimers with precise ratio COG 
or MFCO ligands per dendrimer were isolated via reverse-phase HPLC according to 
modified literature procedures.[11] Briefly, multiple injections of the averaged material 
were performed with a C18 column on a water/acetonitrile gradient with 0.1% TFA. 
Fractions were collected as the material eluted and combined to obtain monomer samples 
with precisely x = 0-5 COG ligands, or x = 0-4, 5+ MFCOs, and dimer samples with x = 
0-2, 3+ COGs. Products were purified using PD-10 desalting protocols, with DI as the 
equilibration buffer and samples dissolved in 10xPBS, and then lyophilized to dry. 
Samples were characterized by UPLC. Curve fitting of UPLCs by Igor Pro was 
performed to provide yield, purity, and HPLC number of MFCO averages. 
 
Synthesis of G5-Ac-(COG-MTX)n G5-Ac-(MFCO-MTX)n, D-Ac-(COG-MTX)n, D-Ac-
(COG-MYX)4.0(avg) and G5-Ac-(MFCO-MTX)4.0(avg)  conjugates. Dendrimers with defined 
numbers of covalently bound methotrexates were synthesized via click reaction of precise 
ratio G5-Ac-COG/MFCOn or D-Ac-COG/MFCOn conjugates and γ-azido-MTX. Briefly, 
dendrimer conjugates were dissolved in DMSO to 40 mM with respect to the click 
ligand, and a 10 fold excess of γ-azido-MTX (40 mM in DMSO) was added. Solutions 
were agitated for 48 hours, then diluted to 2.5 mL with 10xPBS and purified using PD-10 
desalting columns, gravity protocols. Further purification was performed via 10kDa cut-
off dialysis against DI with 16 media changes. Dried samples were characterized by 
1
H-
NMR spectroscopy and UPLC (see Supporting Information). Curve fitting of UPLCs 
provided yield, purity, and HPLC MTX averages. 
 
Methods. 
High Performance Liquid Chromatography. Isolation of precise conjugates was achieved 
using a Waters 600 Controller, Waters 2707 Autosampler, and Waters 2998 Photodiode 
Array running Empower 2 Software, additionally equipped with a Waters Fraction 
Collector III on a Phenomenex Jupiter 300Ȧ C18 Prep Column (21.2 x 150 mm, 5 µm 
particles). The weak solvent (Solvent A) was HPLC Grade Water with 0.1% TFA, and 




gradient employed at 16 mL/min was as follows: 2.1 min load step at 95%A/5%B, 3.9 
min gradient to 80%A/20%B, 15 min gradient to 65%A/35%B, 5 min gradient to 
55%A/45%B, followed by 3 min was at 20%A/80%B, then equilibrating at starting 
conditions for 5 min before next injection. Averaged conjugate was dissolved to 20 
mg/mL concentration and 910uL injections were used. Five second fractions were 
collected starting at 9 min 30 sec into each run for a total of 120 fractions. Analytical 
chromatograms were collected on a Waters Acquity UPLC equipped with a scaled 
method using a Phenomenex Jupiter 4.6 x 100 mm column. 
.LC Peak Fitting. UPLC chromatograms were fit with Gaussian peaks using Igor Pro 
Version 6.0.3.1 software. Peak widths within a chromatogram were kept constant.  
Nuclear Magnetic Resonance Spectroscopy. NMR experiments were performed on 
Varian VNMRS 500 and Varian MR400 instruments. 
1
H-NMR spectra were obtained 
used 10 second pre-acquisition delays and a total of 64 scans. All sample solutions were 
set to a dendrimer concentration of 5 mg/mL in deuterium oxide.  
Dihydrofolate Reductase Assay. Dihydrofolate Reductase Activity Assay was purchased 
from Sigma Aldrich and employed according to the manufacturer’s directives.   
Isothermal Titration Calorimetry. G5-Ac-(MFCO-MTX)4.0(avg) (70, 200, 400 µM with 
respect to MTX), G5-Ac-(MFCO-MTX)4+ (313.3 µM with respect to MTX), free MTX 
(200 µM)   and FBP (4 µM) solutions were prepared in PBS buffer and then degassed for 
25 minutes.  Before loading, the syringe and cell were each rinsed with degassed PBS 
buffer 3 times. The reference cell of the ITC was refilled with degassed, nano-pure water 
every two days.  After flushing the sample cell with buffer, the project syringe with 
buffer the syringe was filled with the MTX solution and the sample cell was filled with 
the FBP solution. Using ITCRun software the parameters of the ITC were set (Stir Rate: 
250 rpm, Injection Interval: 1000 s, Injection Volume: 12 µL, Injections: 20, 
Temperature: 25°C) and the instrument to allowed auto equilibrate before starting the 
titrations.  Controls were performed by injecting PBS buffer into the same concentration 
of FBP solution as used in the experiments with MTX.  These control runs were then be 
subtracted from the experimental runs to account for heat from mixing or dilution.  After 
the control was subtracted from the experimental run, the data was analyzed using 




(independent model) which then gave the thermodynamic parameters of the binding 
interaction. 
Surface Plasmon Resonance. SPR experiments were conducted in a Biacore® X 
instrument (Pharmacia Biosensor AB). An immobilized folate binding protein (FBP) chip 
was prepared following the instrument prompted protocols, using a solution of 0.2M 
EDC and 0.05M NHS as an activating solution, 1mg/mL FBP solution as the 
immobilization solution, and ethanolamine as the deactivation solution. The chip was 
characterized using free FA and methotrexate solutions ranging from 0.1 to 2mM. 
Conjugate samples were dissolved in fresh HBS-EP buffer (Fischer Scientific) at 60uM 
and serially diluted to 10, 5, 2.5, and 1.25 µM in buffer. Runs were multichannel, (FC1-
FC2) at 10 mL/min. The system was allowed to equilibrate at the beginning of each run 
for no less than 300 seconds, followed by a 2 minute, 30 µL (50-5-5-5 via bubble 
method) injection. The system was monitored for no less than 500 seconds per injection. 
Between each run, the chip was washed with a 5 µL injection of pH 1.5 buffer to remove 
bound materials followed by a prime step prior to the next injection. 
KB FAR+ Cytotoxicity. KB cells overexpressing folic acid receptors were plated at 
10,000 cells/well in 96-well plates for incubation overnight at 37°C. Treatment (free 
MTX and monomer conjugates) was done in triplicate for 48 hours in complete media 
without folic acid (dialyzed serum used), after which XTT assays were performed.  
 
Results. 
Preparation of average 
dendrimer/ligand conjugates 
(Scheme 5.1). All conjugates 
prepared were white solids. 
Overall reaction yields 
ranged from 37-43%. Peak 
fitting of the UPLC 
chromatograms was 
employed to determine the 
average ligand-to-
Scheme 5.1. Conjugation of (a) monomer to COG and (b) dimer to 
COG via EDC/NHS coupling, and  (c) monomer to MFCO, and (d) 
dimer to MFCO by direct. Conjugations followed by full 




dendrimer ratio.  
Isolation of dendrimer conjugates 
contain precise ratios of COG 
and MFCO click ligands (Figure 
5.1). The quantitative results of 
the three isolations are 
summarized in Table 1. The 
purities of the target valency of 
the isolated, precise ratio ligand-
to-particle conjugates range from 
90-100%. Samples containing a 
high average number of MFCO 
ligands, G5-Ac-MFCOx, D-Ac-
MFCOx, and D-Ac-COGx, 
conjugates were obtained with 
averages of 6.6, 5.3, and 6.2 
ligands-per-particle respectively. 
Importantly, these samples 
contain no unfunctionalized (x = 
0) or monofunctional (x = 1) 
materials, making them good 
controls for the observation of 
multivalent (e.g. chelation) effects. A summary of the isolations can be found in Table 
5.1. 
Synthesis of dendrimer/MTX conjugates (Scheme 5.2). Click reactions efficiencies ranged 
from 46-100% with mass recoveries over 95%. A detailed analysis of each sample’s 
fractional composition is summarized in Table 5.2. 
Dihydrofolate Reductase Assay (Figure 5.2). Results are summarized in Figure 2. The 
negative control (FA with no inhibitor) showed a change in absorbance at 235 nm of 
0.04-0.05 units. G5-Ac (isolated from G5-Ac-COGn(avg) sample) served as additional 
negative control and had similar results to the uninhibited sample. The positive control 
 Figure 5.1. (left) rp-HPLC traces and fractions collected from 
average conjugations of (a) G5-Ac-COGx (b) D-Ac-COGx (c) 
G5-Ac-MFCOx and (d) D-Ac-MFCOx (right) rp-UPLC traces 




(FA inhibited by free MTX) 
showed complete inhibition of 
enzyme activity at all three 
concentrations of MTX (1nM, 10 
nM, 100 nM) tested. G5-Ac-
(COG-MTX)n samples did not 
effectively inhibit at a dendrimer 
concentration of 1 nM, only 
partially inhibited the protein 
activity at 10nM, and fully 
inhibited the activity at 100 nM. 
D-Ac-(COG-MTX)1 partially 
inhibited the protein activity (20-
40%) at all three concentrations, 
while D-Ac-(COG-MTX)3+ 
partially inhibited (~60%) the 
activity at 1 nM and 10 nM, and had complete inhibition of the protein at  100 nM. 
 
Isothermal Titration Calorimetry (Figure D1). The free MTX control showed the 
Scheme 5.2. Click of precisely defined G5-Ac-COGx, G5-Ac-MFCOx, D-Ac-COGx, and D-Ac-
MFCOx conjugates to -azido-MTX. 




expected exothermic binding behavior to FBP. The stochastically conjugated monomer 
G5-(MFCO-MTX) sample (Figure D1a) displayed endothermic binding, demonstrating a 
thermodynamic cost for binding to the substrate. The high average G5-Ac-(MFCO-
MTX)4.4 sample showed no interaction (neither endothermic nor exothermic) with the 
FBP substrate via this technique. 
 
Surface Plasmon Resonance (Figure 5.3). G5-Ac-(COG-MTX)n (n = 0.9, 1.9, 2.9) 
samples all indicated only weak, reversible binding at all concentrations tested. D-Ac-
(COG-MTX)n  (n = 1.1, 2.0) samples were also dominated by reversible binding, however 
D-Ac-(COG-MTX)6.0 had a fraction that did not completely dissociate on the timescale of 
this study. There was a corresponding, but smaller, amount of slow dissociating material 
in flow cell 2 for this material (See Figure D2). G5-Ac-(MFCO-MTX)n samples all had 
an undesired interaction with the surface in the control flow cell 2, rendering these 
samples unusable by this technique (Figure D3). 
KB FAR+ Cytotoxicity. G5-Ac-(CO-MTX)n samples were not cytotoxic. All observed 
cytotoxicity in initial studies was attributed to 3-8% free MTX in the samples as 
determined by rp-UPLC (see Figure D4). G5-Ac-(MFCO-MTX)n samples had no 
cytotoxicity (Figure D5). 





PAMAM dendrimer is an 
extensively studied vector for the 
multivalent delivery of 
hydrophobic drugs.[2, 4, 28-30] 
Specifically, the conjugation of 
methotrexate to G5 PAMAM has 
been examined thoroughly for 
many years.[1, 30-32] Although 
early studies showed that this 
system has great promise for in 
vivo applications,[30] challenges 
in scalability and reproducibility 
of the results have prevented 
clinical advancements. In 
Figure 5.3. SPR results of all click products. Color gradients represent least concentrated (light) to 
most concentrated (dark) injections. (a) G5-Ac (b) G5-Ac-(COG-MTX)0.9 (c) G5-Ac-(COG-MTX)1.9 
(d) G5-Ac-(COG-MTX)2.9 (e) D-Ac (f) D-Ac-(COG-MTX)1.1  (g) D-Ac-(COG-MTX)2.0  (h) D-Ac-
(COG-MTX)6.0   
Figure 5.2. DHFR inhibition assay results for (a) G5-COG-
MTX conjugates and (b) D-COG-MTX conjugates. Colors are 
consistent with Figure 1. All assays were performed at 3 
concentrations  for  free MTX or conjugate (1 nM, 10 nM, and 




addition, detailed scientific understanding of these systems has been hampered by the 
presence of trailing generations (G1-G4) and oligomers in the dendrimer employed for 
synthetic and biological studies.  Recently developed methods of isolating PAMAM 
materials as a function of dendrimer size[25] and conjugate valency[10, 11, 27] have 
created a unique opportunity to analyze biological activity of multivalent conjugates and 
substantially improve valency control and characterization of multivalent conjugates. 
Here, we present the first comparison of PAMAM monomer and dimer conjugate by 
measuring binding characteristics (SPR and ITC) and biological activities (DHFR assay 
and cytotoxicity).  These experiments probe the effect of vector size both as a design 
principle for its own sake and to attribute chemical/biological behaviors to both species, 
which are present in previous materials.  In addition to valency, the influence of linker 
length/flexibility/hydrophobicity for the system has also been explored. 
Previous studies have indicated that commercially available G5 PAMAM conjugated to 
the CO ligand then clicked to either 5 or 10 -azido-MTX demonstrated multivalency by 
SPR, cellular uptake, and cytotoxicity.[8] This material contained both monomer and 
dimer materials, convoluting the analyses of the SPR (a mass-sensitive technique). The 
samples studied were also stochastically conjugated, with the #MTX = 5 and #MTX = 10 
containing approximately 15 and 22 ligand-to-particle combinations respectively. While 
this study showed an increase in binding avidity, uptake, and cytotoxicity when #MTX 
increased, the complicated mixture of vector size and ligand-to-particle ratios makes an 
exact mechanistic assignment difficult. The methods employed here allow for the de-
convolution of both factors from vector size (i.e. increased molecular weight, increased 
reachable surface area do to a larger radius, and decreased solubility) and valency. 
Briefly, G5 PAMAM dendrimer monomer (G5) and dimer (D) were isolated from 
commercially available material as outlined previously.[25] Stochastic conjugations to 
fluorinated (MFCO) and non-fluorinated (COG) ring strain promoted click chemistry 
ligands were performed via amide coupling for both vectors. The resulting materials 
contained averaged numbers of conjugated ligands, with ~14 different ligand-to-
dendrimer ratios in each sample (ranging from 0 to 13 covalently attached ligands). These 
stochastic mixtures were then isolated by rp-HPLC following previously reported 




successfully employed to isolate monomer and dimer PAMAM conjugates to 3 published 
ligands to date. The presumed mechanism allowing this isolation protocol is a favorable 
interaction between the conjugated, hydrophobic ligand and the reverse phase column. 
The MFCO ligand, which contains a longer carbon chain in addition to the fluorine on the 
cyclooctyne, has significantly higher resolution than the shorter COG ligand. This fact is 
visualized by comparing Figure 5.1a and c, where G5-Ac-MFCO2.0(avg) has baseline 
resolution between n = 0 and 1, and n = 1 and 2 samples (Figure 5.1 c) whereas G5-Ac-
COG4.7(avg) has peak overlap for all peaks, even n = 0 and n = 1 (Figure 5.1 a). The 
difference between the x = 1 and x = 2 peak centers is 0.64 min for the G5-Ac-COG 
conjugates compared to 1.02 for the MFCO conjugates. The improved resolution likely 
results from the greater hydrophobicity of the longer chain resulting in greater interaction 
with the C18 stationary phase, leading to increased retention as a function of number of 
ligands. The increased resolution is repeated in the dimer conjugates; however the 
resolution of both dimer species is less than their corresponding monomer. As the time 
difference in peak centers for x = 1, 2 is nearly identical between the monomer and dimer 
for both ligands (0.59 and 1.04 for dimer conjugated to COG and MFCO, respectively), 
the reduced resolution is the result of the increased peak width of the dimer species (this 
broadening is the result of a broader distribution of branching defects[25]). Better HPLC 
resolution allows for the isolation of higher precise numbers, increased yield of all 
conjugates, and increased purity of resulting samples.  
The conjugate samples, containing G5 monomer or dimer conjugated to precise numbers 
(x = 0 – 3) or high average (3+ or 4+)  numbers of either ligand, were then “clicked” to -
azido-MTX. Click efficiencies were approximately equal for monomer and dimer 
conjugates. As expected, the fluorinated MFCO ligand had higher click efficiencies under 
similar conditions to the non-fluorinated COG. While not all reactions went to 100% 
completion, the MFCO conjugates resulted in fewer conjugate species than the 
corresponding COG conjugates (Table 5.2). For example, the click reaction of monomer 
with 3 MFCO ligands went to 89% completion with 62% of the product containing 3 
clicked MTX by UPLC. By way of contrast, the reaction employing 3 COG ligands had 
63% click efficiency with only 13% of the product containing 3 conjugated MTX.  




MTX, DHFR inhibition assays 
were performed. Both the 
monomer and dimer COG-MTX 
conjugates showed activity 
(Figure 5.2). As such, it can be 
concluded that conjugation of 
MTX to the dendrimer through 
the COG linker does not 
completely extinguish its 
inhibition activity against DHFR. 
A few additional important 
observations can be made. Firstly, 
both vector types required 
approximately 100 times the 
equivalent solution MTX 
concentration to reach similar 
inhibition levels as free MTX. 
Therefore, the inhibition activity 
of MTX is substantially reduced 
by conjugation through this linker. 
Secondly, for the monomer 
samples, there is no apparent 
relationship between the 
conjugate valency (n = 1 – 3) and 
inhibition ability within the 
detection limits of the experiment 
(Figure 5.4a). Figure 5.4b 
illustrates that total solution MTX concentration the inhibition capabilities of the 
conjugates, with full inhibition starting around 100 nM effective MTX concentration 
(compared to free MTX, which fully inhibited the assay at 1 nM).  Inhibition assays for 
the MFCO conjugates are still ongoing (shortage of assay kit). 
Figure 5.4. Inhibition assay results of G5-Ac-(COG-MTX)n 




The ability of the G5-MFCO-MTX conjugates to bind to FBP was measured using ITC. 
ITC measures the thermodynamics of binding between a ligand (i.e. free or conjugated 
MTX) and receptor (i.e. FBP) in solution. In a simplistic experiment, a favorable 
interaction between a ligand and receptor will give a net increase in heat, indication that 
the reaction is exothermic. This observation is the case for free MTX binding to FBP. For 
the case of the stochastically conjugated G5-Ac-(MFCO-MTX)4.0(avg), which has an 
average of 4.0 MTX but contains dendrimers clicked to 0 to ~13 MTX, the heat of 
binding was endothermic. This observation indicates that binding between the conjugate 
and protein can occur, but there is an energetic cost. By contrast, there was no observable 
binding between the isolated high average G5-Ac-(MFCO-MTX)4.4 sample, which 
contains only dendrimer clicked to 3 or more MTX. On interpretation of these results 
would be that the flexibility and hydrophobicity of the MFCO linker cause it to fold into 
the interior regions of the G5 dendrimer, and consequently the enthalpic penalty to 
hydrate the ligand and allow for MTX/protein interaction is significantly higher which 
negatively impacts the enthalpy of binding. Because the lower average sample shows 
some interaction with the protein, it is possible that there is cooperativity within the 
MFCO linkers that further block the MTX from interacting with the protein in the higher 
average sample. An alternative explanation of this data would be that the rp-HPLC 
isolation protocols cause a fundamental change to the dendrimer (i.e. protonation of 
internal amines by trifluoroacetic acid in the HPLC eluent causing a conformational 
change in the three dimensional dendrimer structure) which blocks the protein interaction 
and/or decreases the time the clicked MTX is outside of the dendrimer interior.  This 
theory would explain the difference between the “high averaged” conjugate (which 
displayed no binding) and the stochastic average G5-Ac-(COG-MTX)avg~4 conjugate 
(which displayed endothermic binding). 
SPR experiments allow for the extraction of kinetic information about the binding 
between a ligand (i.e. free or conjugated MTX) in solution flowing over a surface of 
immobilized receptors (i.e. FBP on a dextran surface). A second chip surface is employed 
as a control, which does not contain the protein, allowing for the subtraction of non-
specific interactions of the conjugate and the surface. Both vectors and linker systems 




conjugated to MTX through the MFCO linker have a negative overall subtracted signal in 
injection/association phase which would indicate “negative” binding, an impossibility. 
Closer examination of the individual flow cell data reveals that while both flow cells have 
positive signal in the injection phase, the signal in the unmodified cell is higher than that 
in the FBP immobilized cell (FC1). This obsevation indicates that the conjugates have 
more interaction with the dextran surface that does not contain any FBP (FC2). 
Theoretically, this non-specific interaction should be equivalent in both flow cells. 
However, because the chip employed had a very high percentage of surface coverage 
with FBP, there is less dextran available in FC1 for nonspecific interaction. While this 
non-specific interaction prevents analysis of the MFCO linker data, it can be qualitatively 
observed that the dimer high average sample, D-Ac-(MFCO-MTX)4.4 (Figure D3h), 
appears to have enough specific interaction with FBP on FC1 to overcome the 
contribution of the non-specific interaction and be observed in the association phase. The 
dissociation phase of this data also has a standard shape; however without a solid 
understanding of the non-specific interactions, quantitative fits of this data are not sound. 
Both the monomer and dimer sample sets clicked to the MTX through the COG linker 
bound to the FBP with minimal nonspecific interaction with FC2. The control samples 
(fully acetylated monomer and dimer with no MTX) have similar binding to both chips, 
which when subtracted give relatively flat chromatograms (Figure 5.3a and e). In 
contrast, all three tested valencies for the monomer show both a dendrimer and total 
solution MTX concentration dependent binding with the FBP surface. Figure 5.5 reveals 
two interesting conclusions. Firstly, the monomer data shows enhanced binding during 
the association phase as valency increases (Figure 5.5a). However, this trend is readily 
explained by the increased total concentration of MTX as valency increases (Figure 
5.5b). There is no multivalency effect for increasing the MTX valency on the G5 
monomer. The dimer data shows a slightly different trend. Solution concentration of 
MTX does not explain the trend of binding in the association phase (Figure 5.5d) and 
dimer more a greater average number of MTX ligands actually show less surface binding 
for a given total concentration of MTX. However, there does appear to be a dependence 
on signal during association strictly on dendrimer concentration (Figure 5.5c). This 




nonspecific mass effect. The interaction still must be “keyed” by conjugated MTX, as 
there is negligible accumulation observed in the D-Ac sample (Figure 5.3e), however the 
non-specific van der Waals binding quickly dominates any MTX effects. 
For all injections, the signal initially rises sharply at the beginning of the injection and 
quickly reaches equilibrium between association and dissociation. This behavior is 
indicative of a fast-on, fast-off relationship. At the end of the injection, all 
chromatograms quickly return to baseline, confirming the fast dissociation of all bound 
Figure 5.5. Saturation of SPR signal during the binding phase as a function of (a) conjugate 
concentration for monomer samples, (b) solution MTX concentration for monomer samples (c) 




species. This observation suggests that even the divalent (66%) and trivalent species 
(13%) in the G5-Ac-(COG-MTX)2.9 experience only monovalent binding to the FBP 
surface. 
By comparison, a recent similar study by van Dongen, Banaszak Holl et al.[18] observed 
greatly increased avidity via SPR for monomeric G5-Ac-(COG-FA)n (n = 0, 1, 1.2, 1.9, 
2.7) conjugates, with a significant portion of bound material not dissociating over the 
timescale of the experiment. Because this observation held true for even a purely 
monovalent (folic acid-to-dendrimer ratio of 1) sample, it was concluded that the 
observation of increased avidity was due to the sum of weak van der Waals interactions 
between the dendrimer and protein surface. It was also determined that this interaction 
must be initiated by an interaction between a single conjugated FA and the FBP on the 
SPR chip surface. MTX, as a structurally modified competitive inhibitor of FA, may 
undergo a similar interaction with the FBP. However, although the experiments here were 
performed on surfaces with both higher protein densities and higher conjugate 
concentrations, a similar avidity increase was not observed at even the highest valency 
tested for the monomer(3).  For the MTX case, there are indications of multivalency for 
the high averaged sample, however, when comparing the overall shape of the G5-FA and 
D-MTX sensograms (Figure 5.6) it becomes clear that there are some fundamental 
differences. For the G5-FA samples, nearly all materials that bound (to a chip density 
dependent saturation point) remained 
permanently attached to the surface. By contrast, 
a large percentage of the D-MTX material 
quickly dissociates after the conjugate flow has 
stopped. 
The D-Ac-(COG-MTX)n conjugates show a 
dendrimer concentration, not MTX concentration, 
dependent association to the protein surface 
(Figure 5.5c). The absolute signal, when 
compared to that of the monomer/MTX 
conjugates, is approximately 10x higher in the 
dimer species at equivalent molar concentrations. 
Figure 5.6. Comparison of the SPR 
sensograms of a D-Ac-(COG-MTX) sample 
to two different G5-Ac-(COG-FA) samples, 




A 2 fold increase may be expected by this technique due to doubling in mass. This 
increase leads to a qualitative assumption that more binding occurs for equivalent total 
solution MTX concentrations in dimer samples than monomer samples.  This five-fold 
increase over the “expected” signal in the association signal is likely the larger mass and 
radius of the dimer and  its lower solubility[25] increasing the nonspecific interaction 
between the dendrimer/FBP. A chelate-type binding can be ruled out as the primary cause 
of exceptionally high signal in the association phase as it is seen in the monovalent D-Ac-
MTX1.1 sample. When examining the dissociation phase, the primarily monovalent (n = 
1.1) and divalent (n = 2.0) dimer-MTX conjugates completely and quickly dissociate at 
the lowest three concentrations (5 µM, 25 µM, 40 µM), indicating a dominance of weak, 
monovalent binding for these species. However, the high average sample at all 
concentrations and divalent sample, at the highest concentrations of the mono and 
bivalent samples, are distinguished by dissociation phases that do not return to the 
original baseline over the time course of the SPR experiment. This behavior indicates a 
much stronger interaction between the conjugate and protein surface, indicating a 
separate mechanism of binding. There are several possible explanations for this 
observation. (1) As there is some nonselective binding at all concentrations for the high 
average sample in FC2, the permanently bound fraction may be due to reduced solubility 
due to the relatively high amount of conjugated MTX. However, this explanation does 
not adequately explain why there is significantly more permanent binding in the FC1, or 
why the total amount of permanent bound material is constant and not concentration 
dependent. Also, the 60 µM injections for mono and bivalent dimer do not have any 
permanent nonselective binding in FC2 but do not completely return to baseline in FC1. 
This observation suggests that while there is some nonselective interaction occurring in 
the high averaged sample, there is still significantly more interaction with the FBP 
immobilized surface. (2) Because the dimer vector is twice as large as the monomer 
vector, it can access roughly 4 times the surface area on the SPR chip. This additional 
surface accessibility may enable chelate-type binding (or multiple weak key interactions 
in the terms of Licata and Tkachenko)[17] of a single conjugate and multiple FBP 
receptors. This type of binding should be achievable for bivalent and higher conjugates 




to the bivalent conjugate, with a small fraction of permanently bound material achieved at 
the highest concentration. (3) The solution MTX concentration in the high average 
sample and highest concentrations in the mono and bivalent samples is finally high 
enough to trigger a lock-and-key mechanism as observed in the folic acid system. The 
relative weakness of the MTX binding is overcome only when the vector is much larger 
(which decreases the solubility/entropy of the vector and increases the total van der 
Waals interactions) and the relative MTX concentration higher (which is achieved by the 
high averaged sample by high local concentrations at lower relative concentrations). In 
the related FA study, any material bound by the lock-and-key mechanism was 
permanently bound. In this case, a significant amount of the bound material still 
dissociates. Thus, the mechanism cannot be identical for MTX and FA. At this point, no 
single proposed mechanism is sufficient to explain all the MTX/dimer data. It is possible 
that the binding seen at the highest concentrations (60 µM) of all dimer valencies is the 
beginning of a MTX-keyed nonspecific interaction, and that the binding at lower 
concentrations of the high valency system is due to multiple MTX/FBP interactions for a 
single conjugate. Further work would need to be done to test this theory, including testing 
higher concentrations of the mono and bivalent systems, and lowering the FBP density to 
eliminate the possibility of multiple interactions in the high valent system. 
Previous SPR studies on dendrimer-COG-MTX conjugates containing mixtures of dimer 
and monomer indicated both monovalent and multivalent binding occurred for stochastic 
valencies of n = 5 and n = 10.[8] The present work indicates that the mechanism for the 
multivalent portion of this binding is the presence of dimers conjugated to 3 or more 
MTX. Considering that the original dendrimer material contained ~14% dimer[25] and 
assuming a Poisson distribution, the “multivalent” portion of the n = 5 and 10 samples 
would be 13% and 14%, respectively. It is possible, therefore, that observed permanent 
binding portion in the previous work is contributed exclusively by high valency dimer 
materials. This work does not examine monomers conjugated to 4 or more MTX, so the 
potential activity of those conjugates cannot be commented on.  
Free MTX is cytotoxic to KB FAR+ cells (Figure D5). Previous work[8] has indicated 
that MTX bound to a commercial G5 dendrimer (containing monomer and dimer 




work indicates that both vector-MTX conjugates are non-toxic to KB FAR+ when bound 
through the longer, MFCO linker. This observation further confirms, in addition to the 
ITC and SPR results, that this linker is not ideal for this specific system, although it gives 
higher yields in both HPLC isolation and click reaction protocols. Monomer-CO-MTX 
conjugates initially showed similar cytotoxicity profiles as previous results (data not 
shown), however this toxicity was later attributed to a small amount (<5%) of unbound 
MTX remaining in the sample (See Figure D2). Studies to determine if the dimer sample 
is cytotoxic are still ongoing. 
 
Conclusions 
New chromatographic methods have enabled the examination of vector molecular weight 
effects (monomer vs. dimer), linker system effects (COG vs. MFCO), and valency effects 
on the highly studied drug delivery system of PAMAM dendrimer conjugated to 
methotrexate. The combined experimental data from DHFR inhibition, ITC, SPR, and in 
vitro experiments allow for several major conclusions to be drawn. Firstly, the presence 
of G5 PAMAM dimers, which contribute to 14% or more of a commercial dendrimer 
sample, contribute significantly to observed activities. They are often overlooked in data 
interpretation, but in mass sensitive techniques such as SPR they actually contribute 
larger signal per particle. They also can reach a larger surface area due to their larger size, 
which can potentially create new activity mechanisms. In this system, dimer appears to 
be responsible for signal previously attributed to pure valency effects via SPR. When 
comparing this data to the mechanism of increased avidity for similar PAMAM-folic acid 
conjugate, it was determined that the MTX/FBP interaction is not strong enough to “key” 
the nonspecific interaction between the polymer and protein until the solution MTX 
concentration is significantly higher, or the dendrimer scaffold is much larger. Further, 
the observed binding is not nearly as strong for MTX as for FA, further distancing the 
two mechanisms. Alternatively, the possibility of a multiple MTX-FBP bridges for the 
high valency dimer cannot be eliminated as it was for the FA system. This idea was first 
described by Licata and Tkachenko,[17] who proposed that weakening the FA bond may 
slow the formation of the nonspecific interactions between dendrimer and protein to 





Secondly; some specific observations for the influence of linkers can be made. Linkers 
can affect both chemical and biological activity. Here, a more hydrophobic linker with 
fluorine modification (MFCO) had more favorable chemical behavior leading to higher 
product yields compared to the original linker (COG). However, this system proved to be 
inactive biologically by three separate techniques. The flexibility of the PAMAM vector 
may limit the importance of the decreased rigidity of this linker and contribute to 
unfavorable thermodynamic costs for binding (i.e. interaction of the hydrophobic linker 
with the aqueous environment). Careful examination of linker effects must be undertaken 
specific to the desired application. Finally, conjugate valency has been examined. Here, 
solution based techniques (inhibition assay) showed little dependence on valency outside 
of effective concentration. However, in a surface based application (SPR), higher valency 
created a new binding mechanism through the chelate effect. Careful consideration of 
vector size and purity, linker chemistry, and conjugate valency are critical for creating 
biologically successful polymeric drug delivery systems. 
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Conclusions and Future Directions 
This dissertation examines the impacts of polymer scaffold and conjugation chemistry 
heterogeneity on the design, synthesis, characterization, and application of multivalent 
polymer conjugates for drug delivery. Several platform design factors were 
systematically studied, including vector size and homogeneity, valency, and linker 
chemistry. Methods to isolate precise ligand-to-vector ratios were expanded to include 
new linker ligand, to generate novel nanostructures, and synthesize well defined 
dendrimer-drug conjugates for mechanistic study. The ability to produce polymer 
conjugates of low mass dispersity and high ligand-to-scaffold ratio purities makes this 
system an ideal candidate for both mechanistic studies and as a future clinical candidate. 
One of the first design principles that must be considered in developing a multivalent 
drug delivery platform with any hope for FDA approval and clinical application is the 
ability to reproduce the material at large scales without loss of activity. To accomplish 
this goal, the scaffold to which drugs, targeting entities, or imaging agents are conjugated 
must be carefully selected. The dendrimer architecture has potential due to its low 
polydispersity/narrow mass range compared to branched or linear polymers. However, 
the work in Chapter 2 shows that the polydispersity of PAMAM dendrimer is often 
overlooked. Importantly, the conclusions of Chapter 5 suggest that oligomer defects, 
which compose ~30% of the commercial material, can have an impact on both 
characterization and observed activity of conjugates containing the oligomeric mixtures. 
Chapter 2 introduces methodology to isolate the monomeric scaffold of interest, reducing 
the mass range by several orders of magnitude. This advancement allows for subsequent 
synthesis of multivalent conjugates that employ dendrimer scaffolds with very narrow 
size ranges, allowing the decoupling of mass effects (i.e. solubility, biodistribution, 
surface area, etc.) from multivalent effects. Consequently, the studies in Chapter 5 
comparing the activities of multivalent monomer-MTX and dimer-MTX conjugates 
conclude that the increased mass and surface area of dimer present in commercial 
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dendrimer significantly impacts the observed binding of the subsequent conjugate. 
Further in vitro and eventually in vivo work is necessary to provide insight to larger 
impacts of high weight materials in present and future dendrimer conjugates. 
Alternatively, the megamers introduced in Chapter 3 may provide a synthetic strategy to 
achieve vectors of the desired size (i.e. synthetic dimers instead of isolated dimer 
fractions) whilst retaining the properties, such as solubility and ease of synthesis, of the 
lower generation. Continued investigation of these synthetic megamers may provide a 
route to modular, bifunctional nanostructures with precise valency. Such advancements 
would require synthesis and isolation of precise ratio ligand-to-dendrimer conjugates with 
primary amine surfaces remaining for functionality. This work is currently ongoing in the 
Banaszak Holl group.  
As highlighted in Chapter 1, the presence of a distribution of ligand-to-vector ratios can 
also impede the advancement of a drug delivery platform. These distributions are difficult 
to characterize by commonly employed techniques, therefore they can go unnoticed. 
However, different distributions in ligand-to-vector ratios lead to the presence of 
significantly different populations in samples that appear identical by many 
characterization techniques. Problems with sample reproducibility is likely to become 
more prevalent as a platform is scaled from the research laboratory to the clinic, as mass 
transport and controlling reaction conditions becomes more challenging. The isolation of 
conjugates with precise click ligand-to-dendrimer ratios, first introduced by Mullen, 
Banaszak Holl et al. and further developed in the work featured in Chapters 3-5 of this 
dissertation, provides one synthetic strategy to overcome such challenges. While the 
synthesis of precise ratios of biologically active entities, such as folic acid or 
methotrexate, has not yet been successful, the narrow and well-defined distributions 
resulting from the reaction of precise conjugates to modified drugs is a major step 
forward. One of the most significant advances in the work presented here, however, is the 
synthesis of dendrimer-drug conjugates with valencies of precisely one drug per 
dendrimer. This accomplishment has allowed us to distinguish between mechanisms of 
binding due to polymer interactions and multivalent drug interactions. For both cases 
examined here, it has been determined that increased avidity (as measured by SPR) of 
multivalent dendrimer conjugates, which has been previously attributed to a multivalent 
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FA or MTX binding effect, are due to a keyed summation of weak van der Waals forces 
between the dendrimer scaffold and protein surface. While the interaction between the 
polymer and protein itself is nonspecific, the relatively stronger and specific initial 
interaction between the conjugated FA or MTX and surface-immobilized protein is 
necessary to initiate the observed binding. This fact is further emphasized because 
dendrimers with no folic acid do not have significant binding to the FBP. FA is a “strong 
key” for this system, and is able to initiate high avidity binding for a monovalent 
dendrimer conjugate at the lowest concentrations studied in Chapter 4. It is clear that  the 
mechanism of free folic acid binding to the FBP is different, as this interaction quickly 
and completely dissociates even at much higher solution concentrations. These results 
have allowed for direct experimental evidence favoring a FA-keyed mechanism that was 
one of three proposed mechanisms in the literature to explain the observation of high 
avidity in folic acid-dendrimer systems. Thirty-six experimental measurements at various 
valencies and concentrations have also allowed for the development of a kinetic model 
for this system which involves two binding populations; a dissociating population and a 
permanently bound population. The SPR studies with methotrexate provide a “weak key” 
analogue to this study. The much weaker interaction between methotrexate and the FBP 
was shown to not be able to initiate this strong binding mechanism until much higher 
relative concentrations. The lock-and-key mechanism, which has not received much 
attention in the literature, has proven to be consistent with the results of these two cases. 
It therefore should be considered for possibly playing a role in other polymer conjugates. 
Further exploration of monovalent dendrimer conjugates must therefore be done. For 
example, multivalent dendrimer-vancomycin conjugates have shown significantly 
enhanced binding to surfaces that mimic both vancomycin susceptible cell surfaces 
(“strong key”) and vancomycin resistant cell surfaces (“weak key”). A monovalent 
conjugate is necessary to determine whether this binding is due to multivalent binding of 
the conjugate to the surfaces or a vancomycin keyed interaction of the dendrimer with the 
surface. The work presented in Chapters 4 and 5 demonstrate the importance of obtaining 
non-stochastic average conjugates for the determination of active populations in 
multivalent systems. Methodology of obtaining and applying such samples has been 
successfully demonstrated. Further studies of current and future multivalent systems will 
127 
 
add to the greater understanding, development, and improvement of polymer-based drug 
delivery systems. 
Linker chemistry between a vector and drug can have a beneficial impact on the activity 
of the system, providing flexibility and longer range to allow for multivalent interaction 
with a surface immobilized target. However, there can also be thermodynamic penalties 
associated with longer linkers. These tradeoffs have been the subject of many theoretical 
and experimental studies to date with no encompassing conclusions. Hence, it is 
important to consider the needs of the specific scaffold and target in question when 
designing a multivalent conjugate. For example, a rigid scaffold (such as a “hard” 
nanoparticle) may need a more flexible linker to provide the conjugated drug the 
necessary sampling space for binding to a target. An inherently flexible scaffold (like a 
PAMAM dendrimer) may not need this additional added flexibility to achieve binding. In 
the system examined in this dissertation, the linker chemistry has another important role: 
providing the mechanism by which precise ligand-to-dendrimer conjugates can be 
isolated. Hydrophobic interactions between the linker and stationary phase via HPLC 
causes an increased retention time as a function of valency. One of the strengths of this 
system is it’s robustness, with eight ligands successfully employed in separations to date 
(the two ring-strain promoted click ligands and azide ligand described in Chapters 3-5, 
plus the alkyne ligand in previous literature work, two hydrophobic dyes, and two 
additional click ligands (alkene and thiol) which have not yet been published in peer-
reviewed literature). This versatility provides a good platform for further modification 
bioactive molecules. Further functionalities should continue to be tested, such as primary 
amine terminated ligands for peptide coupling, and charged ligands for studies of 
controlled numbers of charges on a nanoparticle surface for cell membrane interaction. 
More hydrophobic linkers have a greater interaction with the reverse-phase column 
employed here, therefore longer carbon chains and ring structures provide better peak 
separation. This property provides a handle by which the yields and purities of isolations 
may be manipulated. For example, the mono-fluorinated cyclooctyne structure used in 
Chapters 3 and 6 provides the best peak resolution of any system studied to date, possibly 
due to the 5 methylene chain compared to 1 methylene of the shorter cyclooctyne ligand. 
Another benefit of this particular ligand is that fluorine modification significantly 
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improves the subsequent click reaction efficiencies. As such, this ligand seemed the most 
promising for drug delivery applications. However, subsequent testing revealed that the 
conjugates utilizing this linker are inactive. It may be that the very property that improves 
the conjugate’s HPLC resolution (hydrophobicity) causes its inactivity. Hydration of the 
longer carbon chain may be so thermodynamically unfavorable that the ligand, and 
consequently clicked drug, spends most of the time folded into the interior space of the 
dendrimer, which in return means the clicked entity (MTX) is less available for 
interaction with solution and surface targets (FBP on a SPR chip surface). Therefore, 
future studies should target ring-strain ligands that contain the fluorine modification but 
with a shorter methylene chain. This work as a whole demonstrates the necessity of 
carefully selecting the proper linking chemistry for the particular system in question. 
This dissertation has highlighted some of the remaining challenges in creating successful 
multivalent conjugates for biomedical applications. In particular, PAMAM dendrimers 
were discussed as a potential scaffold due to their favorable chemical and biological 
properties, and methodology to produces gram-scale quantities of low mass range G5 
dendrimers has been introduced. The low mass range and hydrophilic nature of 
dendrimers has also allowed for the development of dendrimer conjugates with precise 
ligand-to-dendrimer ratios, allowing for the generation of drug-functionalized conjugates 
with well-defined valency. This accomplishment allows for the determination of active 
populations (i.e. stronger binding) within a stochastic mixture. Future directions for this 
system should focus on developing linker chemistries with optimized properties for 
isolation and click reaction. Further mechanistic and biological testing of drug conjugates 
should also occur, including the FA and MTX systems studied here additionally 
conjugated to precise numbers of dye and other systems such as the vancomycin 
conjugates previously mentioned. Additionally, future studies employing lower 
generations of dendrimer (for example, G3 with a molecular mass approximately one 
quarter of the G5 monomer) with the “strong key” folic acid would allow for a 
quantitative assessment of the contributions of polymer mass to the nonspecific 







Supplementary Information for Chapter 2 
 
Size Exclusion Chromatography. Size exclusion experiments were performed by gel 
permeation chromatography on an Alliance Waters 2695 separation module equipped 
with a 2487 dual wavelength UV absorbance detector (Waters Corporation), a Wyatt 
HELEOS Multi Angle Laser Light Scattering (MALLS) detector, and an Optilab rEX 
differential refractometer. Columns employed were TosoHaas TSK-Gel Guard PHW 
06762 (75 mm × 7.5 mm, 12 mm), G 2000 PW 05761 (300 mm × 7.5 mm, 10 mm), G 
3000 PW 05762 (300 mm × 7.5 mm, 10 mm), and G 4000 PW (300 mm × 7.5 mm, 17 
mm). Column temperature was maintained at 25 ± 0.1 °C with a Waters temperature 
control module. The isocratic mobile phase was 0.1 M citric acid and 0.025 wt % sodium 
azide, pH 2.74, at a flow rate of 1 mL/min. The sample concentration was 10 mg/5 mL 
with an injection volume of 100 µL. This was used to calculate the weight average 
molecular weight, Mw, and the number average molecular weight, Mn, with Astra 5.3.2 
software. 
 
Potentiometric Titration. Potentiometric titration was carried out using a Mettler 
Toledo DL55 Titrator equipped with a Mettler Toledo DG-111-SC pH probe and custom 
software. A known mass of sample was dissolved in 20 mL of 0.1 M NaCl solution and 
the pH was adjusted to 2-2.5 with 0.1 M HCl. The solution was then autotitrated with 
volumetric standardized 0.1 M NaOH with 0.02 mL injections until pH 12 was reached. 
The results were analyzed using GPC Mn to give the average number of primary amines 
per dendrimer in a sample.  
 
Determination of Extinction Coefficients. Solutions were diluted in DI water to 0.1-
0.25 mg/mL. Measurements were taken on a Shimazdzu UV-1601. Each measurement 
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Figure A1. Known amounts of TFA spiked into dendrimer samples (blue diamonds) 
have a linear relationship with 
19
F NMR peak intensity. Effective TFA removal depends 
on the G5 mass. loading of the PD-10 columns, as seen by colored stars: 5 mg (red), 10 
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Figure A2. Change in NMR spectra of as-received G5 PAMAM as a function pH. 
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Table A1.  Summary of mass analyses on fractions T and I-IV. 
 
ppm T I II III IV** 
3.5 88 153 278 317 264 
3.3 108 177 331 405 404 
3.1 93 152 218 321 293 
2.9 182 312 578 711 691 
2.7 101 171 316 331 369 
2.5 185 314 570 694 638 
 
Table A2.  Integration values for 
1
H NMR of fractions T and I-IV relative to an internal 
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peaks 
GPC 
Sample Mn Mw PDI 
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 MALDI-TOF-MS GPC 
Fraction Peak Max (Da) Mn Mw PDI 
As-received G5 26,400 28,270 30,820 1.090 
i (F38) 21,000 21,060 21,200 1.007 
ii (F42) 27,200 25,940 26,210 1.024 
iii (F47) 29,600 28,560 28,860 1.010 
iv (F52) 29,800 31,160 31,500 1.045 
 

















Figure A6. Calibration curves used to determine extinction coefficients of fractions T 






























Sample Extinction Coefficient [(mg/mL)
-1
] Extinction Coefficient [M
-1
] 
T 9.5(+/-2.0) 1.7(+/-0.6)E+05 
I 10.0(+/-0.3) 2.7(+/-0.1)E+05 
II 9.8(+/-0.9) 4.9(+/-0.4)E+05 
III 7.5(+/-1.0) 5.3(+/-0.6)E+05 
IV 2.3(+/-0.7) 2.1(+/-0.7)E+05 
 
 


















Figure B1. (left) Semi-prep HPLC isolation of precisely defined G5-Aziden species, colored bars represent 
combined fractions (right) Subsequent reinjection into a UPLC shows peaks do not recenter, analogous to 





Figure B2. NMRs of G5-MFCOn. Ratio between acetylated peak at 1.9 (3 protons per each of 93 primary amines 
as determined by potentiometric titration) compared to 5 protons between 1.5 and 1.3 on MFCO ligand. 
n avg (by NMR) avg (by UPLC) % Purity (UPLC) % Recovered 
0 0.0 0.0 >95% 47% 
1 1.0 1.0 >95% 58% 
2 2.0 2.0 >95% 77% 
3 2.8 3.0 >95% 46% 
4 3.4 4.0 >95% 43% 





Figure B3. NMRs of G5-Aziden. Ratio between acetylaed peak at 1.9 and the aromatic peaks of the azide ligand. 
 
 
n avg (by NMR) avg (by UPLC) % Purity (UPLC) % Recovered 
0 0.0 0.0 >95% 59% 
1 1.0 1.0 >95% 70% 
2 2.0 2.0 >95% 41% 
3 2.5 3.0 >95% 38% 
4 3.5 4.0 >95% 33% 















H-NMR of G5-Ac-COG4.0(avg) in D2O. The peak at 1.97 ppm is the acetyl peak for the 
dendrimer arm, equal to 93*3-x (93 is the number of arms on G5 monomer, 3 protons per acetyl group, and 
x being number of arms functionalized with COG). The multiplet at 4 ppm should integrate to 5 protons per 









Table C1. G5-Ac-COGx Isolation Results 
1H-NMR values are skewed, especially at higher valencies, because they assume that each 
dendrimer in the population has the same number of primary amines. However, branching 
defects have been shown to contribute to the peak width observed in rp-HPLC. Additionally, all 
work to date shows that the “more perfect” dendrimer (i.e. with more arms and less defects) is 
better retained on the column. Therefore, at higher valencies, when a more narrow set of 
fractions is collected to maintain high sample purity, the number of end groups per dendrimer is 
decreased by an undetermined amount. 
 
Figure C3. UPLC of starting materials (dotted lines), and click products at 285 nm (yellow lines) and 210 




Figure C4. NMR of click products in D2O for n=1.0 (red), 1.2 (orange), 1.9 (green), 2.7 (blue) from bottom 
to top. The peak at 8.6 ppm should integrate to 1 proton per MTX on the dendrimer, and the peaks at 7.7 




Figure C5. Individual flow cell chromatograms for low density chip. (a) n = 0, FC1 (b) n = 0, FC2 (c) n = 
1.0, FC1 (d) n = 1.0, FC2 (e) n = 1.2, FC1 (f) n = 1.2, FC2 (g) n = 1.9, FC1 (h) n = 1.9, FC2 (i) n = 2.7, 




Figure C6. Individual flow cell chromatograms for high density chip. (a) n = 0, FC1 (b) n = 0, FC2 (c) n = 
1.0, FC1 (d) n = 1.0, FC2 (e) n = 1.2, FC1 (f) n = 1.2, FC2 (g) n = 1.9, FC1 (h) n = 1.9, FC2 (i) n = 2.7, 




Figure C7. SPR chromatograms (solid lines) on the low density chip overlaid with the four proposed fits 
(dotted lines). (a) n = 1.0, 1.25 µM (b) n = 1.0, 2.5µM (c) n = 1.0, 5 µM (d) n = 1.0, 10 µM (e) n = 1.0, 20 
µM (f) n = 1.2, 1.25 µM (g) n = 1.2, 2.5µM (h) n = 1.2, 5 µM (i) n = 1.2, 10 µM (j) n = 1.2, 20 µM (k) n = 
1.9, 1.25 µM (l) n = 1.9, 2.5µM (m) n = 1.9, 5 µM (n) n = 1.9, 10 µM (o) n = 1.9, 20 µM (p) n = 2.7, 1.25 




Figure C8. SPR chromatograms (solid lines) on the high density chip overlaid with the four proposed fits 
(dotted lines). (a) n = 1.0, 1.25 µM (b) n = 1.0, 2.5µM (c) n = 1.0, 5 µM (d) n = 1.0, 10 µM (e) n = 1.2, 1.25 
µM (f) n = 1.2, 2.5µM (g) n = 1.2, 5 µM (h) n = 1.2, 10 µM (i) n = 1.9, 1.25 µM (j) n = 1.9, 2.5µM (k) n = 








Figure C9. Sensograms generated during chip immobilizations. (a) Low density chip, FC1 (protein RUs: 




Synthesis of COG Ligand 
Synthesis of 8,8-dibromobicyclo[5.0.1]octane (S1). In an oven dried flask under nitrogen, 
cycloheptene (4.43mL, 38mmol, 1.0equiv.), potassium tert-butoxide (8.52g, 76mmol, 
2.0equiv.), and anhydrous hexanes (9mL) was added together. Mixture was stirred and 
cooled to -10C in an ice/acetone bath. Once to temperature, bromoform (4.9mL, 
57mmol, 1.5 equiv.)was added dropwise. Once the mixture appears as a milky brown 
color, it was brought to room temperature (25C) and stir overnight.  Water (50mL) was 
added and the mixture was acidified with concentrated hydrochloric acid. Extract with 
ethyl acetate (3x20mL) and wash with water (3x20mL). Mixture was dried with MgSO4, 
filter, and solvent was removed under reduced pressure. No further purification necessary 




Scheme C1. Synthesis of Methyl-2-bromocyclooct-1-en-3-glycolate. 
Synthesis of Methyl-2-bromocyclooct-1-en-3-glycolate (S2): In an oven dried flask 
under nitrogen, anhydrous toluene (5.0mL), S1 (2.50g, 9mmol, 1.0equiv.), and methyl 
glycolate (6.35mL, 84mmol, 9equiv.) were added. Mixture was stirred at room 
temperature (25C) and flask was covered with aluminum foil. Silver perchlorate (3.85g, 
19mmol, 2 equiv.) was added to reaction flask and stirred for 90minutes. Silver salts 
filtered out and washed with ethyl acetate. Remove solvent under reduced pressure and 
immediately chromatograph using 2-15% ethyl acetate:cyclohexanes to produce a yellow 








Synthesis of cyclooct-1-yn-3-glycolic acid (S3): In an oven dried round bottom flask 
under nitrogen, Suspension of sodium methoxide (0.0278g, 0.5mmol, 0.5 equiv.) in 
DMSO (5mL) was made and S2 (0.2866g, 1mmol, 1.0equiv.) and DMSO (1mL) was 
addded. Stir at room temperature for 15 minutes. Additional sodium methoxide (0.0835g, 
1.5mmol, 1.5 equiv.) and DMSO (0.5mL) was added and mixture stirred until reaction 
was completed (determined by TLC). Water was added (0.3mL) and solution stirred for 
one hour. Reaction was acidified with 1.0M HCl solution. Extract with ethyl acetate 
(2x25mL). Organic Layer was dried over MgSO4, filtered, and removed solvent in vacuo. 































Figure D1. ITC results for (a) stochastic average G5-Ac-
(MFCO-MTX) and (b) high average G5-Ac-(MFCO-MTX) 






Figure D2.  Individual flow cell data for dendrimer CO-MTX conjugates. (a) G5-Ac-(COG-MTX)0.9 
FC1 (b) G5-Ac-(COG-MTX)0.9 FC2 (c) G5-Ac-(COG-MTX)1.9 FC1 (d) G5-Ac-(COG-MTX)1.9 FC2 
(e) G5-Ac-(COG-MTX)2.9 FC1 (f) G5-Ac-(COG-MTX)2.9 FC2 (g) D-Ac-(COG-MTX)1.1  FC1 (h) D-
Ac-(COG-MTX)1.1   FC2 (i) D-Ac-(COG-MTX)2.0  FC1 (j) D-Ac-(COG-MTX)2.0   FC2 (k) D-Ac-




Figure D3. SPR sensograms for dendrimer-MFCO-MTX conjugates show negative binding phases, 
corresponding to high nonselective binding in FC2. 
  
Figure D4. Free MTX is detected by absorbance at 285 nm (orange lines) but less so at 210 nm (purple 





Figure D5. Cytotoxicity of (a and b) monomer (n = 1.0, red; n = 1.7, orange; n = 2.7, green; n = 4.4, 




Figure D6. Comparison of UPLC chromatograms (210 nm) of click reaction starting materials 






H-NMR of G5-(COG-MTX)n, for n=0.9 (red), 1.9 (orange), and 2.9 (green). 
Figure D8. 
1






H-NMR of G5-(MFCO-MTX)n, n=1.0 (red), 1.7 (orange), 2.7 (green) and 4.4 (blue). 
Figure D10. 
1
H-NMR of D-(MFCO-MTX)n, n=1.1 (red), 2.1 (orange), and 4.4 (green). 
